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DNA is the main carrier of inheritance and DNA damage will thus have serious consequences. 
DNA double-strand breaks (DSB) are amongst the most lethal forms of DNA damage. One DSB 
can lead to catastrophic consequences including cancer and cell death. To fix it, there are two 
main mechanisms-- homologous recombination (HR) and non-homologous end joining (NHEJ). 
 
My PhD project focuses on NHEJ. Unlike HR, NHEJ is not limited by the cell cycle as it does not 
require a template for recombination. Also, NHEJ has been shown to be the preferred DSB 
repair pathway in higher eukaryotic organisms including human. NHEJ is dynamic and flexible 
but can be separated into three steps - DNA end recognition, end synapsis and processing, 
and end ligation. The main objective of my project is to understand the interaction in the 
complex between DNA-PKcs and Artemis, which is the major nuclease in the step of end 
synapsis and processing to help clean up the modified DSB ends caused by external factors 
including ionizing radiation. It is also the only discovered human endonuclease cleaving 
hairpin DNA, which is indispensable in V(D)J recombination— a mechanism that provides the 
immunodiversity of antibodies and T-cell receptors.  
 
During my PhD, I purified Artemis and DNA-PKcs, conduct biochemical and biophysical 
characterisation of these proteins and used cryo-electron microscopy (cryo-EM) as the main 
structural method. The nuclease assays for investigation of endonuclease activity targeting 
hairpin DNA revealed that XLF and XLF/XRCC4 have a stimulating effect on the endonuclease 
complex without and with Ku. Moreover, I have identified the region of Artemis interacting 
with DNA-PKcs and collected cryo-EM data for complexes of DNA-PKcs with different Artemis 
constructs, revealing the interaction mode between DNA-PKcs and Artemis. In addition, I 
further explored the cryo-EM structure of the DNA-PKcs to provide a firmer ground for 
modelling and the related complex study. 
 
A part of my PhD project focuses on the preliminary drug discovery of Artemis/ DNA Ligase IV 
complex. An intrinsically disordered Artemis C-terminal peptide interacts with DNA Ligase IV 
through concerted folding, showing a site that can be most easily targeted by small molecules. 
Therefore, during my PhD, different constructs of DNA Ligase IV have been screened and the 
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fragment-based drug discovery approach was initiated to provide chemical tools or candidate 
drug molecules to inhibit the Artemis-DNA Ligase IV binding site. Moreover, collaboration 
work with the Strick group enabled us to monitor the temporal organisation of NHEJ using 
the single-molecule method, which identified the function of PAXX as an early participating 
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Chapter 1. Introduction  
 
1.1 DNA, DNA Damage and DNA Double-Strand Break 
 
Deoxyribonucleic acid (DNA) is the main carrier of inheritance. It was first isolated and 
identified in the 1860s by Friedrich Miescher, followed by works of other scientists including 
Phoebus Levene and Erwin Chargaff to reveal more Chemistry details. Based on the previous 
Chemistry understanding and the X-ray diffraction pattern of DNA from Maurice Wilkins and 
Rosalind Franklin, in 1953 James Watson and Francis Crick proposed the structure of DNA. As 
the substance of inheritance, DNA encodes genes, which are the basic functional and physical 
units of heredity (https://ghr.nlm.nih.gov/primer/basics/gene). It was estimated by the 
Human Genome Project that there were around 20000 genes coding proteins but the number 
has subsequently decreased to 19000. Despite of the complicated interpretation and 
connection between the molecular basis of inheritance (DNA) and the functional unit of 
inheritance (gene), there was a clear cycle and flow of genetic information from DNA to RNA 
to protein. This was first proposed by Francis Crick in 1957 as the “central dogma” of 
molecular biology. As the starting point and the heart of the central dogma, DNA plays a 
fundamental role in maintaining normal phenotype and passing on genetic information to 
new cells. Cells have developed a series of mechanisms to avoid DNA from being mistakenly 
interrupted as DNA damages or misrepair can easily lead to genome instability due to 
interrupted genetic information, causing abnormal pathological phenotype. 
 
However dangerous they are, DNA damages happen all the time caused by external factors 
around us and internal factors within us. External factors include UV radiation and chemical 
reagents, tobacco smoke for example, and internal factors include replication-fork collapse, 
reactive oxygen species and self-controlled DNA editing and recombination, V(D)J 
recombination for example. It was estimated that one cell could experience over 1,000,000 
DNA changes per day (Lodish, 2000). 
 
In general, there are five types of DNA damage - base loss or modification, 
mismatch/nucleotide insertion and deletion, crosslink, DNA single-strand break and DNA 
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double-strand break. Base loss and modification are the most frequent DNA damage in cells 
mainly caused by external UV light. Mismatch/nucleotide insertions and deletions are mainly 
caused by errors during DNA replication process.  Crosslinks are damages of DNA caused by 
reagents reacting with two nucleotides of DNA on the same strand (intra-strand crosslink) or 
between the two strands (inter-strand crosslink). As the name suggests, DNA single-strand 
break (SSB) has one strand of phosphate backbone damaged and can be caused by 
topoisomerase, while DNA double-strand break (DSB) involves breaks in the phosphate 
backbones of both complementary DNA strands. 
 
Among all the types of DNA damage, DSBs are the most lethal. Unrepaired or misrepaired 
DSBs will cause significant loss of genetic information and disruption of genome stability, 
resulting in a series of consequences including cell death and carcinogenesis. All DSBs can be 
divided to two types, pathological DSB and physiological DSB, and there are various sources 
for different types of DSB.  
 
In the case of pathological DSBs, the DSB is mainly developed from SSB. For example, ionizing 
radiation is a main exogenous factor for DSB. It stimulates the production of radiolysis radicals 
in the cell that would further attack the phosphate backbone of DNA and lead to a SSB (Ward, 
1994; Thompson, 2012). When the dose of the ionizing radiation is high, it is likely that two 
SSBs could happen on the two complementary DNA strands. When those SSBs are close 
enough, for example in the range of one helical turn, they will result in DSBs (Milligan et al., 
1995). To have one such DSB, roughly 10 SSBs are produced by ionizing radiation (Ma et al. 
2012). Moreover, pathological DSBs could be developed from SSBs in normal cellular 
processes. For example, a nick in one strand of DNA could easily develop into a DSB during 
DNA replication.  Actually, the majority of the spontaneous DSBs are developed during DNA 
replication (Syeda, Hawkins and McGlynn, 2014).  
 
Unlike pathological DSBs, physiological DSBs are mainly spontaneous DSBs cleaved on 
purpose by the cell. Those programmed DSBs are designed for self-controlled genome editing 
to increase diversity. A good example is our immune system, which produces the dangerous 
DSBs and makes full use of it to increase the variety of immune responses. Two important 
processes of our immune system under this scenario are the V(D)J recombination and class 
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switch recombination (CSR), creating diversity of antibodies and T cell receptors. In addition 
to the immune system, DSBs are also induced for recombination of homologous 
chromosomes from different parental origins during the sexual reproduction (Lam and 
Keeney, 2015). During this recombination, hundreds of DSBs are made by a meiosis-specific 
and topoisomerase-II-like endonuclease, Spo11, at non-random hotspots (Keeney, 2008). 
Moreover, recent research indicated that programmed DSBs also exist in stimulated mouse 

























1.2 Human DSB Response 
 
Although DSBs are not rare and can lead to catastrophic consequences in our cells, there is a 
highly regulated and delicate system that efficiently senses, controls and repairs all DSBs. The 
system is known as the DSB response. 
 
Generally, the DSB response is complicated and covers many physiological processes, but can 
be separated into three steps including DSB sensing, signal transducing and effecting, as 
previously proposed (Jackson, 2002). Cells first respond to DSBs by detecting them through a 
series of DSB binding proteins (sensors). The sensors then recruit and activate a list of 
transducers, which are kinases that amplify the signal through the protein kinase cascade and 
diversify the original signal of one DSB to many downstream proteins, known as effectors, 
that moderate all kinds of activities including apoptosis, cell cycle control, transcriptional 
regulation, increased dNTPs level and the DSB repair. 
 
Three main sensor-and-transducer pathways are involved in response to DNA DSB, including 
the RPA- ATRIP/ATR pathway, the MRN- ATM pathway and the Ku70/80- DNA-PKcs pathway 
(Blackford and Jackson, 2017). All the three kinases (ATR, ATM and DNA-PKcs) belong to the 
family of phosphoinositide 3-kinase (PI3K)-related kinases (PIKKs) and share similar structural 
features. For example, the kinase domains of all three members are located at the C-terminal 
region with an upstream FRAP-ATM-TRRAP (FAT) domain and a downstream FAT C-terminal 
(FATC) domain (Bosotti, Isacchi and Sonnhammer, 2000; Mordes et al., 2008). Also, their 
whole N-terminal regions before the FAT domain are composed of helical solenoid HEAT 
repeat domains at different lengths, which regulate the protein-protein interactions of PIKKs 
with other DSB-response components (Perry and Kleckner, 2003).  
 
In the case of the MRN- ATM pathway, the MRN (MRE11-RAD50-NBS1) complex first binds to 
the DNA ends at DSBs. ATM is then recruited to the DSB site via the C terminus of NBS1. The 
mechanism of the activation of ATM kinase activity remains unclear. It was proposed that the 
MRN complex recruits and activates ATM at the DSB sites as the MRN complex could activate 
the kinase activity of ATM in vitro (Lee and Paull, 2004, 2005). However, there are also cases 
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of MRN/DSB-independent activation of ATM kinase activity under the circumstances of 
oxidative stress or chromatin changes (Guo et al., 2010; Olcina et al., 2013).  
 
Although the mechanism of ATM stimulation remains uncertain, it is certain that ATM 
phosphorylates various kinds of proteins, at the level of hundreds, after stimulation 
(Matsuoka et al., 2007).  It is not understood how many substrates are functionally important 
but some downstream pathways are proven to be significant for the ATM-induced DDR 
(Maréchal and Zou, 2013). For example, to amplify the signal, ATM initiates the kinase cascade 
via phosphorylating other protein kinases including CHK2 kinase. CHK2 kinase could further 
phosphorylate cdc25, which is a phosphatase that becomes downregulated when 
phosphorylated by CHK2 kinase. The down regulation of Cdc25 will keep the Cdk (cyclin-
dependent kinase) at the phosphorylated deactivated status, interfering with progress 
through cell cycle. The activated CHK2 could phosphorylate the tumour suppressor p53, 
leading to induction of p21. The upregulation of p21 will further inhibit the activity of Cdk and 
slow down the cell cycle.  
 
Unlike ATM that targets at the double-strand sites, ATR sits on the single-strand sites of DSB 
and is the DDR kinase involved in the DNA replication stress response. ATR is recruited by its 
partner protein ATRIP, which comes to the single-strand DSB sites via the interaction with 
replication protein A (RPA) after RPA binds to single-strand DNA directly to form the RPA-
coated ssDNA (Zou and Elledge, 2003). After recruitment to DSB sites, ATR kinase activity is 
further stimulated by other activator proteins, including TopBP1 and ETAA1.  
 
Like ATM, activated ATR also phosphorylates a series of proteins, many of which are also 
substrates of ATM, indicating that while the upstream situations of DSBs may vary, the 
downstream pathways may finally converge to have similar responses. A good example is the 
phosphorylation of checkpoint kinase and the effect of slowing or stopping cell-cycle 
progression. ATR first phosphorylates and stimulates CHK1 (Hekmat-Nejad et al., 2000; Guo 
et al., 2000; Liu et al., 2000; Zhao and Piwnica-Worms, 2001). The activated CHK1 then 
phosphorylates Cdc25A, which will result in its proteasomal degradation. Without Cdc25A, 









Figure 1. DNA double-stranded break damage response (Modified from Figure 2 of Blackford and 
Jackson 2017). Different factors can result in DNA DSBs and there are three main pathways that might 
respond including Ku/DNA-PKcs, MRN/ATM and RPA/ATRIP/ATR. Downstream effectors of the three 
pathways will lead to a series of responses including DNA repair, cell cycle control, transcriptional 
regulation, senescence and apoptosis.  
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DNA-PKcs, unlike ATM and ATR, is more directly involved in a DSB-repair pathway called non-
homologous end joining (NHEJ). It is recruited to DSB sites via the interaction with Ku80 C-
terminal domain (CTD) of Ku70/80 complex, which binds to double-strand DNA ends directly 
with a high binding affinity (Dvir et al., 1992; Gottlieb and Jackson, 1993). Although the 
molecular mechanism of the activation of kinase activity needs further investigation, DNA-
PKcs becomes activated when interacting with Ku70/80 and DNA, phosphorylating a series of 
proteins including many of the NHEJ components including itself. However, it remains unsure 
if the phosphorylation of those components except of itself is important for NHEJ.  
 
Moreover, activated DNA-PKcs also phosphorylates a few of ATM/ATR substrates. For 
example, DNA-PKcs regulates the phosphorylation of H2AX and has an effect on cell-cycle 
progression (An et al., 2010). However, the downstream DDR pathways of DNA-PKcs, except 
for DSB repair, are not as clear and extensively studied as those of ATM and ATR. It was 
recently shown that DNA-PKcs regulates the DNA damage response through inhibitory 

















1.3 Human DSB Repair Pathways 
 
To repair DSBs, there are two main mechanisms in our cells-- homologous recombination (HR) 
and non-homologous end joining (NHEJ) (Chang et al., 2017). There are also two minor and 
intrinsically mutagenic pathways called alternative end joining (alt-ER) and single-strand 
annealing (SSA), which will not be discussed in detail in this thesis. As the name implies, a 
homologous template (sister chromatin) is needed for HR to make sure the DSB is repaired 
correctly using the other intact double-strand DNA. While in the case of NHEJ, the two ends 
of DSB are directly joined together without any template, it is important for the cell to fix the 
DSBs using the appropriate pathway and the decision of this process is not fully understood 
but there are several proposals as to how our cells make this decision.  
 
At the cellular level, the pathway choice of DSB is highly connected to the cell cycle phase. 
NHEJ is functional throughout the whole cell cycle except for M phase, while HR is limited to 
the S/G2 phase when sister chromatin is available.  
 
At the molecular level, there are two pathways— one by BRCA1/CtIP and the other by 53BP1 
that promote HR (DNA end resection) and NHEJ (DNA end protection) respectively. When 
53BP1 comes to the DSB site through the interaction with the modulated histone markers of 
the ubiquitylated K15 of H2A-type histones, it can be phosphorylated by kinases including 
ATM (Fradet-Turcotte et al., 2013). RIF1 then binds to the phosphorylated 53BP1, suppressing 
the repositioning of 53BP1 and making the chromatin region too compact for other nucleases 
to come close (Chapman et al., 2013). This limits the DNA end resection for HR and directs 
the pathways to NHEJ. BRCA1 can antagonize 53BP1 in different ways. For example, BRCA1 
could promote a phosphatase called PP4C, which could further dephosphorylate 53BP1 and 
release the binding of RIF1 (Isono et al., 2017). 53BP1 could then reposition on the chromatin, 
to allow nucleases including EXO1 to do the resection of DNA end for HR or other pathways 
that require DNA end resection including single-strand annealing (SSA) and alternative end 
joining (alt-EJ) (Ceccaldi, Rondinelli and D’Andrea, 2016). In addition to the marker of H2AX, 
recent research showed that the methylation of H4K20 also plays a role in DSB-pathway 
decision as H4K20me0 can be recognised by ARD of BARD1, which is in complex with BRCA1 
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(Nakamura et al., 2019). However, 53BP1/RIF1 can bind to the site of H4K20me2, leading to 
the process of NHEJ (Botuyan et al., 2006; Greeson et al., 2008).  
 
Also, the pathway choices can be connected with DNA-end types. When one-end DSBs are 
formed at the replication fork, HR is the main pathway to fix them. However, interestingly, in 
the G2 phase when two-end DSBs occur (i.e. caused by IR), NHEJ dominates the repair process, 
fixing around 70% of them, while HR takes charge of repairing the rest 30% despite the 
opinion that HR is more accurate and secure and NHEJ is more error prone and mutagenic 
(Shibata et al., 2011). In fact, NHEJ is highly efficient and accurate under most of the cases 





Figure 2. Human DNA DSB repair pathways (Modified from Figure 4 Chang et al., 2017). There are 
four DSB-repair pathways in total: non-homologous end joining (NHEJ), homologous recombination 
(HR), alternative end joining (a-EJ) and single-strand annealing (SSA). Among the four pathways, NHEJ 
and HR are the dominant pathways responsible for most DSB repair and will be further introduced 
in following chapters. SSA and a-EJ pathways are minor and mutagenic pathways that will not be 
discussed. 
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1.3.1 Homologous Recombination  
Homologous recombination (HR) can be divided into three main steps- end resection, Rad 51 
assembly and stand invasion and resolution of the intermediate. It starts with the DNA end 
resection to produce 3’ single-strand DNA (ssDNA). This initial step involves many proteins, 
including MRN, CtIP, EXO1 and BLM (Sartori et al., 2007; Nimonkar et al., 2011). The trimmed 
3’ ssDNA can then become a good binding partner for Rad51, which is a DNA-dependent 
ATPase, to form nucleoprotein filament. However, the ssDNA is firstly bound by the 
replication protein A (RPA) (Zelensky, Kanaar and Wyman, 2014). To facilitate the formation 
of Rad51-DNA complex, many mediator proteins are required. Basically, BRCA1 recruits 
BRCA2 through the binding partner PALB2 (Xia et al., 2006; Sy, Huen and Chen, 2009; Zhang 
et al., 2009). BRCA2 then promotes the binding of Rad51 to ssDNA while removing RPA 
(Zelensky, Kanaar and Wyman, 2014). The defining step of HR is that 3＇Rad51-ssDNA 
complex will invade into a homologous duplex, forming the strand invasion intermediate (D 
loop) (Jasin and Rothstein, 2013). The invading  3＇ssDNA is used as a primer and extended 
by DNA polymerase to copy the missing information from the unbroken homologous duplex.  
 
The D loop will later be resolved in several ways, which will not be introduced in detail here, 
leading to the final result of noncrossover (NCO) or crossover (CO) (Klein and Symington, 
2012). Generally, the resolution of the intermediate, which may be regulated by the cell cycle 
(Matos et al., 2011), is complicated, involving many proteins including BLM/TOP3α /RMI1 
complex, MUS81/EME1 complex, GEN1 and SLX1/SLX4 (Wu and Hickson, 2003; Ho et al., 2010; 
























Figure 3. Schematic diagram of homologous recombination.  
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1.3.2 Non-Homologous End Joining  
As mentioned, non-homologous end joining (NHEJ) is one of the main DSB repair pathways 
and the preferred repair pathway in humans and other higher-level organisms including 
vertebrates. It is highly dynamic and has many components used for different types of DSBs. 
However, no matter how complex the process of NHEJ may be, it can be summarised in terms 
of temporal organisation and categories of proteins involved. 
 
The temporal organisation is usually separated into three mains steps: end recognition, end 
synapsis/bridging and processing, and end ligation (Liang et al., 2017; Reid et al., 2015; Ochi, 
Wu and Blundell, 2014).  
 
The first step, end recognition, is the starting point where the DSB site is located. Ku70/80 
first binds to the DSB ends and recruits DNA-PKcs via the C-terminal domain (CTD) of Ku80 to 
form the holoenzyme of DNA-PK (DNA, Ku70/80 and DNA-PKcs) (Lieber, 2010). DNA-PKcs then 
becomes activated and phosphorylates other downstream proteins and itself, also recruiting 
some other components including Artemis, which is one of the major nucleases involved in 
NHEJ (Chang and Lieber, 2016). 
 
The second step, end synapsis/bridging and processing, is to make sure the DNA ends are 
spaciously closed together for further ligation when they are ligable. This is also the most 
dynamic and complex step. DNA-PK molecules interact with each other and can form synapsis 
(DeFazio et al., 2002; Ma et al., 2004; Spagnolo et al., 2006). A recent single-molecule study 
has also demonstrated that PAXX can also be involved in the end synapsis together with DNA-
PK (Wang et al., 2018).  Moreover, a crystallisation and EM study showed that XLF/XRCC4 can 
form elastic and flexible long filaments, which may be helpful for DNA bridging especially 
when the DSB ends are distant apart (Roy et al., 2012a; Mahaney et al., 2013). Sometimes, 
the ends are damaged or not ready for ligation. For example, there are usually many 
modifications including crosslinks or base modifications in the cases of DSBs caused by 
ionizing radiation. Another classical example is the V(D)J recombination process where the 
physiological DSBs are produced for the recombination of V/D/J segments (Roth, 2014). 
RAG1/2 complex comes to the flanking region of the targeted segments and cleaves the DNA 
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to create hairpin ends, which cannot be ligated and needs an endonuclease named Artemis 




Figure 4. Non-homologous end joining (NHEJ) temporal and spatial organisation. (A) Temporal 
organisation of NHEJ: NHEJ can be divided into three steps—end recognition, end synapsis/bridging 
and processing, and end ligation; (B) Spatial organisation of NHEJ: Main components of NHEJ are 
labelled in the network. A blue label means that the structure of the protein or a part of the protein is 
known while a black label means unknown. An arrow indicates binary interaction. A green arrow 
means that the structure of the protein complex is known while grey arrow means that there is no 
structural information of the complex. 
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The third and final step of NHEJ, end ligation, involves joining the two broken ends, and 
mediated by the NHEJ ligase complex: DNA ligase IV, XRCC4, and XLF. XLF and XRCC4 can 
affect the activity and stability and more details will be introduced later in the thesis. It is also 
possible that the newly discovered protein PAXX is playing a role in the NHEJ, as it is 
structurally homologous to XRCC4 and XLF (Ochi et al., 2015). It is kown that PAXX functions 
with XLF and XRCC4 to regulate the progress of NHEJ. Moreover, PAXX can increase the 
synapsis duration by 7 times when added to the Ku/DNA-PKcs/XRCC4/XLF/Ligase IV reaction 
system (Wang et al., 2018).  
 
From the perspective of the categories of proteins involved in human NHEJ, there are five 
classes of proteins: the DNA-PK complex, the nucleases, the polymerases, the ligase complex 
and others. The DNA-PK complex and ligase complex were mentioned previously in the NHEJ 
temporal organisation and as they are indispensable for the process while the other kinds of 
protein may be involved in NHEJ under different conditions. 
 
The nucleases involved in NHEJ mostly are helping to resection the 5ʹ or 3ʹ overhang by the 
exonuclease or endonuclease when the ends are incompatible. This will expose or generate 
small regions of nucleotides (usually 2-4) with microhomology between two DNA strands to 
facilitate the end ligation. As mentioned previously, Artemis is the major nuclease involved in 
NHEJ. Around 20%- 50% of the DSBs caused by ionizing radiation need Artemis for repair 
(Chang and Lieber, 2016). Other nucleases that may contribute in this process include but not 
be limited to the aprataxin and PNKP-like factor (APLF), ERCC1, ERCC4 (XPF), and exonuclease 
1 (EXO1). 
 
The polymerases participating in NHEJ have 4 members: Pol λ, Pol μ, TdT, Pol θ. They all 
belong to a subfamily of DNA polymerases: Pol X family polymerases. Although it is now 
recognised that NHEJ is actually efficient and generally accurate, the polymerases can 
introduce extensive mutations. 
 
Other NHEJ components are required in NHEJ mainly due to the need to modify the DNA ends. 
For example, polynucleotide kinase (PNKP) is needed when the 5ʹ end is missing the 
phosphate group and requires phosphorylation. In human, PNKP is also a phosphatase. It 
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could also remove phosphate on the 3ʹ ends that are caused by some oxidative damages 
(Bernstein et al., 2005). Sometimes, DNA ligase IV does not complete the ligation and forms 
an intermediate product where an AMP group is still covalently bound to the 5ʹ-end of one 
strand of the DSBs. Under this circumstance, an enzyme called aprataxin is needed to cleave 
the AMP group (Ahel et al., 2006). Moreover, Tyrosyl DNA phosphodiesterase 1 (TDP1) is the 
only enzyme that is currently known to process the process 3ʹ-phosphoglycolates (3ʹ-PGs) 
(Kawale and Povirk, 2018).  3ʹ-PGs is a common damage of DSB caused by ionizing radiation, 
accounting for 10% of all the IR-induced DSB (Zhou et al., 2005). 
 
Although NHEJ is complicated with numerous components involved in different 
interacting/processing steps, certain NHEJ components are central to the process and 
relevant to the background of this PhD thesis. I will therefore give an introduction to these 






















Ku70/80 is a protein complex composed of two proteins, Ku70 (69kDa) and Ku80 (83kDa), 
which have similar topology and form together a ring structure that binds DNA double helices 
at double-strand breaks (Figure 5).  
 
Each protomer has a N-terminal α/β domain, belonging to the von Willebrand (vWA) family, 
which is made up of a six-stranded β sheet in a Rossman fold (residues 35-251 in Ku70; 
residues 8-165 in Ku80).  This is followed by a ß-barrel central domain (residues 257-436 in 
Ku70; residues 199-423 in Ku80) and an ARM domain (residues 440-528 in Ku70; residues 
427-542 in Ku80) (Walker, Corpina and Goldberg, 2001). In the case of Ku70, the globular SAP 
(SAF-A/B, Acinus and PIAS) domain (559-609) forms a three-helical bundle at the C terminus 
(Zhang et al., 2001). The C-terminal region of Ku80  has a linker between the N-terminal 
globular domain/ core domain and a C-terminal 6-helical bundle (595-704), which is followed 
by a conserved region at the C terminus (721-732) that interacts as a helix with DNA-PKcs 
recruiting it to the DNA damage site (Zhang et al., 2004).  
 
Ku70/80 is one of the most important components in NHEJ and has homologues in yeast and 
some bacteria (Matthews and Simmons, 2014; Emerson and Bertuch, 2016). The homologues 
in bacteria are much smaller at 30-40 kDa than Ku70/80. In addition, unlike Ku70/80, the 
bacterial homologues have only the central domain, which is mainly the heterodimerization 
region, without the vWA domain and C-terminal domain (Pitcher, Brissett and Doherty, 2007). 
 
In the Ku70/80 complex, the vWA, the ß-barrel central and the ARM domains together form 
the globular domains of the complex. The heterodimerisation of the complex is mediated by 
the central domain, of which the extended loops and α helices form the interconnected ß-
strands (ARM). The ring structure has a positively-charged inner surface that binds DNA of 
minimum length 14bp (Walker, Corpina and Goldberg, 2001). Ku70/80 binds to DNA double-
strand break ends strongly with affinity in the nM range. Although it was proposed that the 
SAP domain may play a role in the interaction with DNA, the C-terminal domain does not 
contribute to the binding affinity to DNA (Frit et al., 2019). Furthermore, there is no sequence 
specificity of Ku-DNA binding. Although it does not bind to some specific DNAs including 
circular DNA, linear single-strand DNA and supercoil DNA, Ku70/80 can bind to various DNA 
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double-strand ends including blunt ends, DNA ends with short 5ʹ and 3ʹ overhang, DNA hairpin, 
cisplatin and damaged DNA ends caused by ionising radiation (Ono et al., 1994; Turchi and 
Henkels, 1996; Pang et al., 1997; Walker, Corpina and Goldberg, 2001; Arosio et al., 2002).  
 
Figure 5. Structure of Ku70/80 complex (Modified from Figure 1 of Wu et al., 2019). [A] Schematic 
diagram of Ku70 and Ku80- Both Ku70 and Ku80 have a similar structural organisation of a core 
region (including vWA domain, ß-barrel domain and the ARM domain) and the C-terminal region 
(CTR); [B] Crystal structure of Ku70/80 core region in complex with DNA (Walker et al., 2001) and 
the NMR structure of the Ku80 CTR globular domain (Zhang et al., 2004).  
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The roles of the two vWA domains are not fully understood. The Ku80 vWA domain plays a 
role in the binding of many other Ku-binding proteins, containing the Ku-binding motifs (KBM) 
including APLF, XLF, WRN and CYREN (Li and Comai, 2000, 2001; Grundy et al., 2012, 2016; 
Rulten and Grundy, 2017; Nemoz et al., 2018). These protein-protein interactions play 
important physiological role. The binding of Ku with APLF and XLF can promote the accuracy 
and efficiency of NHEJ (Nemoz et al., 2018). The interaction between Ku80 and WRN regulate 
the pathway choice between NHEJ and alt-EJ (Shamanna et al., 2016). CYREN (cell-cycle 
regulator of NHEJ) is an NHEJ inhibitor at the deprotected telomeres to prevent chromosome 
joining in the S and G2 phases (Arnoult et al., 2017). Although no structure is available, it was 
shown that the N-terminal KBM of CYREN binds to Ku and can be displaced from Ku by an 
excess of APLF A-KBM, indicating that CYREN is binding to the same site of Ku80 vWA (Grundy 
et al., 2016). The interaction between CYREN N-terminal KBM and Ku80 inhibits NHEJ. The 
function of Ku70 vWA domain, on the other hand, is not as well defined as that of Ku80. 
Mutated Ku70 S155/D156 helps to increase the survival rate following the IR treatment; in 
fact the S155A mutation on its own is sufficient to increase the survival rate while the 
phosphomimetic mutation (S155D) was able to reverse the effect via controlling the 
activation of transcriptional factor 2 (ATF2) and the downstream apoptosis pathway (Fell and 
Schild-Poulter, 2012). This indicates that the Ku70 vWA domain may play a regulatory role in 
signalling of the DDB but the mechanism remains unclear. 
 
The role of the C-terminal domains (CTD) also remains unclear. Ku70 CTD has been proposed 
to be involved in DNA binding both through the flexible linker region (536–560) and the last 
10 amino acid residues (600-609) (Chou et al., 1992; Wang, Dong and Reeves, 1998). In the 
case of Ku80, the NMR structure of the six-helical bundle of C-terminal domain showed that 
the conserved residues clustered on two major surface regions, indicating that this domain is 
involved in protein-protein interaction (Zhang et al., 2004). However, 15 years after the 
structure was solved, the interaction partner still remains unclear as is the function of the six-
helical bundle. The last helix  of 12 amino-acid residues at the C terminus of Ku80 interacts 
specifically with DNA-PKcs and plays a role in activating the DNA-PKcs kinase activity, which 




An important question about the Ku70/80 complex is how and when it binds to and moves 
away from DNA ends. Ku is known to bind strongly to the DNA ends on its own, providing the 
first step in NHEJ. PARP1 may be a regulator of Ku binding to DNA as Ku70/80 dominates the 
DSB ends in the G1 phase, while PARP1 later competes with Ku70/80 in the S and G2 phases 
(Yang et al., 2018). Moreover, through its enzymatic activity, PARP1 removes Ku70/80 in S/G2 
phase (Yang et al., 2018). Ku is recruited to the DSB sites rapidly but only stays there for a 
short period of time as the Ku signal decreases steadily a few hours after the initial damage 
in laser microirradiation experiments (Kim et al., 2005; Mari et al., 2006). It is unlikely that the 
Ku70 and Ku80 dissociate from DNA due to the high affinity of binding and the structure of 
Ku70/80 in complex with DNA does not reveal any possible releasing conformational change 
(Walker, Corpina and Goldberg, 2001; Rivera-Calzada et al., 2007). Study on Xenopus laevis 
showed that the polyubiquitination of Lys48 of Ku80 will lead to the degradation by SCF (Skp1-
Cul1-Fbxl12) E3 ubiquitin ligase complex (Postow et al., 2008). It was also found in human 
that E3 ubiquitin ligase RNF8 (RING finger protein 8) would result in the polyubiquitination of 
Ku80 (Feng and Chen, 2012). The depletion of RNF8 will decrease the efficiency of NHEJ and 
extend the Ku retention on DNA (Feng and Chen, 2012). There is also another hypothesis that 
DNA direct nicking allows the escape of Ku70/80. In the yeast system, MRX (Mre11- Rad50-
Xrs2) can perform an endonucleolytic incision next to the DNA end followed by DNA digestion 
to allow Ku70/80 releasing (Neale, Pan and Keeney, 2005; Wu, Topper and Wilson, 2008; 
Langerak et al., 2011). These proposed mechanisms are quite different and more 
investigation is needed. To point out, the Ku70/80 removal studies were carried out in 
different organisms and those different mechanisms could be due to the divergence between 









1.3.2.2 DNA-PKcs/ DNA-PK 
DNA-PKcs (DNA-dependent protein kinase catalytic subunit), as mentioned previously, is the 
core component of DDR and NHEJ. It is the largest member of the family of PI3-kinases with 
4128 amino-acid residues, mainly composed of four parts: HEAT repeats (Huntingtin, 
Elongation Factor 3, PP2 A, and TOR1), FAT region [FRAP (FKBP12-rapamycin– associated 
protein), ATM (ataxia-telangiectasia mu- tated), TRRAP (transformation/transcription domain 
associated protein)], the kinase region and the FATC (FAT C-terminal) region. 
 
Although the DDR pathways of DNA-PKcs are not fully understood, in vitro studies have shown 
that DNA-PKcs can phosphorylate a series of NHEJ components including Ku70/80 (Chan et 
al., 1999; Douglas et al., 2005), Artemis (Goodarzi et al., 2006), XRCC4 (Yu et al., 2003), XLF 
(YU et al., 2008), PNKP (Zolner et al., 2011), and DNA-PKcs itself (Douglas et al., 2002, 2007; 
Meek et al., 2007). Interestingly, although DNA-PKcs belongs to the family of PI3-kinases, 
these in vitro experiments show that the phosphorylation pattern of DNA-PKcs does not have 
the expected SQ/TQ consensus. The interaction of DNA-PKcs and Artemis activates the 
endonuclease activity of Artemis, which is indispensable for V(D)J recombination. However, 
whether this is due to phosphorylation of Artemis by DNA-PKcs remains unclear. Actually, in 
the aforementioned cases (Artemis, PNKP, XRCC4 and XLF), the phosphorylation after DDR is 
conducted more by ATM rather than or in addition to DNA-PKcs (Jette and Lees-Miller, 2015). 
The crosstalk between ATM and DNA-PKcs on many NHEJ proteins is complicated. 
Nevertheless, there is one well-understood target of DNA-PKcs phosphorylation and it is DNA-
PKcs itself.  
 
The autophosphorylation of DNA-PKcs mainly sits at two clusters-- ABCDE cluster (2609- 2647; 
T2609, S2612, T2620, S2624, T2638, T2647) and PQR cluster (2023- 2056) (S2023, S2029, 
S2041, S2053, S2056). In vitro experiments showed that DNA-PKcs can have 
autophosphorylation at many SQ/TQ sites (T2609, S2612, T2638 and T2647) and non SQ/TQ 
sites (S2624, S3205) (Douglas et al., 2002). In vivo experiments showed that 
autophosphorylation occurs on even more residues (S2056, T2609, S2612, T2620, S2624, 
T2638, T2647, T3950) and the phosphorylation on S2056 after DSB is widely recognised as a 
reliable indicator of DNA-PK activation (Cui et al., 2005; Douglas et al., 2007; Meek et al., 
2007). ATM/ATR also phosphorylate on the ABCDE cluster. ABCDE and PQR clusters 
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reciprocally mediate end processing of NHEJ (Cui et al., 2005). Phosphorylation on the ABCDE 
cluster promotes end processing while phosphorylation on the PQR cluster inhibits it. Also, 
Phosphorylation on the ABCDE cluster helps but is not sufficient or necessary for the kinase 
dissociation (Douglas et al., 2007; Uematsu et al., 2007; Dobbs, Tainer and Lees-Miller, 2010). 
Without proper structural information of DNA-PKcs and the structure of DNA-PKcs in complex 
with binding partners including Ku70/80 and Artemis at the atomic level, it is difficult to 
understand how the mechanisms of the autophosphorylation affect the complicated 
physiological roles DNA-PKcs plays in NHEJ.  
 
Structural studies on DNA-PKcs have been challenging due to the size of this protein but were 
first carried out over 20 years ago using electron microscopy (EM) and atomic force 
microscopy (AFM) (Cary et al., 1997; Yaneva, Kowalewski and Lieber, 1997). The structure of 
DNA-PKcs, the catalytic subunit of DNA-PK was reported at 22Å resolution using the method 
of cryo-EM imaging and electron crystallography (Chiu et al., 1998; Leuther et al., 1999). Later, 
EM studies showed that DNA-PKcs is a circular structure with a crown/head domain with the 
highest resolution at 7Å (Boskovic et al., 2003; Rivera-Calzada et al., 2005, 2007; Williams et 
al., 2008). cryo-EM was also used to study the holoenzyme of DNA-PK (Spagnolo et al., 2006). 
 
Our group published the first crystal structure of DNA-PKcs in complex with Ku80CTD at 6.6 Å 
resolution but the N-terminal region was poorly defined and not modelled (Sibanda, 
Chirgadze and Blundell, 2010). It has been difficult to model the DNA-PKcs not only because 
of the low resolution and flexibility but also because it is difficult to obtain the correct register 
of the sequence due to the repetitive nature of the structures of the HEAT repeats. 
 
The breakthrough in the structure determination of DNA-PKcs came in 2017 when a 
subatomic resolution was reported at 4.3 Å of the DNA-PKcs in complex with Ku80 CTD (Ku80 
539-732), in which all the secondary elements and subdomains of the four main regions could 
be visualised (Chirgadze et al., 2017; Sibanda et al., 2017). To solve the sequence registration 
problem caused by the HEAT repeats, the method of selenomethionine (Se-Met) labelling was 
used. There were 228 Se-Mets evenly distributed in the two molecules of the asymmetric unit 
to help identify the sequence. However, only 90% of all 4128 residues were modelled into the 








Structurally, DNA-PKcs could be separated into three parts: the N-terminal region (1-892), the 
Circular Cradle (893-2801) and the C-terminal Head (2802-4128). The N-terminal region has 
38 α-helices forming 4 supersecondary structures with continuous hydrophobic core (N1-N4). 
The Circular Cradle is the largest structural domain with 85 α-helices forming 5 
supersecondary structures (CC1- CC5). The C-terminal Head unit, containing the FAT domain, 
kinase domain and FATC domain, has 64 α-helices. However, the region 2576-2744 was 
difficult to model with four-α-helices (probably representing 2602-2665) hanging down in the 
centre of the empty cavity of DNA-PKcs. This is due to missing or weak densities of this region 
making it difficult to model and define sequence registration. This implies that the region is 
flexible and not rigidly structured. Interestingly, this missing region covers the ABCDE cluster, 
which is important in the autophosphorylation and DNA-PKcs regulation. It is surprising that 
Figure 6. Structural information of apo DNA-PKcs (Adapted from Figure 1 of Sibanda et al., 2017). 
[A] DNA-PKcs molecule from the crystal structure of DNA-PKcs in complex with Ku80CTD with 
different structural units labelled with different colours (PDB code: 5LUQ). The N-terminal region 
is coloured blue; Circular Cradle is coloured green; FAT region is coloured pink; Kinase region is 
coloured yellow and FATC region is coloured light pink. [B] Schematic diagram of DNA-PKcs 
structural composition of the three big units (N-terminal, Circular Cradle and Head) and the 
supersecondary structural units. 
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this region is not structurally stable considering its physiological importance. This region could 
possibly be interacting with other binding partners and more detailed structural information, 
possibly at higher resolution, will be helpful to explain its role in the regulation of DNA-PKcs. 
In addition to the missing density of DNA-PKcs, the density of Ku80 CTD (Ku80 539-732) was 
largely missing. Only three α-helices were modelled in the structure. The helix of the C-
terminus of Ku80 is confirmed to be located at the tip of the circular cradle sitting close to the 
PQR cluster while the other helix-loop-helix remains unknown. The globular domain (Ku80 
595-704) that had been previously studied using NMR was not detected and not built in the 
model. 
 
Soon after the atomic model of DNA-PKcs of our crystal structure was published, cryo-EM 
structures of DNA-PKcs and DNA-PK from two independent groups were released at low 
resolution with chain tracing based on our crystal structure model (Sharif et al., 2017; Yin et 
al., 2017a). Although both of the cryo-EM studies shared the problem of preferred orientation 
of the sample, which leads to an anisotropic map and requires further optimisation, it showed 
how fast cryo-EM can build on and corroborate X-ray studies so improving our knowledge of  
the structures of large proteins and their complexes.  
 
One group published the cryo-EM structure of apo DNA-PKcs at 4.4 Å resolution and DNA-
PKcs with Ku70/80 at a resolution of 5.8 Å (Sharif et al., 2017). In the apo DNA-PKcs structure, 
most of the structure is consistent with the crystal structure but the N-terminal region is lifted 
relatively in the cryo-EM structure. This may be due to the effect of crystal packing where the 
movement of different domains is more restricted in a crystal but freed in the solution 
environment of cryo-EM. The region (2575- 2775) containing the ABCDE cluster is not 
detected in cryo-EM either and there was even no EM density for the four-α-helices region 
(Ku80 2602-2665) previously modelled. This further indicates that the region may be rather 
flexible and needs more structural information. In the 5.8 Å resolution structure of DNA-PK 
cryo-EM structure, although the bands of DNA-PKcs, Ku70 and Ku80 were shown on SDS-PAGE 
gel, neither Ku70/80 nor DNA were detected in the final map. Instead, there is extra density 
located between the N-terminal region and the circular cradle HEAT repeats and it is proposed 
to be the globular region (Ku80 595-704) in the middle of Ku80 CTD. This can also explain why 
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the core domain of Ku70/80 is missing as there is a long flexible linking region (542-595) 























The other group published the cryo-EM structure of DNA-PK at 6.6 Å resolution (Yin et al., 
2017a). Although at lower resolution, the extra density of DNA and Ku70/80 core domain are 
all present and the map shows the assembly of the holoenzyme—DNA goes through the ring 
of Ku70/80 and the N-terminal region of DNA-PKcs while Ku70/70 also sits next to the N-
terminal region and circular cradle. The N-terminal region has a significant uplift compared to 
the apo form of DNA-PKcs.  There is an alanine helix on the circular cradle of DNA-PKcs and it 
is proposed to be the helix from Ku80 CTD while the exact region on Ku remains unknown 
Figure 7. Cryo-EM models of DNA-PKcs and DNA-PK. [A] Cryo-EM model of DNA-PKcs in three 
different views including front, side and back view (PDB code: 5W1R). DNA-PKcs is labelled red 
[B] Cryo-EM model of DNA-PK in three different views including front, side and back view (PDB 
code: 5Y3R). DNA-PKcs is labelled blue; Ku70 is labelled green; Ku80 is labelled yellow and the 
dsDNA is labelled cyan.  
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due to the low resolution. In addition, the globular region of Ku80 CTD is missing in the 
holoenzyme structure unlike the previous cryo-EM map of DNA-PK.  Last but not least, the 
ABCDE cluster included region (DNA-PKcs 2577-2773) is still missing. 
Together, the three structures can give us an idea about how Ku interacts with DNA-PKcs 
(Sharif et al., 2017; Sibanda et al., 2017; Yin et al., 2017). It is clear that the interaction 
between Ku and DNA-PKcs is not a simple Ku80 C-terminus/DNA-PKcs single-site interaction 
and a model of Ku-DNA-PKcs multistep interactions can be deduced from these structures. To 
start with, Ku interacts with DNA and recruits DNA-PKcs at a distance through the C-terminal 
12 amino acids. Once recruited by the Ku80 C terminus, the globular region of Ku80 CTD will 
further interact with DNA-PKcs bewteen its N-terminal region and HEAT repeat, meanwhile 
releasing the C terminus at the PQR site, to bring DNA-PKcs closer to the Ku-DNA hub. This 
interaction may not be specific and strong but it moves DNA-PKcs very close to the DNA end. 
Finally, the DNA end comes in to replace the globular region and the core domain of Ku70/80 
docks at the site between the N-terminal region and circular cradle. In the mean time, another 
Ku 80CTD region comes in and interacts with the circular cradle to prevent the DNA end from 
sliding. 
 
The molecular mechanism for the activation of the kinase moiety of DNA-PKcs remains 
unclear with two main hypotheses about the mechanism. One hypothesis emphasises the 
interaction between K881 and E3933, which are close to the highly conserved region I (HCRI) 
(DNA-PKcs 979- 1121). This interaction is important for the activation as it opens up the active 
site for substrate processing. The other hypothesis is that, due to the significant uplift, the N-
terminal region of DNA-PKcs interacts with the FAT domain, resulting in the opening up of the 
catalytic site. However, the current resolution of the structures may need further 
improvement to allow qualitative comparison of the conformational changes. Also, structures 
of intermediate state of catalysis (e.g. with an inhibitor) may be helpful for further 





















Figure 8. Allosteric activation of DNA-PKcs kinase activity (Adapted from Wu et al., 2019). Four DNA-
PKcs models are used. In the top panel, two DNA-PKcs molecules (green and cyan) from crystal structure 
of DNA-PKcs in complex with Ku80CTD (PDB code: 5LUQ) are superposed. There is a small conformational 
change (Sibanda et al., 2017). The Highly Conserved Region I (HCRI), including the interaction between 
E3933 and K881, is amplified in the window on the left. In the bottom panel, the DNA-PKcs model from 
the cryo-EM structure of the apo DNA-PKcs  (PDB code: 5W1R) (Sharif et al., 2017) is coloured red, 
superposed on the DNA-PKcs model (coloured blue) from the cryo-EM structure of DNAPK holoenzyme 
(PDB code: 5Y3R) (Yin et al., 2017). The uplift of the N-terminal unit leads to interaction between the FAT 
domain and HEAT 1-8. This is amplified in the right window. To clarify, the Ku C-terminal helices are 
omitted from (Sibanda et al., 2017) and DNA and Ku molecules are omitted from (Yin et al., 2017) 
structures. The arrows indicate the conformational changes between the compared models. 
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1.3.2.3 XRCC4 Superfamily- XRCC4/XLF/PAXX 
The XRCC4 superfamily members, XRCC4, XLF and PAXX, are paralogues with divergently 
evolved structures. Although there has been no enzymatic function reported in this 
superfamily, all three members participate in NHEJ and play important roles, some of which 
may be redundant. The first discovered member, after which the superfamily is named, is 
XRCC4. It is an indispensable core member of NHEJ (Giaccia et al., 1990; Li et al., 1995; Andres 
et al., 2012). Mutations in XRCC4 can result in embryonic lethality in mice and 
immunodeficiency and developmental inhibitions in human (Andres et al., 2012). Also, some 
mutations in XRCC4 are found to cause increased risk of cancer (Shao et al., 2013). XLF (XRCC4 
like factor) is the second member to be discovered (Buck et al., 2006). Mutations in XLF can 
lead to radiosensitivity, immunodeficiency, neurodevelopmental disorder (microcephaly) and 
lymphopenia (Buck et al., 2006).  Shown to interacts with DNA Ligase IV complex, XLF 
promotes NHEJ (Ahnesorg, Smith and Jackson, 2006). PAXX is the last discovered member of 
the family and has been shown to promote NHEJ via interaction with key NHEJ components 
including Ku70/80 (Ochi et al., 2015; Xing et al., 2015; Craxton et al., 2018). 
 
XRCC4 is a 38kDa protein with 334 amino acids, which can be divided into 3 domains: the 
head domain (1-118), the helical tail domain (119-213) and the C-terminal domain (214-334) 
(Li et al., 1995).  It is a homodimeric protein which can also form tetramers in vivo (Mizuta et 
al., 1997; Junop et al., 2000; Modesti et al., 2003;). The homodimer interacts with DNA Ligase 
IV to form the tight DNA Ligase IV complex (Sibanda et al., 2001). So far there is no enzymatic 
function of XRCC4 reported. 
 
The structural information for XRCC4 is available for the sequence before the C-terminal 
domain. The head domain has a ß-sandwich globular structure with a helix -turn-helix (HTH) 
motif (Junop et al., 2000; Sibanda et al., 2001). This head domain is important for the 
stabilisation of XRCC4 and for the interaction with XLF, which will be introduced later (Mizuta 
et al., 1997; Grawunder et al., 1998; Modesti, Hesse and Gellert, 1999). The head domain is 
then followed by a long helical tail that forms the supersecondary structure of coiled coil in 






Figure 9. XRCC4 superfamily:  XRCC4, XLF & PAXX. [A] Schematic diagram of XRCC4 (blue), XLF (grey) 
and PAXX (purple) showing similar structural composition of Head domain, Helical tail and C-
terminal domain (CTD); [B] Structures of XRCC4 superfamily: XRCC4 (residues 1-213; blue) in 
complex with DNA Ligase IV peptide (residues 748-784; Dark grey); XLF (residues 1-233; grey); and 
PAXX (residues 1-204; purple). To point out, there is no structural information of CTD of any XRCC4 
superfamily member; [C] Structures of XRCC4/XLF filaments: XLF/XRCC4 filaments have different 
curvatures with same and different XRCC4.XLF constructs. 
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DNA Ligase IV also interacts with XRCC4 in the helical tail between the residue 173 and 195. 
Interestingly, when DNA Ligase IV peptide is cocrystalised with XRCC4, the coiled-coil 
structure extends to cover the region of the helical tail (Sibanda et al., 2001). As for the C-
terminal domain, it is likely to be dispensable for NHEJ activities (Mizuta et al., 1997; 
Grawunder et al., 1998; Modesti, Hesse and Gellert, 1999). Nevertheless, it contains the 
nuclear localisation signal (NLS) and an acidic cluster which promotes autotranscription 
(Mizuta et al., 1997; Grawunder et al., 1998). Also, the C-terminal domain of XRCC4 is the 
main domain of modification including the phosphorylation by DNA-PK mainly at S260 and 
S318 (Yu et al., 2003; Lee et al., 2004). In addition to DNA-PK phosphorylation, T233 on the 
CTD can be phosphorylated by CK2 and interacts with PNKP on the FHA domain (Koch et al., 
2004). S232 and T233 are also phosphorylated to interact with the FHA domain of APLF 
(Cherry et al., 2015). This may apply to other proteins with FHA domain including Aprataxin 
(Clements et al., 2004; Macrae et al., 2008). 
 
The second member of the superfamily, XLF, also known as Cernunnos, has 299 amino acids 
with a molecular weight of 33kDa and like XRCC4 can be divided into 3 domains: the head 
domain (1-135), the helical tail domain (136-233) and the C-terminal domain (234-299). 
Structural information is mostly limited to the head and helical tail domains (1-233). Like 
XRCC4, XLF also forms a homodimer through the helical tail domain to form the coiled coil, 
which also diverges in the middle. Unlike XRCC4, the helical tail domain of XLF is not just a 
single helix but three helices, of which the two C-terminal helices fold back to interact with 
itself. This also precludes DNA Ligase IV binding of XLF. The C-terminal domain is mostly 
unstructured but has the role of interacting with other proteins. For example, the C terminus 
region of XLF (281-299) interacts with Ku80 on the vWA domain to change the conformation 
of Ku70/80 (Nemoz et al., 2018).   
 
Interaction between XRCC4 and XLF takes place through hydrophobic interaction of the head 
domains. The XLF L115 docks in a hydrophobic pocket of XRCC4 formed by M59, M61, L108, 
and F106 (Hammel et al., 2011). This head-to-head interaction is extendable and could result 
in a long filament and four independent groups showed similar left-handed XRCC4/XLF 
filament with a six-fold screw axe (Hammel et al., 2011; Ropars et al., 2011; Wu et al., 2011; 
Andres et al., 2012). However, the filaments have different curvatures, which are amplified 
 45 
through the extended filament, due to the fact that the XLF docks on XRCC4 at different angles, 
indicating that the filament is elastic and flexible. Moreover, it was shown that the XRCC4/XLF 
filament could bind DNA (Yu et al., 2003). There are hypotheses that the filament can form a 
positively-charged, elongated grooved channel that binds DNA (Yu et al., 2003; Hammel et al., 
2011; Menon and Povirk, 2017). However, although the filament stands on its own without 
other NHEJ components in vitro, in vivo study showed that XLF was co-precipitated with not 
only XRCC4 but DNA Ligase IV (Ahnesorg, Smith and Jackson, 2006). In addition, the 
interaction of XLF and XRCC4 is reduced when DNA Ligase IV is absent. However, it remains 
unclear how DNA Ligase IV cooperates with the interaction of XLF and XRCC4 (Calsou et al., 
2003; Jayaram et al., 2008). As for the disassembly of the filament, the phosphorylation of 
DNA-PKcs on XLF/XRCC4 can facilitate the process (Roy et al., 2012a). 
 
The last member of the XRCC4 superfamily, PAXX (Paralog of XRCC4 and XLF) was discovered 
in our group and characterised functionally in collaboration with the Jackson group (Ochi et 
al., 2015). PAXX is the smallest member of this family and has 204 amino acid residues with a 
molecular weight of 22kDa. The head domain covers the region from residue 1 to 113; the 
helical tail domain is comprised of residues 114 and 145, and the rest (PAXX 146-204) is the 
flexible C-terminal domain. Structural information is available on region (1-142) before the 
unstructured C-terminal tail and PAXX shares the same structural organisation with XRCC4. 
However, unlike XRCC4 and XLF, PAXX does not interact with other members of the 
superfamily or form any high-order protein filament. Also, it has the preferred native state of 
homodimers in solution (Ochi et al., 2015). PAXX interacts with Ku70/80 through the C-
terminal domain and the key residues of V199 and F201 (Ochi et al., 2015). Through this 
interaction, PAXX is involved to promote NHEJ (Ochi et al., 2015). Later, it was shown that 
PAXX and XLF have redundant role in NHEJ and that the combined loss of XLF and PAXX can 
result in synthetic lethality in mammals (Balmus et al., 2016; Kumar, Alt and Frock, 2016; 
Lescale et al., 2016; Liu et al., 2017). Moreover, in a side project of my PhD to understand the 
temporal organisation of NEHJ using single-molecule method, we found that PAXX actually 
participates in NHEJ at a very early stage and could help promote DNA end synapsis with Ku 





Artemis belongs to the β-CASP family of the metallo-β-lactamase superfamily and SNM1 
family of human proteins (de Villartay et al., 2009). Artemis is a single peptide with 692 amino 
acid residues, which can be divided into two main parts—the N-terminal nuclease region (1-
385) and the flexible C-terminal tail (385-692). The nuclease region is encoded by exons 1-13, 
while the whole C-terminal tail is encoded by exon 14 (Moshous et al., 2001). The nuclease is 
composed of a metallo- β-lactamase domain, which contains the catalytic core of the nuclease 
(de Villartay et al., 2009), and a β- CASP domain. Structures of β- CASP family proteins show 
that the β- CASP domain, inserted in the C terminal part of the metallo-β-lactamase domain 
acts as a cap to cover the catalytic core of the metallo-β-lactamase domain (Ochi, Wu and 
Blundell, 2014).  
 
From the perspective of its physiological role, Artemis is the major nuclease involved in end-
processing of NHEJ and Artemis-deficient cells show increased ionizing radiation sensitivity 
(Moscariello et al., 2015). Moreover, Artemis is well known for being indispensable for V(D)J 
recombination, which is the fundamental immunological process creating diversity of 
antibodies and T cell receptors (Jung and Alt, 2004). Actually, it was first identified as the gene 
responsible for radiosensitive-severe combined immunodeficiency (RS-SCID) and Athabascan 
SCID (SCIDA) (Moshous et al., 2001).  
 
From the perspective of its enzymatic activity, Artemis has intrinsic 5＇exonuclease activity 
(Li et al., 2014) and weak single-strand DNA (ssDNA) endonuclease activity, which can be 
greatly stimulated by interaction with DNA-PKcs (Goodarzi et al., 2006). More importantly, 
once activated by DNA-PKcs, Artemis cuts the hairpin DNA produced by RAG1/RAG2 complex, 
Figure 10. Schematic diagram of Artemis. Artemis has two domains-- the N-terminal nuclease 
domain and the C-terminal intrinsically disordered tail.  
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allowing the further ligation of coding joints. Furthermore, Artemis is the only vertebrate 
endonuclease reported so far that can open DNA hairpins (Chang and Lieber 2016). 
 
There have been extensive studies on the nuclease activity of Artemis. It was shown that 
Artemis endonuclease activity varies with the nature of the substrate (Ma et al., 2002). 
Artemis cuts at the intersection of dsDNA and ssDNA when the substrate is a 5＇overhang. 
When there is a 3＇ overhang, Artemis cuts four nucleotides away from the intersection (Ma 
et al., 2002). Moreover, Artemis can act on DNA hairpins and cut at a position on the 3＇ side  
and two nucleotides away from the end (Ma et al., 2002). Recently a new hypothesis that 
unites these various cutting patterns in one mechanism (Chang and Lieber 2016) has been 
proposed in which Artemis recognises three points of the substrate: points A, B and C. Point 
A sits on the 5＇ to 3＇strand at the intersection of dsDNA and ssDNA. Point B is on the 
opposite side of point A.  Point C, which is one nucleotide away from point B on the 5＇side, 
is the site where Artemis cuts. This hypothesis fits well with the biochemical analysis of 
Artemis based on different types of oligonucleotide digestion. However, the structure of 
neither the whole Artemis molecule nor the Artemis catalytic domain has been solved and it 
is unclear how Artemis works.  
 
Figure 11. Hypothesis of Artemis endonuclease activity (Adapted from Figure 1 of Chang and 
Lieber 2016). To unite the cutting patterns of Artemis on different DNA ends, three points of the 
substrate are involved—point A, B and C. Point A (blue) is located at the intersection of dsDNA 
and ssDNA on the 5＇ to 3＇strand. Point B (green) sits on the opposite site of point A. Next to 
point B on the 5＇side, point C (red) is the catalytic site where Artemis cuts.  
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Comparison to homologues in the SNM1 family, including SNM1A and SNM1B, indicates that 
H33, H35 and H115 of Artemis probably coordinate a zinc ion. D37 and D136, possibly with 
E5 and E296, could be interacting with a Mg or Mn ion (Ma et al., 2002; Pannicke et al., 2004; 
Huang et al., 2009). It has been shown that Artemis can function as an endonuclease without 
DNA-PKcs when Mn2+ ions are present in vitro (Chang and Lieber 2016). Nevertheless, it is 
uncertain which metal ions are involved in the enzyme activity.  
 
Despite the large number of studies of the endonuclease activity of Artemis, the molecular 
mechanism of the endonuclease activity and how Artemis cuts the hairpin during V(D)J 
recombination still remain unclear 17 years after the discovery of the endonuclease-
functional Artemis/DNA-PKcs complex (Ma et al., 2002). The studies have focused on three 
aspects: protein-protein interactions within the system, phosphorylation of proteins involved, 
and crosstalk between these two aspects.  
 
Early work showed that both the phosphorylation of Artemis and the physical presence of 
DNA-PKcs were important for the DNA-PKcs/Artemis complex to function as an endonuclease 
(Ma et al., 2002). Later, the phosphorylation sites of DNA-PKcs on Artemis were examined by 
different groups and there were different results (Ma et al., 2005; Goodarzi et al., 2006; 
Soubeyrand et al., 2006). The first group showed that there were 11 DNA-PKcs-
phosphorylation sites on Artemis in addition to the three basal phosphorylation sites on 
Artemis defined earlier (Ma et al., 2005). Many of these phosphorylation sites do not belong 
to the SQ/TQ cluster domains (SCD), which were predicted to be the phosphorylated sites of 
PIKK (Ma et al., 2005). However, the work of another group later showed something different 
(Soubeyrand et al., 2006). In vitro study showed that DNA-PKcs can phosphorylate on multiple 
sites while in vivo study showed that the main phosphorylation sites on Artemis had a 
different profile (Soubeyrand et al., 2006). Also, it was shown that the region of Artemis 399-
404 is important for the physical interaction between Artemis and DNA-PKcs (Soubeyrand et 
al., 2006). Especially, residues L401 and R402 are indispensable to the interaction as 
L401G/R402N double mutant was not able to pull down DNA-PKcs from the whole cell extract 
(Soubeyrand et al., 2006).   
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However, the region of Artemis interacting with DNA-PKcs was not defined and there was no 
information about which domain of DNA-PKcs Artemis interacts with. Strikingly, it was also 
shown that the formation of DNA-PKcs/Artemis complex and phosphorylation on certain 
Artemis residues are dispensable for the endonuclease function of Artemis (Soubeyrand et 
al., 2006). Meanwhile, a third group had similar results on the study of DNA-PKcs and Artemis 
(Goodarzi et al., 2006). It had similar phosphorylation profiles in vitro/ in vivo compared to 
the previous study (Soubeyrand et al., 2006) but different to the early one (Ma et al., 2005).  
It was proposed that the differences between these studies may be due to the fact that a 
lower salt concentration was used in the early experiments (Ma et al., 2005) and that may 
cause the differences that are not physiologically sensible (Goodarzi et al., 2006). 
Furthermore, in vitro experiments showed that the endonuclease activity of Artemis is 
supported by Ku, DNA-PKcs and ATP but not ATM as another group earlier showed that 
Artemis is also phosphorylated by ATM (Chen et al., 2005; Goodarzi et al., 2006). Not 
withstanding the differences, there was one thing in common from all these independent 
studies that phosphorylation on the Artemis C-terminal tail by DNA-PKcs (or other PIKKs 
including ATM) was not likely to have an effect on its endonuclease activity (Ma et al., 2005; 
Goodarzi et al., 2006; Soubeyrand et al., 2006). It was proposed at that time that the physical 
presence of DNA-PKcs and/or its autophosphorylation are more relevant to the nuclease 
activity of Artemis (Ma et al., 2005; Goodarzi et al., 2006; Soubeyrand et al., 2006). Six years 
later, it was shown that the C-terminal domain of Artemis is actually important for the hairpin 
cleavage in V(D)J recombination through its interaction with both DNA-PKcs and DNA Ligase 
IV (Malu et al., 2012). In Artemis-deficient human pre-B cells, Artemis W489A, which loses 
interaction with DNA Ligase IV, and Artemis L401G/R402N, which loses interaction with DNA-
PKcs, showed reproducible but moderate decreases in the coding joint formation (Malu et al., 
2012). However, Artemis W489A/L401G/R402N triple mutant had a strong inhibition of the 
formation of a coding joint (Malu et al., 2012). This is in agreement with the previous studies 
and it seems that DNA-PKcs and DNA Ligase IV are playing redundant roles to recruit Artemis 
to the DNA end. Moreover, it was recently shown in vivo that the kinase activity of DNA-PKcs 
is not required for hairpin opening (Jiang et al., 2015). Instead, it is the phosphorylation of 
ATM on DNA-PKcs (or Artemis) that helps recruiting Artemis to the DNA end for processing. 
In addition to the previous aspects mentioned, attention was paid to the role of Ku for the 
endonuclease function of Artemis as Ku is the most important binding partner of DNA-PKcs. 
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There are studies concerning the effect of Ku on Artemis. It was proposed that Ku is important 
for Artemis endonuclease activity as it activates DNA-PKcs for autophosphorylation (Goodarzi 
et al.,2006). It was also proposed that Ku cannot bind to DNA-PKcs/Artemis complex without 
DNA ends or when the kinase activity is inhibited, but the DNA/Ku/DNA-PKcs/Artemis 
complex has a specific phosphorylation profile (Drouet et al., 2006). Moreover, it has been 
shown that Ku 80 C terminus plays an important role in Artemis-mediated processing of DSB 
ends via DNA-PKcs, although it does not come into contact with Artemis (Weterings et al., 
2009). However, further details of the mechanism remain confusing as the latest result 
showed that the autophosphorylation of DNA-PKcs is not important in Artemis recruiting or 
processing (Jiang et al., 2015). The crosstalk of phosphorylation and protein-protein 
interaction becomes more and more complicated with increasing numbers of the NHEJ 
members involved or post-tanslational modification involved, including DNA-PKcs, Artemis, 
Ku, DNA Ligase IV and ATM. Nevertheless, how they affect Artemis function as an 
endonuclease still remains unknown. This is not only due to the complexity of Artemis and its 
interaction network, but also due to the fact that the details of other relevant components 
and their internal interactions remain unclear. Therefore, to understand how Artemis 
functions as an endonuclease, it is important to understand two things: the structure of the 
nuclease domain of Artemis and the interaction between Artemis and DNA-PKcs, the most 
important partner and activator of endonuclease activity. 
 
Yet this is not the end of the story of Artemis. Artemis is interacting with other proteins 
through the C-terminal flexible domain besides DNA-PKcs. For example, as mentioned, 
Artemis 485-495 is important for the interaction between Artemis and the DNA binding 
domain of DNA Ligase IV (Malu et al., 2012). Later, Ochi, Gu and Blundell (2013) showed that 
Artemis residues 485-495 undergo concerted folding and binding with the first two helices of 
DNA Ligase IV to form a three-helical bundle. When interacting with DNA Ligase IV, W489 of 
Artemis forms a hydrogen bond with D18 of DNA Ligase IV, stabilized by interaction between 
F492/F493 of Artemis and F49/F42 of DNA Ligase IV. Moreover, P487 of Artemis sits in the 
hydrophobic pocket formed by L53, A52 and F49 of DNA Ligase IV (Ochi, Gu, and Blundell 
2013). There are also other binding partners with no structural information. For example, 
residues 641-660 of Artemis can bind to the second BRCT domain of an adaptor protein Pax 
transcription-activation-domain interacting protein (PTIP) via phosphorylation (Wang et al., 
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2014). Furthermore, Artemis physically binds to the Mre11/Rad50/Nbs1 complex (MRN 
complex) in an ATM-dependent way under Ionizing-radiation induction (Chen et al., 2005). 
Although the region is not yet defined, it is likely that the C terminus will be the interacting 
part given that hyperphosphorylation of Artemis is associated with Artemis-MRN complex 
interaction (Chen et al., 2005). 
 
These observations relate to the interesting phenomenon of intrinsically disordered regions, 
which are observed in many proteins participating in regulatory processes. Intrinsically 
disordered regions have not been as well investigated as folded proteins in the past despite 
the fact that they are common and many intrinsically disordered regions are highly conserved 
(Dyson and Wright, 2005). This is surprising given that Dunker and colleagues in 2002 (Dunker 
et al., 2002) pointed out that functions of intrinsically disordered polypeptides include 
regulation of transcription and translation, cellular signalling and regulation of large-
multiprotein-complex assembly.  
 
The intrinsically disordered C-terminal region of Artemis recruits other factors and facilitates 
the assembly of the multi-component NHEJ complex. It appears to act like a string “tying” 
together these other components with the covalently linked N-terminal nuclease region. 
Besides Artemis, other examples include APLF, which also has disordered regions interacting 
with other components of NHEJ including Ku (Grundy et al., 2012), are also likely to act as a 












































Figure 12. Interaction network of Artemis. The double arrows coloured ink indicate protein-protein 
interaction and the single arrows coloured purple indicate phosphorylation modification.   
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1.3.2.5 DNA Ligase IV 
Human DNA Ligase IV is an ATP-dependent DNA ligase, belonging to the 
nucleotidyltransferase superfamily like all the human DNA ligases (Shuman and Lima, 2004; 
Alan E.  Tomkinson et al., 2006; Ellenberger and Tomkinson, 2008). Compared to other human 
DNA ligases including DNA Ligase I and DNA Ligase III, it has some unique features. DNA Ligase 
IV is the only human DNA ligase involved in NHEJ as a core NHEJ component and it is dedicated 
to NHEJ. It performs DNA ligation in a three-step process of nucleotidyl-transfer reaction- DNA 
Ligase IV adenylation, adenyl transfer to DNA and DNA backbone sealing (Alan E.  Tomkinson 
et al., 2006; Shuman, 2009). In the first step of DNA Ligase IV adenylation, ATP interacts with 
a lysine residue of DNA Ligase IV to form the lysine-adenosine monophosphate (AMP) 
covalent intermediate. Then in the second step, the active lysine-AMP intermediate attacks 
the 5＇phosphate on the DNA end and transfers the AMP to the 5＇ end. In the last step, the 
3＇hydroxyl group of the DNA reacts with the 5＇phosphate-AMP intermediate to rebuild 
the phosphodiester bond of the broken DNA and release the AMP (Alan E.  Tomkinson et al., 
2006; Shuman, 2009). It was recently shown that NAD+ could also stimulate the adenylation 
of DNA Ligase IV for further DNA ligation (Chen and Yu, 2019).  
  
DNA Ligase IV comprises five domains: DNA binding domain (residues 6-239) (DBD); 
Nucleotidyltransferase domain (residues 240-453) (NTase); OB-fold domain (residue 458-606) 
(OBD); and two BRCT domains (residues 654-740; residues 815-911) linked via a flexible 
region (residues 741-814) (Figure 13). Together, DBD, NTase and OBD are considered as the 
catalytic core of DNA Ligase IV. This catalytic core is highly conserved among the human DNA 
ligases including DNA Ligase I, DNA Ligase III and DNA Ligase IV (Ellenberger and Tomkinson 
2008).  
 
Starting from the N terminus of DNA Ligase IV, DBD is formed of 12 α helices. As the name 
implies, DBD binds DNA non-specifically (Pascal et al., 2004). It shares a similar structure with 
other human DNA ligases but has a relatively long helix α2 and specific conserved residues to 
interact with Artemis (De Ioannes et al., 2012).  The first two helices interact with Artemis C-
terminal region to form a three-helical bundle to strengthen the interaction of Artemis on 
DNA ends (De Ioannes et al., 2012; Malu et al., 2012). The NTase is a common domain among 
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all DNA and RNA ligases with a similar structure (Shuman and Lima, 2004; Ochi, Gu and 
Blundell, 2013; Kaminski et al., 2018). It comprises two parts: one binds to the 3＇ end of the 
broken DNA and the other binds to the 5＇ end. The lysine (Lys 273) that is adenylated for 
further DNA ligation is located at the centre of the NTase domain to target the DNA breakage 
site (Ochi, Gu and Blundell, 2013; Kaminski et al., 2018). OBD is also conserved among all DNA 
ligases. It contains a β-barrel domain with five anti-parallel β-strands and important for 
forming the lysine-AMP intermediate for all DNA ligases (Ochi, Gu and Blundell, 2013; 










Figure 13. Structural information of DNA ligase IV. (A) Schematic diagram of DNA ligase IV. The DNA 
ligase IV is formed of the catalytic core (1-606) and C-terminal region (607-911). The core contains 
three domains-- DNA binding domain (DBD), Nucleotidyltransferase domain (NTD) and the OB fold 
domain (OBD). The C-terminal region contains two BRCT domain linked by a flexible linker; (B) 
Structures of the catalytic core (PDB: 3W5O) and the BRCT domains without the stabilising XRCC4 
(PDB:3II6) of DNA ligase IV (Ochi et al., 2013; Wu et al., 2009). 
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So far, there are four structures of the catalytic domain in different conformations: apo-DNA 
Ligase IV catalytic domain (residues 1-609) (PDB: 3W5O); DNA Ligase IV catalytic domain 
(residues 1-609) in complex with Artemis peptide (residues: 485-495) (PDB: 3W1G); DNA 
Ligase IV catalytic domain lysyl-adenylate (residues 1-620) in complex with nicked DNA (PDB: 
6BKF) and DNA Ligase IV catalytic domain (residues 1-620) in complex with DNA-adenylate 
(PDB: 6BKG) (Ochi, Gu and Blundell, 2013; Kaminski et al., 2018). In the apo-form (PDB: 3W5O), 
the catalytic region is in an “open” state which is stabilised probably by the interaction area 
of 1,104 Å2 between NTase and OBD (Ochi, Gu and Blundell, 2013). Binding of the Artemis 
peptide does not change the conformation, indicating that this protein-protein interaction 
may not stimulate DNA ligation (Ochi, Gu and Blundell, 2013). In the structure of Ligase IV 
catalytic domain lysyl-adenylate (residues 1-620) in complex with nicked DNA, the catalytic 
domain remains in the “open” status (Kaminski et al., 2018). At this stage, DNA Ligase IV 
recognises the DNA nick through the interaction between Arg293/Arg443/Lys449/Lys451 and 
the 5＇phosphate and the following backbone phosphate downstream (Kaminski et al., 2018).  
While the 5＇phosphate sits next to the catalytic site, the closest 5＇phosphate oxygen is 
around 5.4 Å away from the AMP phosphorus atom, which is still far for the nucleophilic 
attack and adenyl-transfer from Lys273 to DNA (Kaminski et al., 2018). This indicates that 
structural repositioning of the Ligase IV lysyl-AMP or DNA 5＇phosphate is required of the 
further ligation steps. Actually, in the structure of DNA Ligase IV catalytic domain (residues 1-
620) in complex with DNA-adenylate, the catalytic domain then adopts a “closed” 
conformation around the nicked DNA (Kaminski et al., 2018). Alignment of the two structures 
of Ligase IV 1-620 in complex with nicked DNA showed that the conformation of the DBD and 
NTase subdomains mostly remain the same while the OBD swivels to encircle the DNA 
substrate completely and to interact with DBD, forming a “latch”. However, it remains unclear 
what triggers the conformational change of the catalytic domain from “open” to “closed”. 
 
Next to the catalytic domain is the C-terminal domain containing two BRCT domains. BRCT 
domain contains four parallel β sheets flanked by one α helix and two α helices on either side 
(Bork et al., 1997). BRCT repeats are common and frequently found in DDR proteins including 
53BP1, BRCA1, BARD1, PARP-1 and TopBP1 which were mentioned previously (Williams, 
Green and Glover, 2001; Derbyshire et al., 2002; Joo, 2002; Birrane et al., 2007; Loeffler et al., 
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2011; Rappas, Oliver and Pearl, 2011). The tandem BRCT repeats are known to bind phospho-
peptides while it is unclear how phospho-peptides interacts with the BRCT repeats of DNA 
Ligase IV though they were expected to interact with Ku70/80 complex (Manke, 2003; 
Rodriguez et al., 2003). Moreover, the tandem BRCT repeats are known to function as protein-
protein interaction domains and the linker between one BRCT domain and the second is also 
important for protein-protein interaction (Watts and Brissett, 2010). A good example here is 
the interaction between DNA Ligase IV and XRCC4. The first structure of the DNA Ligase 
IV/XRCC4 complex revealed the core XRCC4 interaction domain (XID) is the linker between 
BRCT1 and BRCT2 (DNA Ligase IV 748-784) (Sibanda et al., 2001). The binding of DNA Ligase 
IV interacts on XRCC4 changes the conformation of the coiled coil but what effect it has 
remains unclear (Sibanda et al., 2001). Later, a structure with longer construct of DNA Ligase 
IV C-terminal region showed that, instead of just the XID, BRCT2 is also interacting with XRCC4 
and this interaction is necessary for the stabilisation of DNA Ligase IV/XRCC4 complex in cell 
(Wu et al., 2009). In addition to the influence on protein-protein interaction, the BRCT1 
domain is also proposed to be important for NAD+ recognition and adenylation of DNA Ligase 

















1.4 Structure in Biology 
 
1.4.1 Structure, Function and Drug Discovery  
Studying structure provides detailed knowledge and insights that are not only important for 
understanding the structure and function of important biological molecules but are also 
central to selection of targets for structure-guided drug discovery. For example, 
understanding the structure of a protein and its evolution can provide us with the detailed 
mechanism of how the protein fulfils its physiological roles. For example, the catalytic sites of 
the nucleases SNM1A and SNM1B are highly structurally conserved, indicating a similar mode 
of exonuclease catalysis. Furthermore, we can usually locate the functional site of a protein 
based on the structure and evolutionary conservation. For example, for DNA-PKcs, although 
there was no structural information of ATP or substrate binding, based on the available 
information of the existing structures of other PI3-kinases, we can have an idea of the mode 
of phosphorylation of DNA-PKcs.  
 
The connection and interplay between structure and function are not just limited to catalytic 
pockets and enzyme activity. Many proteins have non-enzymatic functions which are also 
highly connected to the structures. A good example would be the discovery of PAXX, which 
was discovered in our group (Ochi et al., 2015). Although there was no known biological role 
of PAXX, it was predicted to be involved in NHEJ due to the structural similarity with other 
XRCC4 superfamily members. Later collaboration on cellular study showed that PAXX 
interacts with Ku and is involved in NHEJ. Therefore, understanding the structure can be 
significant for predicting the function of the protein with unknown physiological role, guiding 
the subsequent cellular physiological study.  
 
Furthermore, structure on its own can provide us with indications of potential roles of the 
protein. In the case of DNA-PKcs, the kinase domain is only around 300 residues at the C-
terminus of a protein comprising 4128 residues. The structure demonstrated that it sits on 
the head unit of the whole molecule, with other domains including N-terminal bridge and 
circular cradle acting as stages on which other molecules assemble. Recently it has been 
shown that the N-terminal arm is involved in the allosteric regulation of kinase activity. 
 58 
However, there are still structural domains of DNA-PKcs with unknown functions, indicating 
that other functions of DNA-PKcs may not have been revealed. 
 
Biological function can also be mediated by intrinsically disordered regions, which are 
common cell regulatory systems and often are highly conserved (Dyson and Wright, 2005). 
Dunker and colleagues in 2002 (Dunker et al., 2002) pointed out that functions of intrinsically 
disordered polypeptides include regulation of transcription and translation, cellular signalling 
and regulation of large-multiprotein-complex assembly.  In NHEJ, there are many intrinsically 
disordered regions that appear to play the regulatory roles, some providing access to short 
foldable regions and others linking different components in a flexible manner. These include 
the XLF domain interacting with Ku70/80, APLF domain interacting with Ku70/80 and Artemis 
domain interacting with DNA Ligase IV. 
 
Studying the structure can also be very important for understanding diseases and drug 
discovery. Folding of a protein allows residues that are distant in primary structure to interact 
with each other; this is difficult to understand without 3D structure determination. With the 
structural information of the driver protein of a specific disease, the mutations from patients 
can be located, producing a clear picture of the molecular origins of the disease. Moreover, 
the structure of target proteins with a drug candidate or antibody could provide a detailed 
mode of action (MOA). Furthermore, structures of the protein can be used for high-
throughput screening (HTS) and fragment-based drug discovery (FBDD).  
 
In fact, from the perspective of oncology, the NHEJ system is a good target. Biologically, one 
of the underlying hallmarks of cancers is the genomic instability, which leads to a higher 
propensity to accumulate DNA damage (O’Connor, 2015). To make use of this hallmark, DNA-
damaging radiotherapy and chemotherapy were introduced some time ago to induce further 
instability in cancer cells and to kill them. However, in various cancers, the expression of DSB 
repair genes is altered. Activation and upregulation of DSB repair genes is one of the reasons 
for the resistance of radiotherapy and chemotherapy (Srivastava and Raghavan, 2015). 
Considering that NHEJ is the predominant DSB repair pathway in the mammalian system, 
targeting NHEJ would be attractive strategy to treat cancer especially in combination with 
radiotherapy or chemotherapy. Many pharmaceutical companies are targeting DNA repair for 
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cancer treatment including Astra Zeneca and Merck, and one key target is DNA-PK of NHEJ 
(https://www.astrazeneca.com/what-science-can-do/stories/ddr.html). In addition to DNA-
PK and other enzymes in NHEJ, the protein-protein interaction sites in NHEJ may be also good 
starting points for drug discovery. Structurally, the interactions between globular domains 
and intrinsically disordered regions tend to be the most druggable protein-protein 
interactions (Jubb, Blundell and Ascher, 2015). In this respect, the interaction between 
Artemis and DNA Ligase IV is of great interest. The fact that DNA Ligase IV is the only ligase 


























1.4.2 Methods of Structure Determination 
To solve the structure of protein and to build the final atomic model, three different methods 
are most often used: X-ray crystallography, Nuclear Magnetic Resonance (NMR) spectroscopy, 
and electron microscopy (EM). These methods present different challenges and each has their 
own forte. 
 
In the case of X-ray crystallography, the protein requires purification, crystallisation and 
stability in an intense beam of X-rays. As protein molecules are packed symmetrically and 
repeatedly in crystal, they will produce an X-ray diffraction pattern with the amplitude of X-
ray wave recorded. Together with other methods to determine the phase, the diffraction 
pattern must then be analysed to determine the electron distribution within the molecule to 
obtain the final result of the map of electron density. The map can then be interpreted to 
locate the position of each atom. X-ray crystallography is excellent at providing atomic 
information with fine details showing every single atom in the molecule. However, the protein 
has to be crystallised for X-ray crystallography and this can be difficult or even impossible in 
many cases. It can take years to find the ideal condition, if there is any, for the protein to be 
crystallised. Classic examples include the ribosome and DNA-PKcs in NHEJ which took over a 
decade to produce decent crystals. In general, X-ray crystallography is the method to study 
the structure of relatively stable and ordered proteins that form nice crystals. It has also been 
the method for routine structure-based drug discovery.   
 
Instead of showing the exact location of each atom, NMR spectroscopy gives information 
about the local conformation and the distance between atoms that are close to one another. 
For NMR experiments, the protein is first purified, then placed in a strong magnetic field and 
probed with radio waves. A characteristic set of observed resonances can be analysed to give 
the list of atomic nuclei close to one another and to specify the local conformation of atoms 
bonded together. The obtained restraints can then be used to build the model of the protein 
showing the relative location of each atom. NMR has the advantage that it provides 
information of protein in solution and it is the preferred method to study the structure of 
flexible protein. However, NMR is limited by the size of the protein. It is not useful for large 
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proteins due to the sample behaviour in solution and the problem of signal peaks overlapping 
in the spectra. 
 
The most often used EM is either negative staining or cryo-EM, based on whether the sample 
is treated with negative stain. High-resolution structures can be defined using cryo-EM, which 
is the rapidly developing technique of structure study. Cryo-EM is the main technique used 
for structure study in this research and more details will be introduced in the section 1.4.3. 
Unlike X-ray crystallography and NMR, EM images the protein directly using electron beams. 
For EM, the protein is purified, loaded on grids and placed under electron microscopes. When 
the grid is placed in microscope, there are two ways of collecting data for subsequent analysis: 
single particle analysis (SPA) and cryo-electron tomography (cryo-ET). Currently, protein 
structures by EM at atomic resolution are mostly done using single-particle analysis. To obtain 
high resolution in single-particle analysis, a large number of protein particles, usually tens of 
thousands to millions, are extracted from the micrographs to get clear 2D projections from 
all different angles, which will later be used to reconstruct the 3D model. Cryo-EM has the 
advantage that it does not require protein crystals and can visually examine the protein 
particles directly. Furthermore, cryo-EM allows the protein to stay in native condition without 
restraints such as crystal packing and can tolerate flexibility of the protein to a certain extent. 
However, it still remains highly challenging to achieve high resolution for flexible regions of 
the protein. Moreover, cryo-EM is currently not good at solving structures of small protein 
particles as it will be difficult to identify the angles of projection of small particles for 2D and 
3D classification. Nevertheless, many developments are undergoing in the field of cryo-EM 
and it has shown the potential of solving structures of small proteins including the record-
keeping 52 kDa streptavidin (Fan et al., 2019).  
 
In addition to the three methods for structure determination, there are many other 
facilitating methods that are not as definitive but could facilitate the structure study by adding 
restraints and providing biophysical and biochemical information, including Circular 
Dichroism (CD), Analytical UltraCentrifugation (AUC), and a series of different Mass 
Spectrometry (MS) approaches, including native MS, crosslinking MS, and Hydrogen–
Deuterium eXchange (HDX). The details of these techniques will not be discussed but it is 
important to point out that all those techniques together can provide a powerful toolbox for 
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structure study of various types of proteins and complexes and a new integrated structural 
































1.4.3 Cryo-EM Resolution Revolution 
Cryo-EM is the main method I have been using in my PhD to study the structure of NHEJ 
complexes and it has been developing at a very high speed. The breakthrough of cryo-EM to 
become a routine method for solving structures at atomic resolution came around 2013 when 
the direct electron detector was launched. After that, a series of structures including TRPV1 
ion channel, F420-reducing [NiFe] hydrogenase and the large subunit of the yeast 
mitochondrial ribosome were solved at resolutions of 3.2- 3.4 Å, heralding the beginning of 
the new era of cryo-EM and structural biology (Li et al., 2013; Liao et al., 2013; Allegretti et 
al., 2014; Amunts et al., 2014). Compared to x-ray crystallography and NMR spectroscopy, 
cryo-EM is a new member of the “near-atomic resolution” club. 
 
In general, the cryo-EM workflow can be separated into three steps including sample 
preparation, data collection and data analysis (Figure 14). In sample preparation, the aqueous 
sample is first loaded on specific cryo-EM grids. The grid is comprised of two components, the 
metal grid bar and a layer of covering membrane with empty holes. There are three common 
parameters to take into consideration including the metals of the grid bar, the material of the 
covering membrane and the pattern/size of the empty holes on the membrane. Common 
metals of the grid bar include copper and gold. As for the covering membrane, usual options 
are carbon (e.g. Quantifoil) and gold (e.g. Ultrafoil). The hole shapes and arrays can vary from 
precise and well-defined (e.g. 1.2/1.3) to open and disordered (e.g. Lacey carbon). In addition, 
there are many other advanced parameters of grid types including surface modification like 
PEGylation and extra supporting films such as graphene oxide (GO). Different proteins behave 
differently on the grids and there is no one grid that suits all samples. Therefore, the 
parameters mentioned should be considered for optimisation for sample preparation. 
 
The aqueous sample (usually 2µl-3µl) is first applied to the grid and blotted with filter paper 
to remove the excess of liquid under a specified force of blotting for a defined period of time 
with a machine (e.g. Vitrobot). The grid is then plunge-frozen in liquid ethane to vitrify the 








Figure 14. Cryo-EM workflow (Adapted from Figure 2 of Murata and Wolf, 2018). The three steps 
of cryo-EM include sample preparation (aqueous sample and sample vitrification), data collection 
(low dose image collection by cryo-EM for single-particle analysis or subtomogram averaging) and 
data processing, which will be introduced in detail later. 
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After sample preparation comes the data collection. Cryo-EM is similar to the EM used in the 
field of Material Science or Engineering as the same technique of transmission electron 
microscope (TEM) but running under the cryo-environment using liquid nitrogen. To achieve 
an electron beam with high energy and short wavelength, high accelerating voltages are used 
in cryo-EM, for example 200kV (e.g. Thermo Fisher Scientific Talos Arctica/ Glacios; JEOL CRYO 
ARM 200) and 300kV (e.g. Thermo Fisher Scientific Titan Krios; JEOL CRYO ARM 300). However, 
unlike many samples from Material Science or Engineering, the biological samples are very 
fragile, with low tolerance to the radiation damage caused by the electron beam. Therefore, 
cryo-EM uses a low-dose image collection strategy. In addition, there are two ways of data 
collection with stage rotation or without stage rotation.  
 
Stage rotation is involved in cryo-electron tomography (cryo-ET). In this case, the grid is tilted 
for a series of angles (e.g. From -60 ° to +60 °) to record a stack of images known as the 
‘tiltseries’. The tiltseries is then aligned to the common rotation axis to build the 3D tomogram 
via weighted back-projections or other methods. The sub-tomograms of the macromolecules 
can then be extracted from the built tomogram for alignment and averaging to reconstruct 
the map of the macromolecules at a finer level.  
  
No stage rotation is used in single particle analysis (SPA). In this case, instead of collecting 
tiltseries, movies of subframe collection are recorded with different defocus values for 
subsequent analysis. Compared to cryo-ET, the resolution revolution was mainly driven by 
the improvement of all aspects of SPA, which defined cryo-EM structures at near atomic level 
regularly. SPA is also the method used for cryo-EM experiment in my PhD project and will be 










Figure 15. The processing of SPA. (A) Schematic diagram of the main steps and elements of SPA from 
the original movies to the final high-resolution map (Modified from Figure 2 of Carroni and Saibil, 
2016). (B) Workflow of Relion 3.0 to achieve high-resolution cryo-EM map using SPA. The star labels 
emphasize on the new function of Relion 3.0 (Modified from Figure 1 of Scheres, 2016). 
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In general, the data processing of SPA is flexible and varies depending on the behaviour of the 
sample but can be separated into two parts: micrographs processing and particle processing. 
Micrographs need aligning, averaging and correcting first, before being used for particle 
picking and 2D, 3D analyses (Figure 15A). 
 
With the rapid development of cryo-EM, there are many software packages now on the 
market for SPA and common ones include Relion, eMAN, Scipion, Sphire, cryoSPARC, cis-TEM 
and SIMPLE (Tang et al., 2007; Elmlund and Elmlund, 2012; Scheres, 2012; de la Rosa-Trevín 
et al., 2016; Moriya et al., 2017; Punjani et al., 2017; Grant, Rohou and Grigorieff, 2018). 
Different packages have their own advantages on data processing and different hardware 
requirement. For example, cis-TEM and SIMPLE do not require GPU for the data processing. 
During my PhD project, Relion has been the major package used for data analysis and it is one 
of the dominant software in the field (Figure15 B). 
 
To do SPA in Relion, micrographs are first processed with motion correction and contrast 
transfer function (CTF) estimation and correction. All the movies of the subframes are traced 
for the beam-induced movement, aligned and averaged to produce the motion-corrected 
micrographs. The micrographs are then sent for CTF estimation and correction. All the 
micrographs with good CTFs will be selected.  
 
After CTF correction, a subset of micrographs with good CTFs are chosen. The user should 
pick the particles of interest from them using a self-defined mask and later extract them with 
a self-defined box. These particles will be then applied to 2D classification to generate 2D 
projections of the target protein. This could give a fast feedback of the quality of the dataset 
and also produce templates for the following auto picking on all micrographs. In auto picking 
of the full dataset, hundreds of thousands of the particles can then be picked and again be 
subjected to 2D classification to obtain 2D projections of the full set of particles and clean up 
the contamination within the particles picked.  
 
A subset of the particles with good 2D projections will be selected for 3D processing with an 
3D initial model. The optimal model can be generated from previously existing structure 
models (e.g. from X-ray crystallography) or built from the previous 2D classes. The 3D 
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classification can then be done to distinguish the heterogeneity and conformational changes 
within the chosen particles to identify subsets that have different 3D conformations or include 
contamination. The nice subsets would be further subjected to high-resolution 3D auto-refine 
for details and then sent to postprocessing for sharpening. The particle processing does not 
have to stick to the classic workflow and could be done iteratively to optimise the subsets of 
particles and the 3D maps. 
 
After obtaining the optimised final map, the final step is modelling and validation. Currently, 
there are some cryo-EM modelling packages that are transformed X-ray crystallography 
modelling packages, including CCP-EM and Phenix. Although the property of the final maps 
of cryo-EM and crystallography are different, the modelling stage is mainly similar and will 






















1.5 Project Objectives 
 
The objectives of my research are to study the biochemistry and structure of the human DNA-
PKcs/Artemis endonuclease complex and the interaction of Artemis with other NHEJ 
components including DNA Ligase IV.  
 
To fulfil the objectives, various approaches have been taken: 
• Bioinformatics analysis of Artemis to identify the possible region of Artemis that 
interacts with DNA-PKcs 
• Cloning, protein expression and purification of different constructs of Artemis, DNA-
PKcs and DNA Ligase IV. 
• Characterisation of the protein constructs purified including enzyme assays, and 
biophysical analysis.   
• Initiation of fragment-based drug discovery including screening of the fragment library 
to target the interaction between DNA Ligase IV and Artemis. 
• EM studies, including preliminary negative staining screening of DNA-PKcs and 
Artemis and subsequent cryo-EM studies on different constructs of the DNA-
PKcs/Artemis complex  
• Analysis based on the cryo-EM results. 
 
During my PhD, some of the objectives were modified in response to published work from 
other groups. The objective most significantly changed is the screening of stable constructs 
of Artemis nuclease region. A paper came out in the second year of my PhD showing that the 
disordered C-terminal tail of Artemis folds back to interact with the nuclease region, 
explaining why It had proven highly difficult to obtain stable constructs of the nuclease region 
alone. Therefore, instead of reconstructing the nuclease region, more effort has been spent 
on the full-length Artemis and the interaction with DNA-PKcs.  
 
In addition to the objectives mentioned, I was also involved in the collaboration between the 
Blundell group and the Strick group on understanding the temporal organisation of NHEJ 
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using a single-molecule study. The collaboration work was published on Nature Structural & 




1.6 Overall Organization of The Thesis 
 
The thesis is organised in the following way: 
• Chapter 2 describes all the material and methods used in the research described in 
the thesis 
• Chapter 3 describes the initial bioinformatics analysis of Artemis that provides insights 
into protein structure and interactions and guides the design of different Artemis 
constructs. 
• Chapter 4 describes the purification of protein constructs 
• Chapter 5 describes the characterisation of the purified proteins. 
• Chapter 6 describes cryo-EM structural work regarding the DNA-PKcs/Artemis 
complexes and DNA-PKcs. 
• Chapter 7 discusses the main outcomes of my thesis and gives a perspective of future 













Chapter 2. Material and methods 
 
2.1 Bioinformatics Analysis 
 
2.1.1 Structural alignment & sequence alignment 
Structural homologues are searched using HHpred (Homology detection & structure 
prediction by HMM-HMM comparison). To find the homologues of specific genes, 
HomoloGene database (https://www.ncbi.nlm.nih.gov/homologene) and PSI BLAST 
(Position-Specific Iterated Basic Local Alignment Search Tool) (https://blast.ncbi.nlm.nih. 
gov/Blast.cgi) are used (Altschul et al., 1997; Soding, Biegert and Lupas, 2005). Structural 
homologues were aligned using the ModSuite station written by Dr Bernardo Ochoa from 
Blundell group. ModSuite combines two analysis tools: BATON and FUGUEALI (Shi, Blundell 
and Mizuguchi, 2001). BATON takes in PDB files of homologous proteins of the protein of 
interest, producing aligned structure files of the homologues. FUGUEALI aligns the protein of 
interest to the proteins that have been structurally aligned by BATON. Sequence alignment 
was performed by the Muscle programme built in the SeaView package (Edgar, 2004; Gouy, 
Guindon and Gascuel, 2010).  
 
2.1.2 Secondary structure prediction & modelling 
For the structured region, Jpred was the main programme used to predict the secondary 
structures of protein constructs   (http://www.compbio.dundee.ac.uk/jpred/) (Drozdetskiy et 
al., 2015). To model specific protein constructs, Modeller was used following the structural 
alignment (Šali and Blundell, 1993). I-TASSER was also used to predict the structure of the 
protein constructs in parallel (Zhang, 2008).  
 
2.1.3 Intrinsically disorder analysis 
For the unstructured region, IUPRED was applied to the sequence to analyse the level of 
intrinsic disorder (http://iupred.elte.hu/) (Dosztanyi et al., 2005).  To predict the intrinsically 
disordered region that plays a role in protein-protein interaction, Anchor was used to search 
for the intrinsically disordered regions that have the potential to go through concerted folding 
when interacting with binding partners (http://anchor.elte.hu/) (Dosztányi, Mészáros and 
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Simon, 2009).  In addition, DisEMBL (http://dis.embl.de/) (Linding et al., 2003) and FoldIndex 
(https://fold.weizmann.ac.il/fldbin/findex) (Prilusky et al., 2005) are used to predict the 
intrinsic disorder and foldability. 
 
2.2 Molecular Biology 
 
2.2.1 Recombinant constructs and plasmids 
The recombinant constructs of NHEJ components built and purified in the thesis are listed in 









Art_Q363_GFP Artemis 1 363   
Art_S385_GFP Artemis 1 385   
Art_D394_GFP Artemis 1 394   
Art_P426_GFP Artemis 1 426   
Art_Q363_His Artemis 1 363   
Art_S385_His Artemis 1 385   
Art_D394_His Artemis 1 394   
Art_P426_His Artemis 1 426   
Art_363-399 Artemis 363 399   
Art_385-413 Artemis 385 413   
Art_399-408 Artemis 399 408   
Art_399-426 Artemis 399 426   
Art_413-426 Artemis 413 426  
Art_FL Artemis 1 692   
Art_FL_Dead Artemis 1 692 H115A 
Ku80_CTD Ku80 593 732   
Lig4_240 DNA Ligase IV 1 240  
Lig4_230 DNA Ligase IV 1 230   
Lig4_609 DNA Ligase IV 1 609   
LX4_WT 
DNA Ligase IV 1 911   
XRCC4 1 334   
LX4_Dead 
DNA Ligase IV 1 911 K273A 
XRCC4 1 334   
PAXX PAXX 1 204   





The following table includes forward and reverse primers for building recombinant constructs 
and the hairpin DNA (YM164) for nuclease activity analysis purified by desalting and made by 






Plasmid  Comments 
Art_Q363_GFP Intein-GFP (C) p438 codon optimised for insect cell 
Art_S385_GFP Intein-GFP (C) p438 codon optimised for insect cell 
Art_D394_GFP Intein-GFP (C) p438 codon optimised for insect cell 
Art_P426_GFP Intein-GFP (C) p438 codon optimised for insect cell 
Art_Q363_His 8His (C) p438 codon optimised for insect cell 
Art_S385_His 8His (C) p438 codon optimised for insect cell 
Art_D394_His 8His (C) p438 codon optimised for insect cell 
Art_P426_His 8His (C) p438 codon optimised for insect cell 
Art_363-399 8His-GST (N) pGAT3 codon optimised for E.coli 
Art_385-413 8His-GST (N) pGAT3 codon optimised for E.coli 
Art_399-408 8His-GST (N) pGAT3 codon optimised for E.coli 
Art_399-426 8His-GST (N) pGAT3 codon optimised for E.coli 
Art_413-426 8His-GST (N) pGAT3 codon optimised for E.coli 
Art_FL 8His (C) p438 codon optimised for insect cell 
Art_FL_Dead 8His (C) p438 codon optimised for insect cell 
Ku80_CTD 8His-GST (N)  Gift from Dr Qian Wu 
Lig4_240 8His-GST (N) pGAT3 Gift from Dr Takashi Ochi 
Lig4_230 8His-GST (N) pGAT3 Modified from Lig4_240 
Lig4_609 6His-SUMO pOPINS Gift from Dr Takashi Ochi 
LX4_WT 
6His (C) 




pRSFDuet1 Modified from LX4_WT 
  
PAXX 6His (N) pGAT3 Gift from Dr Takashi Ochi 
Table 2: Summary of oligonucleotides 
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Construct Name Primer Sequence Vector 
p438_Artemis_F ATCCAGTGCTCTTCC ATGTCCTCATTTGAAGGGCAGATG p438 
Art_Q363_intein_R ATCTCCCGTGATGCA CTGGCTTGACCGACACAGTGGTTTG p438 
Art_S385_intein_R ATCTCCCGTGATGCA GCTGTCTCGGTGCACAGTCCGGGCT p438 
Art D394_intein_R ATCTCCCGTGATGCA GTCAAACAGATAATCGTCCTCTTCC p438 
Art_P426_intein_R ATCTCCCGTGATGCA TGGCTGCTTCTCAGACACAGCGGTC p438 
Art_Q363_His_R TTATCCACTTCCAAT TTAATGGTGATGGTGATGGTGCTGG CTTGACCGACACAGTGGTTTG p438 
Art_S385_His_R TTATCCACTTCCAAT TTA ATGGTGATGGTGATGGTGGCTG TCTCGGTGCACAGTCCGGGCT p438 
Art_D394_His_R TTATCCACTTCCAAT TTAATGGTGATGGTGATGGTGGTC AAACAGATAATCGTCCTCTTCC p438 
Art_P426_His_R TTATCCACTTCCAAT TTA ATGGTGATGGTGATGGTGTGG CTGCTTCTCAGACACAGCGGTC p438 
Art_363-399_F TTCCAGGGTTCCATGCAGTCTACCGAACCGAAAT pGAT3 
Art_363-399_R CGAGGTCGACGAATT TTAAATCGGCAGCGGGTCATCGAA pGAT3 
Art_385-413_F TTCCAGGGTTCCATG AGCGAAGAAGAAGATGACTACC pGAT3 
Art_385-413_R CGAGGTCGACGAATT TTA CGGGTGAAAGGTTTCCGGATACG pGAT3 
Art_399-408_F TTCCAGGGTTCCATG ATTCCGCTGCGCCATAAAG pGAT3 
Art_399-408_R CGAGGTCGACGAATT TTA CGGATACGGAACTTTATGGCGC pGAT3 
Art_399-426_F TTCCAGGGTTCCATG ATTCCGCTGCGCCATAAAG pGAT3 
Art_399-426_R CGAGGTCGACGAATT TTA CGGCTGTTTTTCAGAAACTG pGAT3 
Art_413-426_F TTCCAGGGTTCCATGCCGGAAGTGTTCAGCATGACGGCAGTTT CTGAAAAACAGCCG pGAT3 
Art_413-426_R CGAGGTCGACGAATTTTACGGCTGTTTTTCAGAAACTGCCGTC ATGCTGAACACTTCCGG pGAT3 
Art_FL_Dead_QC_F TCCTGCCAGCAGGAGCCTGTCCAGGTAGCGT p438 
Art_FL_Dead_QC_R ACGCTACCTGGACAGGCTCCTGCTGGCAGGA p438 
LigIV_P231Stop_F AGGCAACTGCATGATTAATCTGTAGGACTCAGT   
LigIV_P231Stop_R ACTGAGTCCTACAGATTAATCATGCAGTTGCCT   
YM164 TTTTTGATTACTACGGTAGTAGCTACGTAGCTACTACCGTAGTAAT   
 
 
2.2.2 PCR for Ligation Independent Cloning (LIC) 
PCR of specific DNA segments was done using Q5 High-Fidelity DNA polymerase (NEB). 
Generally, a PCR reaction has a total volume of 50ul of: 1x Q5 buffer, 200uM dNTPs mixture, 
 75 
0.5uM forward primer, 0.5uM reverse primer, 20ng template DNA and 1U Q5 High-Fidelity 
DNA Polymerase. The protocol of thermocycler used for the amplification is shown in the 
following table.  
 
Initial Denaturation 98°C 30 s 
35 cycles 98°C 10 s 
*50-72°C 30 s 
72°C 30 s/kb 
Final extension 72°C 2 mins 
*The annealing temperature is calculated by  NEBTm Calculator (http://tmcalculator.neb. 
com/ #!/main) 
 
After amplification, the PCR product was applied to 1% agarose gel, cast with TBE buffer and 
EtBr (Thermo Fisher Scientific), at 100V for 50 minutes to check the outcome of the PCR 
reaction. The target DNA band would then be extracted from the gel using the QIAquick 
Extraction Kit (Qiagen) following the protocol. There was one modification to point out that, 
instead of using 50ul of the elution buffer (Buffer EB) provided in the kit, 30ul of Milli-Q water 
was used for the final elution of DNA.  
  
 
2.2.3 Ligation Independent Cloning (LIC) 
To insert the amplified target DNA fragments into the linearlised vector, In-Fusion HD Cloning 
Plus kit (TaKaRa Bio) was used. The total reaction was 10ul including 2ul of In-Fusion enzyme 
and 8ul of linearlised vector and insert fragment mix. The amount and ratio of the linearlied 
vector and insert fragment was calculated via the In-Fusion molar ratio calculator 
(https://www.takarabio.com/learning-centers/cloning/in-fusion-cloning-tools/in-fusion-mol 
ar-ratio-calculator). The mixture was incubated at 50°C for 15 minutes for the reaction to 




2.2.4 Site-directed mutagenesis PCR 
To mutate specific amino acid residues for mutation analysis or introduce a new stop codon 
for new truncated constructs, site-directed mutagenesis was done using the QuikChange Site-
Table 3: Protocol of thermocycler for PCR 
 76 
Directed Mutagenesis Kit (Agilent Technologies). The total reaction volume was 50ul of 1x 
reaction buffer, 200uM dNTP, 50ng dsDNA template, 125ng forward primer, 125ng reverse 
primer and 2.5U PfuTurbo DNA polymerase. The protocol of thermocycler used for the 
amplification is shown in the following table.  
 
1 cycle 95°C 30s 
18 cycles 
95°C 30 s 
55°C 1 min 
68°C 
1 min/kb of 
plasmid 
 
Once all the listed cycles are completed, the reaction mixture is added with 0.5ul of DpnI 
(20u/ul) and incubated at 37°C for 60 minutes to digest the starting unmutated plasmid 
templates. 
 
2.2.5 Transformation of bacteria and plasmid amplification 
For the amplification of the target plasmid, it was first transferred into bacteria cell. In most 
cases, Subcloning Efficiency™ DH5α Competent Cells (Invitrogen) were used following the 
protocol. Specifically, 10ng of DNA plasmid was first added to 50ul of competent cells in a 
1.5ml microcentrifuge tube. The mixture was first incubated on ice for 30 minutes and later 
receives heat shock for 20 seconds in a 42°C water bath.  The tube was then placed on ice for 
2 minutes, after which 450ul of super optimal broth with catabolite repression (SOC) medium 
was added to the mixture for another 60-minute incubation in a 37°C shaker. After the 
recovery, 100ul of the cell culture was plated onto the previously prepared agar plate, which 
had the specific antibiotics added according to the target plasmid resistance, in a 37°C 
incubator overnight for selection of the successfully transferred bacteria cells. The plate was 
then used for colony picking for plasmid amplification and sealed with parafilm and stored 
under 4°C. 
 
To amplify the plasmid, a single colony collected from the selection plate was added to 5ml 
of lysogeny broth (LB) for culture in a 37°C shaker overnight. The LB was previously prepared 
with the specific antibiotics relevant to the target plasmid. After overnight incubation, the 
cells were collected and the target plasmid was extracted using the QIAprep Spin Miniprep 
Table 4: Protocol of thermocycler for site-directed mutagenesis 
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Kit (Qiagen) following the protocol. There was one modification to point out that, instead of 
using 50ul of the elution buffer (Buffer EB) provided in the kit, 30ul of Milli-Q water was used 
for the final elution of DNA.  
 
 
2.3 Protein Sample Expression and Purification 
 
2.3.1 Protein expression in E.coli 
Commercial BL21(DE3) Competent E. coli cells (New England Biolabs) were transferred with 
the target plasmid with the protein construct previously built in, following the relevant 
protocol. A colony from the selection plate was picked and added to the preculture, Terrific 
Broth (TB) or LB, with the relevant antibiotics. The preculture was then incubated in the 37°C 
shaker overnight for the later large-scale expression in TB or LB. The volume of the preculture 
was dependent on the volume of the later large-scale expression. Generally, 10 ml of 
preculture was required to inoculate 1L of media with the required antibiotics. The inoculated 
large-scale cultures were then incubated in the 37 °C shaker until the OD600 value reached 
0.6. At this point, there were two options for further induction of protein expression. First, 
isopropyl β-D-1-thiogalactopyranoside (IPTG) could be added to the media to reach a final 
concentration of 1mM and the cultures remained in the 37 °C shaker for another 3 hours for 
protein expression. Second, the media could be left in the 16°C shaker for the media 
temperature to drop back to 16°C. Then IPTG could be added to the media to reach a final 
concentration of 1mM and the cultures remained in the 16 °C shaker overnight for protein 
expression. 
 
After the incubation for protein expression, the cultures were centrifuged at 4,200 rpm for 
20 minutes at 4°C using the JS-4.2 rotor and J6-MI centrifuge (Beckman Coulter) for cell 
collection. The supernatant was discarded and the resulting pellets of cells were either 




2.3.1 Protein expression in insect cell 
Commercial Sf9 cells (Gibco®) were used as the expression system of insect cell. To start with, 
the recombinant constructs built in the p438 plasmid were transformed into the commercial 
MAX Efficiency DH10Bac competent E. coli cells (Invitrogen) to produce bacmid following its 
protocol. The bacmid was then analysed by PCR, using M13 forward and M13 reverse primers, 
to see if the recombinant construct is inserted into the bacmid. The successfully reconstructed 
bacmids were then used for generating viruses to transfect insect cells following the protocol 
of Bac-to-Bac™ Baculovirus Expression System (Gibco®).  Generally, to generate baculovirus 
(P1 virus) for future insect cell transfection, the bacmids obtained previously were transfected 
into Sf9 cells in Serum-Free Media (SFM) with Cellfectin Reagent. After incubation for 4h at 
27°C, the media was replaced with complete growth media and incubated for another 5 days. 
The baculovirus was harvested. The P1 virus was then amplified with 25ml of sf9 cells at a 
concentration of 2 million cells/ml to produce P2 virus. The P2 virus was then tested in a 
growth inhibition assay, where 1ml of 5x, 25x or 125x dilution of P2 virus was added to 25ml 
of cell culture at a concentration of 1 million cells/ml, to calculate the titer of virus. After 
calculating the titer, a 3-4-day time-course small-scale expression test was carried out to test 
the optimal expression time after virus addition to the system. Basically, 25ml of cell culture 
at a concentration of 2 million cells/ml was transfected by the P2 viruses with a MOI value of 
2. Everyday 2 ml of cells were collected. They were later lysed and analyzed by running 5%-
12% SDS-PAGE gel. The big-scale insect cell expressions were incubated for protein expression 
based on the expression test. After the incubation for protein expression, the cultures were 
centrifuged at 4,000 rpm for 15 minutes at room temperature in a JLA8.100 rotor (Beckman 
Couter) for cell collection. The supernatant was discarded and the resulting pellets of cells 
were either directly lysed for further protein purification or flash frozen in liquid nitrogen and 
stored at -80 °C. 
 
2.3.2 Cell lysis  
For the cell lysis, sonicator was mainly used. Cell pellets were thoroughly resuspended in 
specific cell lysis buffer based on the purification protocol of different protein constructs with 
cOmplete Mini, EDTA-free protease inhibitor cocktail (Roche). Usually, 30ml- 40ml of the 
resuspended mixture in the 50ml Falcon tube was lysed each time with the Vibra-Cell VCX130 
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ultra-sonicator (Sonics & Materials Inc) using the amplitude of 60%- 70% for a total of 1-2 
minutes using the pulse cycle of every 10-second sonication followed by 20-second break to 
limit the heat generated during sonication. After sonication, the lysate was balanced 
accurately in the Nalgene™ Oak Ridge High-Speed PPCO Centrifuge Tubes (Thermo Fisher 
Scientific), which were then centrifuged at 30,000 × g at 4 °C for 45 minutes. After the 
centrifugation, the supernatant was collected and filtered using the 0.2 μm Sartorius™ 
Minisart™ Single use filter unit (Sartorius™) for the further purification. 
 
2.3.3 Nickel affinity purification 
For the nickel-affinity purification, two products were mostly used including Ni-NTA Agarose 
resins (Qiagen) and HisTrap™ High Performance columns (GE Healthcare). Ni-NTA Agarose 
resins were mainly used for insect cell purification or small-scale expression test and HisTrap™ 
High Performance columns were used for the rest. Generally, the nickel affinity purification 
could be separated into three steps- initial equilibration, sample application and wash and 
elution. For the initial equilibration of the column, 5-10 column volume (CV) of initial buffer 
was used to equilibrate the column. The composition of the initial buffer depended on the 
lysis buffer of the cell of specific protein constructs. The initial buffer should have the same 
pH and salt concentration as the previous cell lysis buffer with extra imidazole at the final 
concentration of 15mM. Also, the reducing agent of the initial buffer was either β-
mercaptoethanol (BME) at the final concentration of 2mM or tris (2-carboxyethyl) phosphine 
(TCEP) at the final concentration of 1mM. After the initial equilibrium, the cell-lysis 
supernatant was loaded to the column, followed by the column washing where the column 
was washed with at least 5-10 CV of washing buffer which is same as the initial buffer in most 
of the cases. The final elution step varied based on the concentration change of imidazle. It 
could be linear-gradient elution, stepwise elution or one-step elution using 500mM imidazole. 
This should be based on the purification protocol of different protein constructs.  
 
The eluted His-tag protein fraction was usually dialysed at 4°C overnight to reduce the amount 
of imidazole. This step could be combined with TEV protease to cleave the His tag. The ratio 
between the amount of TEV protease added and the amount of target His-tag protein was 
1:100. After dialysis and cleavage, the sample was filtered using the 0.2μm Sartorius™ 
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Minisart™ Single use filter unit (Sartorius™). The filtered sample was then loaded to the 
preequilibrated HisTrap™ High Performance column for a “reverse” His-tag purification to get 
rid of the uncut His-tag protein. The flowthrough of the column was collected for the following 
purification steps. 
 
2.3.4 Glutathione S-transferase (GST) affinity purification 
GSTrap HP columns (GE Healthcare) were mainly used for the GST affinity purification. The 
whole procedure is similar to Ni affinity purification mentioned above. The GSTrap HP column 
was first equilibrated with the 5-10 CV initial buffer, which is similar to the cell-lysis buffer 
without the cOmplete Mini, EDTA-free protease inhibitor cocktail (Roche). The cell-lysis 
supernatant was then loaded to the column followed by column washing with 5-10 CV initial 
buffer. Unlike Ni affinity purification, the final elution of GST affinity purification was usually 
one-step elution due to the high specificity of the GST tag. During this step, the column was 
loaded with elution buffer which is the same as the initial buffer with extra L-reduced 
glutathione at the concentration of 25mM. The eluted fraction was usually treated in the 
similar way to that of the Ni affinity purification with dialysis, TEV cleavage, filtering and 
“reverse” GST-tag purification. The flowthrough was then collected for the coming 
purification steps. 
 
2.3.5 Ion Exchange Chromatography 
For the ion exchange chromatography, various columns were used including HiTrap Q HP (GE 
Healthcare), HiTrap SP HP (GE Healthcare), Mono Q (GE Healthcare), Mono S (GE Healthcare), 
HiTrap Heparin HP (GE Healthcare) and hydroxyapatite column (Biorad). Generally, ion 
exchange chromatography was also separated into three steps- equilibration, sample 
application and wash and elution. To start with, the column was equilibrated with the initial 
buffer of low salt, meaning low ionic strength. The sample to be loaded was also previously 
dialysed in the same buffer of low salt. The sample at low salt was then applied to the 
equilibrated column for binding. The column was then washed with 5-10 CV of the equilibrium 
buffer. The elution could be stepwise elution and linear elution. In most of the cases, linear 
elution was used. There were two buffers- the buffer with low salt concentration (eg. 10mM 
NaCl) and the buffer with high salt concentration (eg. 1M NaCl). The protein was eluted on an 
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ÄKTA system (GE Healthcare) using the linear gradient from 100% low-salt buffer to 100% 
high-salt buffer within the elution volume of 20 CV. To point out, the hydroxyapatite column 
(Biorad) is incompatible with Tris and EDTA, which should be avoided in the buffer. 
 
2.3.6 Size Exclusion Chromatography  
For the size exclusion chromatography, considering the size of the protein construct and the 
amount of protein sample, different columns were used including Superdex/ Superose 
columns. Previously collected elution fraction containing the target protein was first 
concentrated using proper Vivaspin spin concentrators (Sartorius) to the smaller volume, 
which is usually the 1% CV of the gel filtration column. The sample was then centrifuged at 
13000x g for 15 minutes at 4°C to accelerate the precipitation of aggregate and insoluble 
contamination in the sample. Later, the centrifuged sample was added to the specific gel 
filtration column, which was preequilibrated with the buffer designed as the final storage 
buffer for the purified protein. The gel filtration was performed using the ÄKTA system (GE 
Healthcare). 
 
2.4 Protein Biochemical and Biophysical Analysis 
 
2.4.1 Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis (SDS-
PAGE) 
To analyse the size of the protein and visualise the protein sample, protein samples were 
applied to SDS-PAGE. Before added to the gel, protein samples were first mixed up with 4X 
loading buffer (200 mM TRIS pH 6.8, 10% SDS, 0.05% bromophenol blue, 20% glycerol, and 
700 mM β-mercapto-ethanol) and incubated on the 98°C Mini Dry Bath Incubator (Starlab) 
for 10 minutes for denaturation.  
 
Two types of SDS-PAGE gels were used for analysis- commercial SDS-PAGE gels including the 
NuPAGE™ 4-12% Bis-Tris Protein Gels (Invitrogen) and the homemade SDS-PAGE gels. In the 
case of using the NuPAGE™ 4-12% Bis-Tris Protein Gel, samples were added and run at 200V 
for 50 minutes in NuPAGE MOPS SDS running buffer (Invitrogen) for medium- to large-size 
proteins or run at 200V for 30 minutes NuPAGE MES SDS running buffer (Invitrogen) for small-
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size proteins. As for the homemade SDS-PAGE gels, they were usually run at 150V for 70 





 Once the electrophoresis was completed, the gel could be stained with Coomassie Blue 
staining (Expedeon) or silver staining using the Pierce™ Silver Stain Kit (Thermo Fisher 
Scientific) following the protocol. 
 
2.4.2 Nickel Affinity Pull-Down Assay 
The nickel affinity pull-down assay was used to identify the fragments of Artemis C-terminal 
peptides interacting with DNA-PKcs. The resin used in the assay was Ni-NTA Agarose (Qiagen) 
and the initial/wash buffer was: 20mM HEPES pH7.5, 200mM NaCl, 15mM imidazole and 
2mM MBE. 5ul of the beads were used in one pull-down experiment group, equilibrated with 
the initial/wash buffer. After equilibration, 1ul of Artemis peptide at the concentration of 
75uM and 4ul of DNA-PKcs at the concentration of 1uM were added to the beads for 
incubation at 4°C for 60 minutes. The system was then washed three times with the 
initial/wash buffer and eluted using the elution buffer which was similar to the initial/wash 
buffer but with 300mM imidazole instead. The elution fraction was added with the 4X loading 
buffer, denatured and applied to the NuPAGE™ 4-12% Bis-Tris Protein Gel (Invitrogen) for 
running at 200V for 30 minutes under 1x NuPAGE MES SDS running buffer (Invitrogen). The 
gel was last stained using the Pierce™ Silver Stain Kit (Thermo Fisher Scientific). 
 
Reagent per 15% running gel per 5% stacking gel 
Milli-Q water 1.1ml  950μl 
Acylamide (30%) 2.5ml  225ul 
1.5M Tris-HCl pH8.8 1.25ml   \ 
0.5M Tris-HCl pH6.8 \ 400μl 
10% SDS 100μl 17μl 
25% Ammonium persulfate 40ul 7μl 
TEMED 10μl 2ul 
Table 5: Recipe of homemade SDS-PAGE gel 
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2.4.3 Ligation Assay 
Ligation assay was used to test the purified DNA ligase IV complex. To do the assay, 50 ng of 
the linearlised plasmid was mixed with the DNA ligase IV complex, with the final 
concentration of 100nM, in a 20μl reaction volume containing 25mM Tris-HCl (pH 7.5), 150 
mM KCl, 1 mM DTT, 10μg/ml BSA. The mixture was then incubated at 37°C for 30 minutes. To 
stop the reaction, the mixtures were incubated at 50°C for another 30 minutes after adding 
2μl of the stop buffer (100 mM EDTA, 0.1% (w/v) SDS) and 0.2μl of 20 mg/ml Proteinase K. 
Reaction mixtures were applied onto 0.8% agarose gel in 1xTBE buffer for electrophoresis 
(run in room temperature at 70 V for 90 minutes). The gel was stained with SYBR Gold and 
visualized using a UV imager 
 
2.4.4 Nuclease Assay 
Nuclease assay was done to test the activity of Artemis endonuclease activity on DNA hairpin. 
To do the assay, a mixture of hairpin DNA labelled with cyanine dye 3 at the final 
concentration of 20 nM, Artemis at the final concentration of 50 nM, and DNA-PKcs at the 
final concentration of 50 nM and other specified proteins at certain concentrations were 
incubated in 20μl of nuclease buffer composed of 5 mM Tris-HCl pH 7.5, 10 mM KCl, 0.5 mM 
ATP and 1 mM DTT. After the incubation at 37°C for 60 minutes, 20μl of stop buffer containing 
95% formamide, 18 mM EDTA, 0.25% SDS was added and the mixture was treated with heat 
shock at 98°C for 5 minutes. The samples were then quickly cooled on ice and separated in a 
12% denaturing polyacrylamide gel in TBE buffer by electrophoresis at 150 V for 15 minutes. 
After running, the gel was visualised using Typhoon™ FLA 9000 (GE healthcare). 
 
2.4.5 Circular Dichroism (CD) 
Circular dichroism was used to test whether the purified full-length Artemis sample was 
folded. The experiment was conducted using the Aviv Model 410 (Aviv Biomedical) at the 
Biophysics facility of the Department of Biochemistry, University of Cambridge under the help 
of Dr Katherine Stott. Sample preparation and the protocol was referred to the SOP provided 
on the facility website (http://www.biophysics.bioc.cam.ac.uk/?page_id=37).  
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2.4.6 Dynamic Light Scattering (DLS) 
Dynamic light scattering was used to test the molecular size and sample homogeneity for 
cryo-EM preparation. The experiment was conducted using the Malvern Zetasizer Nano S 
(Malvern Panalytical) at the Biophysics facility of the Department of Biochemistry, University 
of Cambridge under the help of Dr Katherine Stott. Sample preparation and the protocol was 
referred to the SOP provided on the facility website (http://www.biophysics.bioc. 
cam.ac.uk/?page_id=37). 
 
2.4.7 Mass Spectrometry (MS) 
Mass spectrometry was mainly used to check if the purified protein was the target construct. 
Protein samples were first run on SDS-PAGE gel and stained using Coomassie Blue staining 
(Expedeon). The stained SDS-PAGE gel was washed with Milli-Q water and stored in 5% 
methanol solution and submitted to the CCPcore mass spectrometry facility (University of 
Cambridge, Department of Biochemistry) for subsequent band cutting, trypsin digestion and 
MALDI-TOF mass fingerprinting. 
 
2.4.8 Differential Scanning Fluorimetry (DSF) 
Differential scanning fluorimetry or thermal shift assay (TSA) was used to test the binding of 
fragments with DNA Ligase IV. The experiment was conducted using the Bio-Rad CFX machine 
(BioRad) at the Biophysics facility of the Department of Biochemistry, University of Cambridge. 
It was carried out in a 96-well plate. Each well contains 25μl of reaction mixture of DNA ligase 
IV at the final concentration of 10μM, saturated fragments in DMSO and 5x Sypro orange dye. 
Appropriate positive (Protein, DMSO and AdoMet) and negative (Protein, DMSO only) 
controls were also included. The measurement was performed using certain thermal cycler 
with 25°C for 10 minutes followed by a linear increase of 0.5°C every 30 seconds until reaching 
the final temperature of 95°C. The results were analysed using Microsoft excel sheet. 
 
2.4.9 Protein crystallisation 
Both commercial and manual crystallisation screens were applied to search for the 
crystallisation condition for DNA ligase IV constructs. The commercial screens were set up 
with the 96-well 2-drop MRC plates (Swissci) using the Mosquito crystallisation robot (TTP 
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Labtech) in the sitting drop manner. One well contains 0.2μl of protein solution and 0.2μl of 
the crystallisation condition buffer. The completed plates were then stored at 19 °C in a Rock 
Imager (Formulatrix) for routine light imaging and UV absorbance imaging. The manual 
screens were set up with the 24-well VXD plates (Hampton Research) in the hanging drop 
manner. One well contains 500μl of the crystallisation condition buffer and one hanging drop 
which contained 1μl of protein solution and 1μl of the crystallisation condition buffer. The 
plates were stored at 16°C in a designated crystallisation room and inspected under 
microscope manually on a daily basis. 
 
2.5 Electron Microscopy Sample Preparation, Data Collection and 
Analysis 
 
2.5.1 Grid preparation (Negative stain & cryo-EM) 
For negative staining, CF400-CU grid (Electron microscopy sciences) was glow discharged 
using PELCO easiGlow GlowDischarge system (Ted Pella Inc., USA) for 30 seconds with the 
15mA current. After glow discharge, 2μl of protein sample was applied to the and incubated 
for 30 seconds. The sample was then blot off using filter paper. The grid surface was later 
washed via touching the surface of a Milli-Q water drop and then blot off with filter paper. 
The operation was repeated with another fresh drop of Milli-Q water. The grid surface was 
then put in contact with a drop of 1% uranyl acetate solution for 20 seconds, blot off with 
filter paper and left for airdry.  
 
For cryo-EM, different grids were used, including QUANTIFOIL R 1.2/1.3 300 mesh Cu/Au 
(Quantifoil); UltraAuFoil 1.2/1.3 300 mesh (Quantifoil). Grids were glow discharged using 
PELCO easiGlow GlowDischarge system (Ted Pella Inc., USA) for 60 seconds with the 25mA 
current. The glow discharged grids were then frozen in liquid ethane using FEI Vitrobot Mark 
IV (Thermo Fisher Scientific) under 4°C and 100% relative humidity. The blot force and blot 
time varied among different samples, buffer conditions and grid types. Generally, the blot 
force was between -5 and +5 and the blot time was between 2 and 4 seconds. 
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2.5.2 Sample screening and data collection 
 Negative staining was merely used for screening of the sample to check if the sample was 
homogeneous. FEI Tecnai F20 (Thermo Fisher Scientific) of the Wolfson Electron Microscopy 
Suite of the Department of Materials Science and Metallurgy, University of Cambridge was 
used for negative staining screening under the help of EM specialists.  
 
Cryo-EM was used for both sample screening and data collection. Different microscopes were 
used for cryo-EM experiments including 300 kv Titan Krios I at eBIC Diamond Light Source 
(Thermo Fisher Scientific), 200 kv Talos Arctica at Department of Biochemistry, University of 
Cambridge (Thermo Fisher Scientific) and 300kv Titan Krios at Department of Biochemistry, 
University of Cambridge (Thermo Fisher Scientific). Different parameters were used for 
different data collections and the details will be listed in the result chapters. 
 
2.5.3 Data analysis 
Collected cryo-EM datasets were analysed mostly by Relion 2.0/3.0. Other packages were also 
tried including cryo-SPARC, Scipion and WARP. After the 3D reconstructions and refinements, 
cryo-EM maps were visualised and analysed with Chimera. Some of the maps were also 
modelled using modelling software including Phenix and CCPEM. Detailed process of data 













Chapter 3. Bioinformatics analysis of Artemis 
 
A bioinformatics analysis of Artemis was first carried out to guide the later experimental 
biophysical and biochemical studies. Previous research had proposed that the nuclease region 
of Artemis extended from residue 1 to 385 but the remaining sequence comprising the C-
terminal region of the protein, referred to here as the C-terminal tail, was suggested from 
functional and biochemical dissection to be flexible without ordered structure (Pannicke et 
al., 2004). For a more detailed analysis, including more certain identification on the nuclease 
region, a series of sequence alignments including structural alignment, secondary structure 
prediction and modelling were carried out. Moreover, intrinsic disorder analysis was used to 
investigate the disordered region of Artemis, with the objective of providing insights of 
further possible protein-protein interaction sites similar to the Artemis-DNA Ligase IV 
interaction site. 
 
3.1 Sequence Alignments for the Nuclease Domain 
 
Different sequence alignments were used to analyse the possible boundary of Artemis 
nuclease region taking into account the available information of structures of the nuclease 
region of the homologues, secondary structure prediction and the conservation of amino acid 
residues. 
 
Initially, following the HHpred analysis, SNM1A and SNM1B, which had structures available, 
were chosen as homologues for structural alignment and comparison, as they aligned with 
the highest probability and lowest e value. SNM1A is a 5'-3' exonuclease and might be 
involved in DNA inter-strand crosslink repair (Sengerová et al., 2012). SNM1B, also named as 
Apollo, the twin brother of Artemis in the ancient Greek religion and myth, is a 5'-3' 
exonuclease playing a key role in telomere protection and maintenance during S phase (Liu 
et al., 2009; Sengerová et al., 2012).  The PDB files of SNM1A and SNM1B used for the 
alignment (5AHR and 5AHO) contained only the nuclease domains of those proteins (700-
1040 for SNM1A and 1-335 for SNM1B) (Allerston et al., 2015). Although the three proteins 
are homologues, the sequence identities among SNM1A 700-1040, SNM1B 1-335 and Artemis 
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1-385 are not high, ranging from 26% to 32% (Table 6). Nevertheless, both structures were 






Assuming that SNM1A(PDB:5AHR), SNM1B (PDB:5AHO) and Artemis share similar structures 
as structural homologs, based on the structural alignment of (Figure 16A), the structured 
nuclease region of Artemis should end around Q363, which is different from the previously 
proposed S385. Moreover, another series of secondary structure predictions were carried out 
within the package of Jpred around the transition zone between the nuclease region and C-
terminal tail (Figure 16B). Predictions of different methods showed different results. In 
summary, the region before R360 is predicted to be structured with high confidence 
consistently, while the region after R360 is predicted either unstructured or structured with 
very low confidence. In addition, sequence alignment of Artemis homologs from different 
species was conducted to understand the degree of conservation of residues at the border of 
the nuclease region and C-terminal tail (Figure 16C). There are some conserved hydrophobic 
patches within the extended C-terminal region after Q363. Also, there are a few conserved 
positively or negatively charged patches included in the same region, which may also be 
relevant to Artemis and DNA-PKcs interaction and will be described in detail. Therefore, 
considering all the analyzed alignments, four residues, Q363, S385, D394, P426, were 
predicted to be possible end points of the Artemis nuclease region.  
 
Table 6. Sequence identities of the nuclease regions of the homologues, SNM1A, SNM1B and 
Artemis. The alignment comparison shows they are distantly related with the sequence identities at 


































Figure 16. Bioinformatics analysis on Artemis nuclease region. (A) Structural alignment of SNM1A 
(PDB:5AHR), SNM1B (PDB:5AHO) and Artemis in JOY format defined below; (B) Secondary structure 
prediction around the possible boundary of Artemis nuclease region and C-terminal tail using Jpred. 
Details on acronyms used: Lupas_21/ Lupas_14/ Lupas_28 are coiled-coil predictions for the 
sequence are binary predictions for each location; JNetPRED is the consensus prediction where 
helices are marked as red tubes and sheets are marked as dark green arrow; JNetCONF shows the 
confidence estimate for the prediction; JNetHMM is the HMM profile-based prediction where 
helices are marked as red tubes and sheets are marked as dark green arrows; JNETSOL25/ JNETSOL5/ 
JNETSOL0 are predictions of the solvent accessibility at the solvent accessibility cut-offs of 25%, 5% 
and 0% where ‘B’ indicates ‘buried’ and ‘-‘ indicates ‘exposed’; JNETPSSM is the PSSM-based 
prediction where helices are marked as red tubes and sheets are marked as dark green arrows; 
JNETJURY-- '*' means that the JNETJURY was used to rationalize highly inconsistent primary 
predictions; (C) Sequence alignment of Artemis homologs from different organisms around the 
possible boundary of  Artemis nuclease region and C-terminal tail. The possible positions of the 
cutoff of nuclease region are labelled with black arrow including Q363, S385, D394 and P426. 
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3.2 Artemis Nuclease Domain Models and Comparison 
 
In addition to the previous sequence alignment and comparison, modelling of the Artemis 
nuclease region (Artemis 1-363) was carried out using two packages: Modeller and iTasser 
(Šali and Blundell, 1993; Zhang, 2008). This was important as it provided a fast and 
straightforward prediction of the structure of interest, which could be used to compare with 
the structures of the homologs (SNM1A and SNM1B).  
 
Figure 17. Comparison of the structures of homologs and models of the Artemis nuclease region 
(Artemis 1-363) using two independent packages of Modeller and iTasser. (A) Structural alignment of 
SNM1A (pdb: 5AHR; orange colour) and SNM1B (pdb: 5AHO; red colour); (B) Structural alignment of 
SNM1A (pdb: 5AHR; orange colour), SNM1B (pdb: 5AHO; red colour), Modeller model of Artemis 1-
363 (cyan colour) and iTasser model of Artemis 1-363 (green colour); (C) Structural alignment of 
Modeller model of Artemis 1-363 (cyan colour) and iTasser model of Artemis 1-363 (green colour); (D) 
Differences between the two models. The aligned models of panel C are rotated 90° and the 








As shown in Figure 17A, the structures of the nuclease region of SNM1A (pdb: 5AHR) and 
SNM1B (pdb: 5AHO) are very similar, even though the sequence identity is low (Table 6). 
Compared to the structures of 5AHO and 5AHR, both models of Artemis 1-363 have a similar 
scaffold but are more flexible as the numbers and lengths of loops are higher (Figure 17B). 
Due to the flexibility difference, 5AHO and 5AHR are more compact relative to the Artemis 
models. The two models predicted by different packages are similar but have clear differences. 
The main differences are within the loops of residues 40-57 and residues 290-308, showing 
that the flexibility of the molecules is challenging the modelling. In addition to the 
inconsistent modelling of some loops, there are other differences (Figure 17C). For example, 
in both models W78 and W267 are placed as exposed residues facing the solvent without any 
stabilisation from nearby hydrophobic amino acid residues. This is unlikely to be the case and 
does not happen in 5AHR and 5AHO. There are many possibilities of this situation. For 
example, there may be other binding partners of Artemis to interact with those exposed 
hydrophobic residues. However, there may be errors in the alignment or more likely building 
regions that are absent from the templates used in the comparative modelling. Whatever the 
reason may be, it is clear that this Artemis nuclease region differs in conformation from those 






















3.3 Intrinsic Disorder Analyses of Artemis 
 
As mentioned above, the C-terminal tail of Artemis, comprising almost a half of the protein, 
has extensive intrinsic disorder. In addition, the previous analysis and modelling of the 
nuclease region also indicated that the largely structured N-terminal region of Artemis is likely 
also to have disordered loops. Therefore, it would be interesting to look at the overall intrinsic 
disorder of the protein. Moreover, the disordered Artemis 485-495 region was shown to go 
through concerted folding to form a helix when in contact with DNA Ligase IV. Analysis of the 
disorder in C-terminal tail may be informative for further prediction and experiment to find 
the similar interaction regions on the Artemis flexible tail. 
 
 To investigate the intrinsic disorder of Artemis, three independent packages were used: 
DisEMBL, FoldIndex and IUPred/Anchor (Figure 18) (Linding et al., 2003; Dosztanyi et al., 2005; 
Prilusky et al., 2005). Generally, all packages predicted that Artemis is highly disordered with 
a clear trend that the C-terminal tail has a higher degree of disorder. In the DisEMBL analysis 
(Figure 18A), three different criteria are taken into consideration including 𝑙𝑜𝑜𝑝𝑠/
𝑐𝑜𝑖𝑙𝑠, ℎ𝑜𝑡	𝑙𝑜𝑜𝑝𝑠	and	𝑅𝐸𝑀𝐴𝑅𝐾 − 465.  
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Figure 18. Intrinsic disorder analysis of Artemis. (A) DisEMBL analysis of Artemis including the 
analysis of loops or coil (blue), Remark 465 (green) and Hot loops (red). The probabilities predicted 
are shown as curves and the scores should always be compared to the relative random expectation 
values, which are the dotted lines; (B) FoldIndex analysis of Artemis where the folded region (green) 
has a positive foldindex and the unfolded region (red) has a negative foldindex; (C) Anchor and IUPred 
analysis of Artemis. The probabilities are shown as curves and the scores should always be compared 
to the probability of 0.5, which is the dotted line. 
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In all three packages, when the disorder probability of a region is higher than the relative 
random expectation value, which is the dotted line, the region is predicted to be more 
disordered. 
 
Loops/coils predicts regions that are not necessarily disordered all the time. However, all the 
disordered regions are found only on loops or coils. Therefore, this could be treated as a 
necessary but not sufficient requirement for a disordered region. The regions that are 
predicted not to be loops or coils are located mainly before residue 360, although almost half 
of the regions before 360 are predicted to be loops or coils. As for the C-terminal tail, only 
three small regions (around 480, around 560 and around 675) are predicted not to be loops 
or coils. The Remark 465 analysis shows the region of missing coordinates in X-Ray structures 
as defined by REMARK-465 entries in PDB. Missing coordinates usually indicate the flexibility 
of intrinsic disorder and could be used as a way to predict disorder. According to the Remark 
465 analysis, the first few amino acids of Artemis are likely to be disordered. Also, most of the 
C-terminal tail after residue 360 is likely to be flexible except for four regions including regions 
around 380-420, 440-450, 470-505, 565-625, 655-690 that may fold in the presence of binding 
partners including other parts of Artemis. As for the Hot loops analysis, it is a subset of the 
Loops/coils analysis and picks out the regions of loops/coils with high degree of flexibility. 
Many of the predicted loops or coils regions within the nuclease region are predicted not to 
be flexible including residue 100-150. However, most of the region before residue 100 is 
predicted to be flexible. Also, more than half of the C-terminal tail, mostly after residue 500, 
is predicted to be flexible loops or coils.  
 
Unlike focusing on the intrinsic disorder of the protein, FoldIndex analysis emphasizes 
whether the protein would fold using the sequence provided. The level of disorder can be 
estimated as the opposite property of foldability of the region. Positive FoldIndex of the 
residue indicates the potential of it to fold while negative FoldIndex means unfolded. 
According to the results (Figure 18B), most of the region before 360 should be folded except 
for the region around 1-60 and 240-290. As for the C-terminal tail, most was predicted to be 
unfolded except for two small regions around 413-426 and 490.  
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The IUPred and Anchor analysis focuses on the prediction of the level of disorder and 
disordered but foldable binding region (Figure 18C). When the probability is higher than 0.5, 
it indicates higher level of disorder (IUPred) or higher potential for the disorder region to bind 
a partner (Anchor). The IUPred showed that the whole region before residue 360 is likely not 
to be disordered. Furthermore, most of the C-terminal tail should be flexible except that the 
probabilities of some regions of the C-terminal tail fluctuate around the level of 0.5 including 
the regions around 390-410, 440-450, 480-490 and 680-692. The Anchor analysis showed that, 
among the flexible regions with IUPred probability bigger than 0.5, some have the potential 
to bind a partner. Those include regions around 415-420, 470-480, 490-495, 510-530, 550-
560, 565-605 and 630-640.  
 
Although the results of all three analyses are not consistent in all aspects, there are some 
common points among them. First of all, the nuclease region is more structured compared to 
the C-terminal tail. However, there are many loops or coils or unfolded regions within the 
region. They are not necessarily intrinsically disordered, although the nuclease region on its 
own may be highly flexible. Besides, the C-terminal tail is largely intrinsically disordered while 
some of the regions may be able to fold or have binding partners. The regions with the 
mentioned potential are mainly sitting on two sites around residue 420 and 490. 
 
Interestingly, the region around 490 is exactly the site where Artemis interacts with DNA 
Ligase IV. As for the region around 420, there was no unknown binding partners or structured 
domain. However, it is not far from the previously proposed site of Artemis (Artemis 399-404) 
interacting with DNA-PKcs. As there is no identification of the region of Artemis interacting 
with DNA-PKcs, it could be that the region around 420 is involved in the interaction of Artemis 
and DNA-PKcs. 
 
To further determine the region of Artemis interacting with DNA-PKcs, in addition to the 
intrinsic disorder analysis, the sequence analysis around the region 399-420 is also important. 
According to the sequence alignment (Figure 16C), within the region of 399-404, although the 
residues L401 and R402 were proposed to be the key residues, only R402 and K404 are 
conserved in all species. In the flanking region around 399-404, there are two regions that 
stand out from the others.  
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The first is the small hydrophobic patch of residues L392 and F393, which are conserved 
among all species, and the flanking negative-charge patch around E386. There is a trend to 
increasing negative charge in more evolutionary advanced organisms. It is unclear if the highly 
conserved hydrophobic patch could be a part of the nuclease region or could be involved in 
the protein-protein interaction. The second region is between T410 and S422, where the 
sequences are not highly conserved but reveal a trend of increasing hydrophobicity. 
 
Therefore, to identify the region of Artemis interacting with DNA-PKcs, considering the 
analysis of sequence alignment and intrinsic disorder, five fragments of the C-terminal region 
of Artemis with an N-terminal His tag and a following GST tag were purified, including Artemis 























The nuclease regions of SNM1A and SNM1B were used for the homology modelling of the 
nuclease region of Artemis. Moreover, with the sequence alignment, the boundary of the 
nuclease region should sit between Q363 and P426. iTasser was also used for the modelling. 
The models indicated that the nuclease region of Artemis contains more loop regions 
compared to SNM1A and SNM1B nuclease region. To point out, the models of Artemis 
nuclease region have some deficiencies. There may be some binding partners of Artemis or 
there may be errors in the alignment or more likely building regions that are absent from the 
templates used in the comparative modelling. In fact, at the beginning first and a half year of 
my PhD, I tried to build truncated constructs of Artemis based on the bioinformatics analysis 
for crystallisation to study the structure of the nuclease domain. Strikingly, all the truncated 
constructs were not stable while the full-length protein, although with a low yield, was 
purified stably. This led me to the idea of whether the proposed N-terminal nuclease domain 
interacts with the C-terminal flexible tail for stabilisation. Later, a paper came out during my 
second year of PhD showed that the C-terminal domain interacts with the N-terminal 
nuclease domain (Niewolik et al., 2017). It was proposed that the region around residues 456-
458 is important for this self-interaction, targeting the residues 1-7 (Niewolik et al., 2017). 
This may also be an autoinhibition of the nuclease activity and explain why Artemis cannot 
cut hairpin DNA on its own (Niewolik et al., 2017). Therefore, it may be better to study Artemis 
at full length rather than truncated recombinants to understand how the nuclease is activated 
or regulated. 
 
In addition, a series of bioinformatics analysis were conducted targeting the intrinsic disorder 
of the protein. They were also used to estimate the region of Artemis interacting with DNA-
PKcs. According to the results, the region between Q363 and P426, which is also the region 
where the nuclease region is likely to end, should contain the region interacting with DNA-
PKcs. At the end, five fragments of the C-terminal region of Artemis were designed to test the 
binding with DNA-PKcs, including Artemis 363-399; Artemis 399-408; Artemis 385-413, 
Artemis 399-426 and Artemis 413-426 
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Chapter 4. Protein Purification 
 
Protein purification is the basic part of the project. Without purified protein, none of 
the later biochemical, biophysical and structural studies can be done. During my PhD, 
protein purification of various constructs has been one of the most challenging and 
difficult parts of the whole project for many reasons: 
 
First, there were no canonical purification methods for some constructs and 
optimisation was needed based on different published protocols (Artemis, DNA Ligase 
IV constructs); 
 
Second, many recombinant constructs are difficult to purify with more than four steps 
of chromatography and DNA-PKcs is purified from HeLa cells, different from the 
recombinant constructs (Artemis, DNA Ligase IV constructs); 
 
Third, some proteins have low yield (Artemis, DNA-PKcs, DNA Ligase IV constructs); 
 
Fourth, Artemis full-length protein is flexible and difficult to obtain 100% purity;  
 
Fifth, the HeLa cells for the purification of DNA-PKcs are expensive. 
 
Various constructs of Artemis, DNA-PKcs, DNA ligase IV and Ku were purified. In this 









4.1 Purification of Artemis Constructs 
 
The purification of Artemis constructs can be separated into two steps, one targeting the full-
length constructs and the other targeting the C-terminal peptides within the intrinsically 
disordered region. 
 
4.1.1 Purification of the full-length Artemis constructs 
Two constructs of full-length Artemis were prepared: wild-type Artemis and Artemis H115A. 
While wild-type Artemis is physiologic and functional, Artemis H115A is catalytically inactive 
as H115 together with H33 and H35 is involved in coordinating one Zn ion. Previous work 
showed that the Artemis H115A mutant has little endonuclease activity (Li et al., 2014). The 
inactive mutant was purified to stabilise and study the conformation when the hairpin DNA 
is locked at the Artemis catalytic pocket. The wild-type Artemis was used to examine the 
enzyme properties of the DNA-PKcs/Artemis endonuclease complex. 
 
The His tag is placed at the C terminus of the full-length constructs for two reasons. First, a 
His tag at the N-terminus could disturb the protein catalytic pocket as the N terminus is close 
to the active site. Furthermore, as the C-terminal tail is highly unstructured and very likely to 
be cleaved by proteases, a His tag at the C terminus allows proteins with the C-terminal tail 
cleaved to be filtered out in the first step of affinity chromatography. 
 
Artemis is so flexible and degradable that the purification has been highly challenging and 
there is no one canonical purification protocol. My purification of the full-length Artemis 
constructs was optimised many times based on published procedures. Although it was 
unlikely to get pure and undegraded Artemis, my method has managed to obtain the 
functional Artemis and remove most of the heterogeneity according to gel-filtration profile 
and the results of electrophoresis. In general, the purification can be considered as three 





4.1.1.1 Purification of wild-type Artemis 
To start with, the Sf9 cells expressing Artemis, incubated for two days after the virus 
transformation, was collected for the purification and lysed in cell-lysis buffer (50 mM Tris pH 
8.0, 500 mM KCl, 2 mM β-mercaptoethanol, 10% glycerol, 0.1% Triton X-100, and 20 mM 
imidazole supplemented with protease inhibitors). 10 ml of Ni-NTA resins (Qiagen) was used 
as the gravity column for the first-step His-tag purification (Figure 19A). 
 
According to the gel, the expression of wild-type Artemis was successful using insect cells but 
a big part of the protein appeared to be insoluble and went into the pellet after the 
centrifugation. Nevertheless, the eluted fraction (50ml) was dialysed against 5L of low-salt 
buffer (50 mM Tris pH 8.0, 100 mM KCl, 2 mM β-mercaptoethanol, 10% glycerol, and 0.1% 
Triton X-100) for the Q-column purification. It was noted that white precipitate formed during 
dialysis. This could be Artemis aggregating as the protein may not be very stable under low-
salt condition considering its flexibility. To avoid blocking the subsequent column, the 
dialysed fraction was filtered using the 0.2μm Sartorius™ Minisart™ Single use filter unit, 
loaded to the HiTrap Q column, washed and eluted with high-salt buffer of 1M KCl. Based on 
the ion-exchange chromatogram and the SDS-PAGE gel, the signal of UV 280nm was relatively 
low, and so was the signal of the band of wild-type Artemis (Figure 19B). This suggests that 
the precipitation during dialysis is very likely to be aggregated Artemis. 
 
There were also bands and smearing of contamination of lower molecular weight. This could 
be caused by the degradation of Artemis compared to the elution fraction immediately after 
His-tag purification. Two bands around the molecular weight of 37 kDa and 25 kDa were later 
confirmed to be parts of Artemis by the Matrix-assisted laser desorption/ionization (MALDI) 
fingerprinting MS (PNAC facility, Department of Biochemistry). MALDI-MS showed that the 
two bands contained the peptides from different regions of Artemis although they are 
significantly smaller than the wild-type construct. It may be due to the low resolution of 
separation of different bands around those molecular weights or the band may be a mixture 














Fractions containing the wild-type Artemis were than concentrated, filtered, centrifuged and 
loaded onto the Superose 6 10/300 column equilibrated with storage buffer (25 mM HEPES 
Figure 19. Purification of the wild-type Artemis. (A) SDS-PAGE gel of the His-tag purification of Artemis 
using Ni-NTA gravity flow; (B) The chromatogram and SDS-PAGE gel of the Q-column purification of 
Artemis using the HiTrap Q column; (C)The chromatogram and SDS-PAGE gel of the gel-filtration 
purification of Artemis using the Superose 6 10/300 column. Wild-type Artemis is highly flexible, 
degradable and heterogeneous. There is no canonical purification protocol and this purification was 
optimised based on the published ones. To confirm which fraction to collect, nuclease assay was used 
to check the final gel-filtration fractions and the nuclease assay will be introduced in detail in section 
4.4. The numbers shown next to gel are the molecular weights (kDa) of the markers. F stands for 
Fraction in the lane labels, followed by the fraction number. The red up arrow identifies the final 
collected fraction. All SDS-PAGE gels were stained using Coomassie Blue.  
 104 
pH 7.5, 500 mM KCl, and 2 mM DTT). During the process of centrifugation, the sample became 
more viscous with an increasing degree of yellow colour and with white precipitate appearing, 
indicating that the sample is easily saturated and not highly tolerant of the process of 
concentration. According to the Superose 6 10/300 chromatogram (Figure 19C), there are 
two main protein peaks at the elution volume of 13ml and 15ml, corresponding to the 
molecular weight of 669 kDa and 440 kDa based on the standard calibration curve from GE, 
which are much bigger than the size of wild-type Artemis (78 kDa). Meanwhile, the SDS-PAGE 
gel showed that the fractions of both peaks contained wild-type Artemis. As the standard 
proteins used for the calibration curve (Thyroglobulin for 669 kDa and Ferritin for 440 kDa) 
are structured and packed, the size of the Artemis may be at the same level considering that 
Artemis is highly flexible and unpacked, with the intrinsically disordered loops and tails 
extending from and floating around the structured core.  
 
However, it was confusing as both peaks contained wild-type Artemis and it was unclear 
which peak should be collected. To ensure that the correct physiologic fraction of sample is 
collected, endonuclease assay was carried out on all the fractions from both peaks. A series 
of endonuclease activity assays were done and will be introduced systematically in chapter 5. 
The yield of the purification of wild-type Artemis is low. From two litres of insect cells, 100μg 














4.1.1.2 Purification of Artemis H115A 
The purification of Artemis H115A is similar to that of the wild-type Artemis with the identical 
buffer conditions. However, this construct behaved a little differently. From the same amount 
of insect cell, there seemed to be more expression of Artemis H115A compared to the 
wildtype, along with more degradation. This was evident after the first step of His-tag 
purification (Figure 20A). Artemis H115A also precipitated during the dialysis with the low-
salt buffer to go through Q-column purification. It was eluted at a similar level of salt during 
the Q-column elution step (Figure 20B). Due to the higher expression level, a larger volume 
of eluate was collected compared to that of the wildtype, resulting in a higher concentration 
level to load the sample onto the gel-filtration column (Superose 6 10/300). The Artemis 
H115A sample precipitated more than the wildtype during the concentrating process. The 
gel-filtration chromatogram is quite different to the one of wildtype (Figure 20C). There are 
two significant peaks in the chromatogram. One is in the void volume (around 7ml) and the 
other elutes at a similar position to the functional wild-type Artemis (around 15ml). According 
to the SDS-PAGE gel, there is continuous presence of the band of Artemis H115A from the 
void volume till the ideal elution position. This is likely to be caused by the over-centrifugation 
during the concentrating process of the sample preparation for the gel filtration. There was 
less sample during the purification of the wild-type Artemis and the centrifugation of the wild-
type sample caused some small aggregates that ended up coming from the peak next to the 
functional batch of wild-type Artemis. While in this case of Artemis H115A, there was more 
protein expressed and the concentration increased compared to that of the wildtype, leading 
to various aggregates of different sizes ranging from the void volume to the region next to 
the ideal elution position. 
 
To ensure that the correct fractions were collected, the chromatogram and SDS-PAGE gel 
were carefully compared to those of the wild-type Artemis and the fraction A15 was finally 
collected. The yield is higher than that of the wildtype. From two litres of insect cells, 300μg 

















Figure 20. Purification of Artemis H115A. (A) His-tag purification of Artemis H115A using Ni-NTA; 
(B) Q-column purification of Artemis H115A using the HiTrap Q column; (C) Gel-filtration purification 
of Artemis H115A using the Superose 6 10/300 column. The purification of Artemis H115A is the 
same as that obtained from the optimised purification of wild-type Artemis. Compared to wild-type 
Artemis, Artemis H115A seems to have better expression while having decreased heterogeneity. To 
confirm which fraction to collect, the final gel-filtration fractions and chromatography were 
compared to those of wild-type Artemis. The numbers shown next to the gel are the molecular 
weights (kDa) of the markers. F stands for Fraction in the lane labels, followed by the fraction 
number. The red arrow indicates the final collected fraction. All SDS-PAGE gels were stained using 
Coomassie Blue.   
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4.1.2 Purification of Artemis C-terminal Fragments 
Artemis C-terminal fragments were produced to investigate the protein-protein interaction 
between DNA-PKcs and Artemis and identify the Artemis C-terminal region that binds to DNA-
PKcs. Based on the bioinformatics analysis and previous research, five fragments were 
purified including Artemis 363-399, 399-408, 385-413, 399-426 and 413-426. 
 
All the fragments are tagged with a N-terminal GST and His tag. The tag was designed to 
weight up the fragments, which are relatively small and difficult to purify on their own. 
Furthermore, it would be difficult to identify the small fragments without a GST tag on the 
SDS-PAGE gel during following experiments.  
 
The purification of the fragments is a one-step GST-tag purification due to the high specificity 
of the GST tag and the low heterogeneity/ complexity of the fragments. For example, in the 
purification of Artemis 413-426 fragment, the transformed BL21 (DE3) cells was collected, 
lysed and centrifuged. The supernatant was loaded onto a GSTrap column, which was then 
washed and eluted with a high concentration of reduced L-glutathione. The elution fractions 
are pure with one major band of Artemis 413-426 and a small band at a lower position, which 
is likely to be the GST tag on its own as the fragment of 413-426 is unstructured and can be 
degraded easily (Figure 21A). The elution fractions then went through buffer exchange, 
concentrating and snap freezing, finally stored at -80 °C.  
 
All the other fragments went through the same process and they were all pure as 
demonstrated in Figure 21B. They also all exhibit a small contamination band below the band 
of the purified fragment, suggesting that the contamination band is a common degraded 















Figure 21. Purification of Artemis C-terminal fragments. (A) GST-tag purification of Artemis 413-426 
using GSTrap column. The red arrow identifies the final collected fraction.; (B) Final purification results 
of the collected samples of other Artemis C-terminal fragments including Artemis 363-399; 399-408; 
385-413; 399-426. The numbers shown next to the gels are the molecular weights (kDa) of the 
markers. All SDS-PAGE gels were stained using Coomassie Blue.   
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4.2 Purification of DNA-PKcs 
 
The purification of DNA-PKcs differs from that of the other recombinant constructs as DNA-
PKcs is purified as a native protein. There is no affinity tag and the native expression level of 
DNA-PKcs in HeLa cells is less than that of the recombinantly expressed proteins. Careful 
identification of the correct band of DNA-PKcs is needed at the beginning to ensure that the 
right samples are collected for the following purification steps. 
 
The material for the native purification of DNA-PKcs is HeLa cell nuclear extract, from which 
DNA-PKcs was actually first discovered in 1990 (Carter et al., 1990). The purification of DNA-
PKcs was optimised based on the published protocols (Gell and Jackson 1999; Sibanda et al., 
2017). There are four steps of purification in total: Q-column purification, heparin-column 
purification, S-column purification and gel-filtration purification. 
 
Initially, Q column loading buffer (20 mM Hepes pH 7.6, 100 mM NaCl, 10%(v/v) glycerol, 0.5 
mM EDTA, 2 mM MgCl2, 5 mM DTT) was added to thaw the frozen nuclear extract. The 
thawed mixture was then dialysed against the Q column loading buffer, loaded onto HiTrap 
Q column, washed and eluted from 100 mM NaCl to 500 mM NaCl. As shown in the SDS-PAGE 
gels (Figure 22A), pure DNA-PKcs sample, which was a gift from Dr Takashi Ochi, was used as 
a marker to help pick up the fractions containing DNA-PKcs. There was no significant peak in 
the chromatogram for the fractions containing DNA-PKcs and the fractions had complicated 
profiles of various protein bands compared to the classic affinity-tag purification of 
recombinant proteins. 
 
 The picked ones were then dialysed, loaded onto HiTrap heparin column, washed and eluted 
100 mM NaCl to 1000 mM NaCl (Figure 22B). Compared to the picked fractions in the Q-
column purification, the fractions with DNA-PKcs eluted as a significant peak in the 
chromatogram. Additionally, the SDS-PAGE gel profiles of the fractions became cleaner and 
the biggest contamination around 50 kDa was removed at lower-salt condition during the 











Figure 22. Purification of native DNA-PKcs. (A) Q-column purification of DNA-PKcs using HiTrap 
Q column; (B) Heparin-column purification of DNA-PKcs using the HiTrap Heparin column; (C) S-
column purification of DNA-PKcs using Mono S column; (D) Gel-filtration purification of DNA-
PKcs using Superose 6 10/300 column. The numbers shown next to gel are the molecular 
weights (kDa) of the markers. F stands for Fraction in the lane labels, followed by the fraction 
number. The red arrows identify the final collected fractions. All SDS-PAGE gels were stained 
using Coomassie Blue.   
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The following step was S-column purification using Mono S column (Figure 22C) (Buffers: 20 
mM Hepes pH 7.6, 10%(v/v) glycerol, 0.5 mM EDTA, 2 mM MgCl2, 5 mM DTT with extra salt 
from 100 mM NaCl to 500 mM NaCl). This was to remove the degraded DNA-PKcs products. 
The fractions containing DNA-PKcs corresponding to the significant peak in the chromatogram 
were collected and concentrated for the final gel-filtration purification. 
 
 The chromatogram of the gel-filtration purification using Superose 6 10/300 column showed 
that the sample was pure with one peak only at the elution volume of 14 ml (Figure 22D) 
within the buffer (20 mM Hepes pH 7.6, 200 mM NaCl, 0.5 mM EDTA, 2 mM MgCl2, 5 mM 
DTT). The elution volume of DNA-PKcs is very close to that of Ferritin (440 kDa), which is of a 
similar size. The SDS-PAGE gel profile also showed clearly a strong band corresponding to 
DNA-PKcs, confirmed by mass spectrometry. There was some degradation of the protein but 
it was consistent with the published purified DNA-PKcs SDS-PAGE profiles as DNA-PKcs has a 





















4.3 Purification of DNA Ligase IV Constructs 
 
The DNA ligase IV constructs purified include the DNA ligase IV along with the XRCC4 
homodimer, the catalytic domain of DNA ligase IV and the DNA ligase IV DBD, of which only 
DNA ligase IV/ XRCC4 and DNA ligase IV DBD will be introduced here. The purification of the 
catalytic domain of DNA ligase IV is not described in this chapter but will be included in the 
supplementary information as the yield of the catalytic domain is too low for the subsequent 
protein biochemical and biophysical characterisation (Figure S1).   
 
4.3.1 Purification of DNA Ligase IV Complex Constructs 
DNA ligase IV complex involves full-length DNA ligase IV and a XRCC4 homodimer. Due to the 
flexibility, the full-length DNA ligase IV was purified in complex with the XRCC4 homodimer 
that stabilises the C-terminal region. To express the complex, sequences of both DNA ligase 
IV and XRCC4 are put together on a co-expression vector (pRSFDuet1).  Similar to Artemis, the 
His tag of DNA ligase IV is located on the C terminus to cope with the flexibility of C-terminal 
region of DNA ligase IV. Two constructs of the complex were purified: the wild-type DNA 
ligase IV complex and the mutant DNA ligase IV complex (LigIV K273A), which is non-
functional. The purification protocol is modified from that published by Wang et al. in 2007. 
and involves four steps including Nickel-affinity purification, ion-exchange purification, gel-
filtration purification and hydroxyapatite purification. The purification of the DNA ligase IV 
complex is similar to that of full-length Artemis due to heterogeneity of the protein samples. 
It was challenging but the purification protocol succeeded in removing most of the 









4.3.1.1 Purification of Wild-Type DNA Ligase IV Complex 
The Rosetta cells carrying the DNA ligase IV/ XRCC4 co-expression vector, induced with IPTG, 
were incubated at 16 °C and 220 rpm overnight. After incubation, the cells were collected, 
lysed and centrifuged (Buffer: 50 mM sodium phosphate buffer pH 8.0, 300 mM NaCl, 10%(v/v) 
glycerol, 1 mM β-mercaptoethanol, 5 mM imidazole, 100 uM PMSF, 1x Complete protease 
inhibitor EDTA-free). The supernatant was applied to the first step of purification using 
HisTrap column. For the washing step, six different buffers were explored with changing salt 
or imidazole concentrations. According to the SDS-PAGE gel (Figure 23A), there were three 
main bands. The one over 100 kDa is full-length DNA ligase IV, the one lower than 75 kDa is 
the degraded DNA ligase IV and the one around 50 kDa is full-length XRC44, confirmed by 
mass spectrometry. It should be noted that the actual molecular weight of XRCC4 is 38kDa, 
which should appear close to the band of 37 kDa in the marker.  However, this phenomenon 
is consistent with the previous purification profiles published (Lee et al., 2000; Wang et al., 
2007) and it is likely to be caused by the amino acid composition of XRCC4. 
 
The elution fraction was then adjusted to lower salt concentration (100 mM) with a no-salt 
buffer to be loaded onto HiTrap Q column for the second-step purification. During the Q-
column purification, some degraded DNA ligase IV and contaminations with low molecular 
weight were removed (Figure 23B). The fractions containing DNA ligase IV and XRCC4 were 
collected and concentrated for the gel-filtration purification. 
 
Superdex 200 16/60 was used for gel filtration (Figure 23C). Most of the excess XRCC4 and 
degraded products of lower molecular weight were removed during this step as they eluted 
at the position of 60 ml. Although the heterogeneous sample resulted in broad and 
continuous peaks without clear separation, the fractions containing most of the DNA ligase 
IV complex appeared at the position of 55 ml. It is close to the elution position of ferritin (440 
kDa), confirming the flexibility of DNA ligase IV complex which is likely to be caused by the 
flexible C-terminal region of DNA ligase IV. The fractions with DNA ligase IV complex and no 












Figure 23. Purification of wild-type DNA ligase IV complex. (A) His-tag purification of wild-type 
DNA ligase IV complex using HisTrap column; (B) Q-column purification of wild-type DNA ligase IV 
complex using the HiTrap Q column; (C) Gel-filtration purification of wild-type DNA ligase IV 
complex using superdex 200 16/60 column; (D) Hydroxyapatite purification of wild-type DNA ligase 
IV complex using Bio-Scale CHT Type I column. The numbers shown next to gel is the molecular 
weight (kDa) of the markers. F stands for Fraction in the lane labels, followed by the fraction 
number. The red up arrow is pointing the final collected fraction. All SDS-PAGE gels were stained 
using Coomassie Blue.   
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Bio-Scale CHT Type I column, used for the final hydroxyapatite purification, was the final step 
in the removal of nuclease contaminants (Wang et al., 2007) (Figure 23D).  The final fraction 
collected was relatively pure with a little degraded DNA ligase IV around 75 kDa. The yield of 




























4.3.1.2 Purification of Mutant DNA Ligase IV (LigIV K273A) Complex 
K273 of DNA ligase IV reacts with ATP to form the lysine-AMP covalent intermediate at the 
beginning of DNA ligation. The mutation (K273A) inhibits the process of DNA ligase IV 
adenylation, making the mutant DNA ligase IV (LigIV K273A) complex non-fuctional.  
 
The purification of the mutant complex is the same as that of the wildtype. However, the 
mutant complex behaved slightly differently. From the same volume of cells, more mutant 
protein complex than wildtype complex is obtained after His-tag purification but with more 
contamination bands (Figure 24A), indicating that the mutant complex has better expression 
or can be more soluble.  Moreover, in the step of Q-column purification, although the elution 
peaks in the chromatogram are similar in shape, those from the mutant purification are at a 
higher salt concentration level (Figure 24B). This suggests that the wildtype and mutant 
should have different ionic properties and the mutant complex should have more exposed 
negative-charge surface area in the buffer. During the gel-filtration purification, the peak of 
the mutant eluted later after 60 ml (Figure 24C). Furthermore, unlike the wildtype, the peaks 
of the mutant complex and XRCC4 and other contaminants are all merged into one. This 
showed that the molecule of the mutant complex may be more compact than the wild-type 
molecule. Last but not least, the hydroxyapatite purification was the last step and the final 
fractions were collected (Figure 24D). The yield of the mutant complex is better than the 

















Figure 24. Purification of mutant DNA ligase IV complex (LigIV K273A). (A) His-tag purification of 
mutant DNA ligase IV complex using HisTrap column; (B) Q-column purification of mutant DNA ligase 
IV complex using the HiTrap Q column; (C) Gel-filtration purification of mutant DNA ligase IV complex 
using Superdex 200 16/60 column; (D) Hydroxyapatite purification of mutant DNA ligase IV complex 
using Bio-Scale CHT Type I column. The numbers shown next to the gel are the molecular weights 
(kDa) of the markers. F stands for Fraction in the lane labels, followed by the fraction number. The 
red arrow indicates the final collected fraction. All SDS-PAGE gels were stained using Coomassie Blue.   
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4.3.2 Purification of DNA Ligase IV DNA Binding Domain   
The DNA ligase IV DBD construct comprises residues 1-230. It was purified for the fragment-
based drug discovery targeting the DNA ligase IV-Artemis interaction site. The sequence of 
DNA ligase IV DBD was inserted in the pGAT3 vector with a N-terminal His-GST tag. The 
purification process includes three steps: GST-tag purification, reverse His-tag purification 
and gel-filtration purification.  
 
The BL21 (DE3) cells expressing DNA ligase IV DBD were collected, lysed and centrifuged with 
the supernatant loaded onto the GSTrap column (Lysis buffer: 50 mM Tris-HCl pH 8, 300 mM 
NaCl, 5 mM DTT, 1x Complete protease inhibitor EDTA-free). The column was then washed 
and eluted. The elution profile showed a strong band of the DNA ligase IV DBD with the His-
GST tag slightly above the band of 50 kDa in the marker (Figure 25A). The eluted sample was 
then added with TEV protease and dialysed at 4 °C overnight (Dialysis buffer: 30 mM Tris-HCl 
pH 8, 150 mM NaCl, 2 mM β-mercaptoethanol). Later, the dialysed sample was loaded onto 
HisTrap column preequilibrated with the dialysis buffer and the flowthrough collected during 
the reverse His-tag purification. This is to remove the undigested protein, cleaved His-GST tag 
and the His-tagged TEV proteases. The column was then washed using buffers with increasing 
imidazole concentrations. According to the gel, there were tag-cleaved DNA ligase IV DBD 
samples non-specifically binding to the column but they were washed off in the first two runs 
of washing with low-imidazole buffer (Figure 25A).  
 
The flowthrough and wash fractions containing DNA ligase IV DBD were then concentrated 
and loaded onto the Superdex 75 16/60 column (Final buffer: 25 mM Tris-HCl pH 7.5, 150 mM 
NaCl, 5 mM DTT). According to the gel-filtration chromatogram and SDS-PAGE gel, the 
uncleaved protein, GST tag and other contaminants of higher molecular weight were all 
removed before the DNA ligase IV DBD came out at the corresponding position (Figure 25B). 
The peak fractions were then concentrated and collected. From four litres of cells, over 10 








Figure 25. Purification of DNA ligase IV DBD (DNA ligase IV 1-230). (A) GST-tag purification and 
reverse His-tag purification of DNA ligase IV DBD using HisTrap column; (B) Gel-filtration 
purification of DNA ligase IV DBD using the Superdex 75 16/60 column. The numbers shown next 
to the gel are the molecular weights (kDa) of the markers. The red arrow indicates the final 
collected fraction. All SDS-PAGE gels were stained using Coomassie Blue.   
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4.4 Purification of Ku80 CTD 
 
Ku80 593-732 corresponds to the C-terminal globular domain of Ku80 and the DNA-PKcs 
interaction sequence.  The sequence of Ku80 CTD was inserted in the pGAT3 vector with a N-
terminal His-GST tag. The purification of Ku80 CTD is based on the published method (Sibanda 
et al., 2010). There are five steps in total including His-tag purification, reverse His-tag 
purification, Q-column purification, reverse GST-tag purification and gel-filtration purification. 
 
The BL21 (DE3) cells expressing Ku80 CTD were collected, lysed and centrifuged with the 
supernatant loaded onto Ni-NTA beads (Lysis buffer: 20 mM Tris pH 7.5, 150 mM NaCl, 2mM 
β-mercaptoethanol, 1x Complete protease inhibitor EDTA-free). The beads were then washed 
twice with low-imidazole buffer and eluted with high-imidazole buffer. There was a strong 
band of protein around 37 kDa in the elution that should correspond to the GST-tagged Ku80 
CTD (Figure 26A). TEV protease was added to the eluted sample and dialysed at 4 °C overnight 
(20 mM Tris pH 7.5, 10 mM NaCl, 2 mM β-mercaptoethanol). During the following reverse 
His-tag purification, the dialysed sample was loaded on to HisTrap column with the 
flowthrough collected to remove the uncut protein and the cleaved GST tags. The TEV 
protease was not highly active in this case and a large proportion of the sample remained 
uncut (Figure 26B). The flowthrough was directly loaded onto the mono Q column for 
purification with an elution salt gradient from 10 mM NaCl to 1 M NaCl. According to the 
chromatogram and SDS-PAGE gel, this step removed most of the contaminants of higher 
molecular weight including the GST tag and the uncut protein. The fractions containing most 
Ku80 CTD were collected. However, to remove remaining GST tag and uncut protein, the 
collected fractions were loaded on to GSTrap column for reverse GST-tag purification. The 
flowthrough was collected and the GST and uncut protein were mostly removed (Figure 26C). 
The flowthrough was subsequently concentrated and loaded onto Superdex 200 10/300 (Final 
buffer: 20 mM HEPES pH 8.0, 150 mM NaCl, 5 mM DTT). Most of the contaminants were 
removed and the final fractions containing Ku80 CTD were collected and concentrated for 



















Figure 26. Purification of Ku80 CTD (Ku80 593-732). (A) His-tag purification of Ku80 CTD using Ni-NTA; 
(B) Reverse His-tag purification and Q-column purification of DNA ligase IV DBD using HisTrap and 
mono Q column; (C) Reverse GST-tag purification and gel-filtration using GSTrap and Superdex 200 
10/300 column. The numbers shown next to gel are the molecular weights (kDa) of the markers. F 
stands for Fraction in the lane labels, followed by the fraction number. The red arrow indicates the 





The purifications of different NHEJ constructs presented various challenges. Many of them 
are highly flexible, leading to high level of heterogeneity and degradation/contamination and 
multiple steps of purifications. Good examples include the purifications of full-length Artemis 
constructs and DNA ligase IV complexes. Moreover, the yields from the purifications of many 
human NHEJ proteins were relatively low, including those of full-length Artemis and DNA 
ligase IV complexes, not to mention the purification of native DNA-PKcs.  
 
Nevertheless, after purification and optimisation, most of the contamination was removed 
and the pure samples were successfully collected. In addition, although limited by the low 
yields of many proteins, biochemical and biophysical characterisations proved useful for 
investigating the properties of the proteins and NHEJ, which will be discussed in chapter 5. 
Last but not least, the purified samples were used for the later cryo-EM structure studies, 



















Chapter 5. Protein Biochemical and Biophysical 
Characterisation 
 
The purified proteins were used for biochemical and biophysical characterisation to study a 
series of questions relevant to targeting the DNA-PKcs/Artemis endonuclease complex, 
including its activity and interactions with other protein of NHEJ. Moreover, various purified 
constructs were used for the collaboration between our group and the Strick group to study 
the temporal organisation of NHEJ. 
 
The first priority was to understand the structure and function of the DNA-PKcs/ Artemis 
endonuclease complex. To investigate this, purified Artemis and DNA-PKcs proteins were 
used in a series of nuclease assays with different NHEJ components. The Artemis H115A 
mutant was used in preliminary structural studies. Pulldown experiments were conducted to 
study the protein-protein interactions between DNA-PKcs and Artemis and to define the 
Artemis region interacting with DNA-PKcs.  
 
Secondly, preliminary screening experiments were initiated targeting the interaction site 
between Artemis and DNA ligase IV with a view to initiating a fragment-based drug discovery 
campaign. 
 
Last but not least, experiments were conducted to understand the temporal organisation of 
NHEJ, especially the end synapsis. These required purified constructs of DNA-PKcs, DNA ligase 
IV complex, and PAXX protein for the collaboration work using single-molecule methods with 












5.1 DNA-PKcs/Artemis Characterisation 
 
Functional assay was conducted to understand the activity of DNA-PKcs/Artemis 
endonuclease complex. Biophysical experiments were used to characterise Artemis H115A. 
Different Artemis C-terminal peptides were applied to pulldown experiments with DNA-PKcs.  
 
5.1.1 DNA-PKcs/Artemis Endonuclease Complex Functional Assay  
Although the purification described in Chapter 4 was successful in removing most of the 
contaminations and heterogeneity of the full-length Artemis constructs, dealing with the 
samples remained challenging. Degradation and aggregation was observed in the different 
steps during the purification. Therefore, it was important to investigate whether the purified 
protein was stable, if it was folded properly and biologically active. In the case of wild-type 
Artemis, the best approach is to carry out a functional assay of the DNA-PKcs/Artemis 
endonuclease complex as it is the only human endonuclease targeting DNA hairpins.  
Figure 27. Functional assay of the DNA-PKcs/Artemis endonuclease complexes including the 
wildtype and mutant targeting the DNA hairpin. The results of the nuclease assay of the DNA-
PKcs/wild-type Artemis complex are shown in the gel on the left and those for the DNA-PKcs/ 
Artemis H115A complex on the right. The substrate is a 20bp dsDNA hairpin with an extra 
sequence of 6nt ssDNA on the 5ʹ end labelled with cyanine dye 3 (the * label). The gels used for 
the assay were 12% denaturing polyacrylamide gel. The gels were scanned using Typhoon™ FLA 
9000 to detect the fluorescence of the cyanine dye 3 label. The band of substrate and the band 
of hairpin opening product are indicated and annotated.  
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For the nuclease assay investigating the hairpin DNA opening activity of DNA-PKcs/Artemis 
complex, a hairpin DNA labelled with 5ʹ cyanine dye 3 was used as the substrate (Figure 27). 
When the endonuclease complex is functional, it should cut at the tip of the hairpin DNA to 
produce a single strand of DNA of around 28nt with the 5ʹ cyanine dye 3 label, which is shorter 
than the uncut DNA of 46nt.  
 
Figure 27 shows results of the DNA-PKcs/ wild-type Artemis complex cut of the hairpin DNA 
at the hairpin end where there was a clear signal of the hairpin-opening product and most of 
the substrate was gone. It was also shown that the endonuclease activity is only active when 
the wild-type Artemis is in complex with DNA-PKcs. On the other hand, the mutant Artemis 
H115A is not functional either in complex with DNA-PKcs or not. 
 
Another set of endonuclease-activity assays was then carried out to investigate whether Ku 
plays a role in modulating DNA-PKcs/Artemis endonuclease complex activity. Ku is known to 
be the first NHEJ component that initiates the whole process and recruits DNA-PKcs. Besides, 
there were previous studies indicating interactions among Ku, DNA-PKcs and Artemis. The 
sample of Ku (full-length Ku70/80 complex) was obtained from Dr Qian Wu and all the 
possible combinations of Ku, DNA-PKcs and Artemis were tested (Figure 28A). The hairpin 
DNA was only opened when there was the DNA-PKcs/Artemis complex. Moreover, the 
presence of Ku slightly reduced the activity of DNA-PKcs/Artemis complex.  
 
Ku has the highest binding affinity to DNA ends. DNA-PKcs is proposed to recruit Artemis to 
process the DNA ends that require cleaving, including hairpin DNA ends. Therefore, Ku is 
highly likely to be involved in the reaction when DNA-PKcs/Artemis complex interacts with 













Figure 28. Effect of Ku together with other NHEJ components on the activity of DNA-
PKcs/Artemis endonuclease complex targeting the DNA hairpin. (A) Nuclease assay of the DNA-
PKcs, wild-type Artemis and Ku. (B) Nuclease assay of the DNA-PKcs, wild-type Artemis, Ku and 
other NHEJ components. The substrate is a 20bp dsDNA hairpin with an extra sequence of 6nt 
ssDNA on the 5ʹ end labelled with cyanine dye 3 (the * label). The gels used for the assay were 
12% denaturing polyacrylamide gel. The gels were scanned using Typhoon™ FLA 9000 to detect 
the fluorescence of the cyanine dye 3 label. The band of substrate and the band of hairpin 








Figure 29. Effect of XLF, XRCC4, XLF/XRCC4 on the activity of DNA-PKcs/Artemis endonuclease 
complex targeting of the DNA hairpin with and without Ku. (A) Nuclease assay of the DNA-PKcs, 
wild-type Artemis and Ku. (B) Nuclease assay of the DNA-PKcs, wild-type Artemis, Ku and other 
NHEJ components. The substrate is a 20bp dsDNA hairpin with an extra sequence of 6nt ssDNA 
on the 5ʹ end labelled with cyanine dye 3 (the * label). The gels used for the assay were 12% 
denaturing polyacrylamide gel. The gels were scanned using Typhoon™ FLA 9000 to detect the 
fluorescence of the cyanine dye 3 label. The band of substrate and the band of hairpin opening 
product are indicated and annotated.  
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There are several hypotheses concerning the reducing effect of Ku. First, it may be that the 
hairpin DNA is shielded from the endonuclease complex as Ku binds to the DNA strongly. To 
test this, the nuclease assay with hairpin DNA, Ku, DNA-PKcs and Artemis was done together 
with a Ku-DNA binding inhibitor from our collaborator (Dr Daruka Mahadevan and Dr Eric 
Weterings from the University of Arizona). However, the inhibitor did not improve the 
nuclease activity, suggesting that shielding of the hairpin DNA by Ku should not be the main 
reason.  
 
Another hypothesis concerning the reducing effect is that other NHEJ components may be 
needed to improve the efficiency when the system contains Ku, DNA-PKcs and Artemis. To 
check this hypothesis, the activity of DNA-PKcs/Artemis endonuclease complex was tested 
with Ku in combination with various NHEJ components that were known to interact with Ku 
or DNA-PKcs or Artemis including XLF, PAXX, XRCC4 and mutant LX4 [mutant DNA ligase IV 
complex (LigIV K273A)]. The mutant LX4 instead of the wildtype was used to ensure that the 
DNA ends would not be ligated to interfere with the results. The protein samples of Ku, XLF 
and XRCC4 were generous gifts from Dr Qian Wu. According to the results (Figure 28B), Ku 
continued to interfere with the DNA-PKcs/Artemis endonuclease activity no matter what 
NHEJ component was added when compared to the group containing only DNA-PKcs/Artemis 
complex. However, among all the groups containing Ku, DNA-PKcs and Artemis, the one with 
XLF and the one with XRCC4 clearly had higher efficiency. Interestingly, XLF and XRCC4, 
belonging to the same XRCC4 superfamily, are known to interact with each other and may 
form filaments. Therefore, the effects of XLF, XRCC4 and XLF/XRCC4 on the endonuclease 
activity were further investigated. The proteins were first added to the Ku/DNA-PKcs/Artemis 
system with a gradient concentration (Figure 29A). It was shown that the increasing 
concentration of XLF did not significantly increase the endonuclease activity while the 
increasing amount of XRCC4 stimulated the activity. Moreover, XLF/XRCC4 had the most 
stimulating effect under the highest concentration.  
 
Furthermore, to test whether the stimulating effect is related to the interaction with Ku, 
another set of endonuclease assay was done to check the effect of XLF, XRCC4 and XLF/XRCC4 
on the DNA-PKcs/Artemis only system (Figure 29B). Interestingly, it was shown that XLF 
improved the efficiency of the endonuclease complex significantly while XRCC4 was not. The 
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stimulating effect of XLF/XRCC4 was better than XRCC4 but not comparable to XLF. In 
conclusion, XLF can significantly improve the efficiency of the DNA-PKcs/Artemis 
endonuclease complex. However, when Ku is involved, XLF and XRCC4 are both needed to 
improve the efficiency of the DNA-PKcs/Artemis endonuclease complex.  
 
Another possible reason for the interfering effect of Ku may be that some of the interactions 
between DNA-PKcs and Ku compete with those between DNA-PKcs and Artemis, reducing the 
activity of the endonuclease complex. To prove this, more insights from the structural studies 
are required. In fact, my later cryo-EM structure study of DNA-PKcs/ Artemis complexes 
structures provided supporting results, which will be introduced in detail in chapter 5.  
 
Last but not least, the interfering effect of Ku can be caused by various factors and the 
hypotheses mentioned above may all contribute to it. It requires further investigation to 




















5.1.2 Artemis H115A Biophysical Characterisation 
The wild-type Artemis was examined to be physiologic via nuclease assays. However, in the 
case of Artemis H115A, it is different as the mutant is no longer functional. Therefore, to 
check the sample heterogeneity and folding, biophysical characterisation using dynamic light 
scattering (DLS) and circular dichroism (CD) was carried out as a quality check of the sample 
(Figure 30). 
 
According the DLS results, the sample was rather pure with one peak only (Figure 30A). It 
suggested that the Artemis H115A sample should be homogeneous in size, which should be 
around 12nm. This is consistent with the gel-filtration chromatogram (Figure 20C). CD result 
showed that Artemis H115A was not unstructured (Figure 30B). Moreover, the CD result 
indicated that the major secondary structure element in Artemis H115A was α-helix. Besides, 
Artemis H115A was also eluted at a similar position to where the physiologically active wild-
type Artemis was eluted in the gel-filtration purification. Therefore, the sample Artemis 
H115A, which is non-functional, should be properly folded and can be used for structural 










Figure 30. Biophysical characterisation of Artemis H115A. (A) DLS result of Artemis H115A; (B) 
CD result of Artemis H115A. The qualitative biophysical characterisation showed that the sample 
of Artemis H115A should be homogeneous in size, with the diameter of the molecule around 
12nm, and folded. 
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5.1.3 Identification of the Artemis C-terminal Peptide Binding to DNA-
PKcs 
Based on the sequence alignment, bioinformatics analysis and previous research mentioned 
in chapter 3, five Artemis C-terminal fragments (Artemis 366-399; 399-408; 385-413; 399-426 
and 413-426.) were purified for defining the region interacting with DNA-PKcs. His-tag 
pulldown assay was carried out on all the fragments with DNA-PKcs.  
 
 
DNA-PKcs was successfully pulled down with wild-type Artemis as expected, showing that the 
pulldown experiment is able to confirm the protein-protein interaction (Figure 31A). In the 
pulldown assays of the Artemis C-terminal peptides, only the fragment containing residues 
399-426 is able to pull down DNA-PKcs with a strong signal of the DNA-PKcs band (Figure 31B).  
Figure 31. His-tag pulldown assay of DNA-PKcs with different Artemis constructs. (A) His-tag 
pulldown assay of DNA-PKcs with wild-type Artemis (B) His-tag pulldown assay of DNA-PKcs with 
Artemis C-terminal peptides including Artemis 363-399; 399-408; 385-413; 399-426; 413-426. The 
gels were NuPAGE™ 4-12% Bis-Tris Protein Gels stained with silver staining. The numbers shown 
next to gel are the molecular weight (kDa) of the markers  
 138 
Previously the region of 399-404 was proposed to be the Artemis interaction site with DNA-
PKcs. The residues L401 and R402 were specifically highlighted as the double mutant of 
Artemis L401G+R402N abolished co-immunoprecipitation of endogenous DNA-PKcs 
(Soubeyrand et al., 2006; Niewolik et al., 2017). However, some of the fragments (Artemis 
399-408 and Artemis 385-413) containing the region did not give any positive result. In fact, 
only Artemis 399-426 was pulled down with DNA-PKcs. It supports the previous 
bioinformatics analysis in chapter 3 proposing that the region around 420 may also be 
involved in the DNA-PKcs/ Artemis interaction. It also indicates that, in addition to the 
interaction from L401 and R402, the interaction from the region between 413-426 is also 
necessary for the DNA-PKcs/Artemis complex. However, Artemis 413-426 on its own was not 
able to pull down DNA-PKcs, confirming that the region of 399-404 is also necessary for the 
interaction.  
 
In conclusion, Artemis 399-426 of the Artemis C-terminal tail is sufficient for the interaction 
between Artemis and DNA-PKcs. For the first time, the sufficient and necessary region of 
Artemis interacting with DNA-PKcs is identified. Moreover, this protein-protein interaction is 
at least a two-patch interaction including the contribution of the region 399-404, which is 
mainly electrostatic, and the contribution of the region of 413-426, which is likely to be 
hydrophobic. Subsequent cryo-EM study of the complex of DNA-PKcs/ Artemis 399-426 
showed the extra density of the Artemis peptide. It revealed an interesting interaction pattern 










5.2 Fragment Based Drug Discovery Initiation on DNA Ligase IV/ 
Artemis Interaction Site 
 
In addition to the interaction with DNA-PKcs, Artemis is interacting with DNA ligase IV and the 
structure of the DNA ligase IV/ Artemis complex has been solved (Ochi et al., 2013). The 
intrinsically disordered peptide of Artemis (485-495) undergoes concerted folding in contact 
with DNA ligase IV, suggesting that the interaction site should be suitable for drug discovery 
(Jubb et al., 2015). During my PhD project, the fragment-based drug discovery (FBDD) 
targeting the DNA ligase IV/ Artemis interaction was initiated (Murray and Blundell, 2010). 
 
FBDD is a promising approach to identify new drugs. Fragments with low molecular weight 
(usually < 300 Da) can bind hotspots on the target protein-- hotspots are regions within the 
protein that provide a relatively large contribution towards ligand binding and specific 
interactions governing the regions (Radoux et al., 2016). Compared to the high-throughput 
screening (HTS), fewer chemical entities need to be screened and usually more than one 
fragment binds, allowing choice of starting points for lead discovery. The initial fragment hits 
in FBDD have lower potency – often in millimolar range - than the more complex molecules 
in typical HTS compound libraries. However, fragments binding at hotspots with directional 
and well-defined interactions have high ligand efficiency (Radoux et al., 2016). These 
fragments are good starting points for linking to other nearby fragments when available or 
elaboration and fragment growth to any close warmspots, where a fragment may not first 
bind but where further interactions can stabilize a ligand as it is grown from a fragment bound 
to a nearby hotspot, to obtain drug-like molecules (Figure 32A) (Thomas et al., 2019). 
 
In the case of DNA ligase IV and Artemis interaction (Figure 32B), there is a potential hotspot 
with a nearby warmspot where Artemis W489 and F493 interact with DNA ligase IV DBD 
(Figure 32B), suggesting that this interaction site will be ideal for FBDD. Considering the large 
consumption on protein sample for initial screening and the stability requirement of the 
target protein, the DNA ligase IV catalytic domain for which the crystal structure in complex 
with Artemis peptide was solved, is not perfect for FBDD. Shorter constructs, for example 
DNA ligase IV DBD, may be better. Structural comparison of the DNA ligase IV catalytic domain 
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and DBD showed that the structure of the DNA ligase IV/ Artemis interaction site does not 




Figure 32. Fragment-based drug discovery (FBDD) for targeting DNA ligase IV/ Artemis 
interaction site. (A) Schematic diagram of FBDD. The initial fragment hits on the hotspot have 
high efficiency but low affinity. Subsequent extension from the initial hit to the nearby warmspot 
can produce more complex drug-like molecule with higher affinity (Figure modified from the 
presentation of Professor Tom Blundell). (B) Potential FBDD on the interaction site between DNA 
ligase IV and Artemis, an ideal site for FBDD as there is a hotspot (Artemis W489 docking site) 
with a nearby warmspot (Artemis F493 docking site) for the initial hit and following fragment 
extension. (C) Comparison of the Artemis binding site in different structures of different DNA 
ligase IV constructs. There is no conformational change on the Artemis binding site between the 
structure of the DBD within the apo DNA ligase IV catalytic domain (grey; PDB: 3W5O) and the 
structure of apo DNA ligase IV DBD (green; PDB: 4HTO). This suggests that the construct of DNA 
ligase IV DBD should be suitable for the FBDD targeting the DNA ligase IV/ Artemis interaction 
site. 
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As the binding affinities of initial fragments are often low, sensitive screening methods are 
required. In my case, to have an efficient and sensitive preliminary screening, differential 
scanning fluorimetry (DSF) or fluorescence-based thermal shift assay was used for the 
screening of DNA ligase IV 230.  
 
The differential scanning fluorimetry (DSF) or fluorescence-based thermal shift assay is 
monitoring the thermal unfolding of the target protein with the help of a fluorescent dye that 
binds to the hydrophobic regions of the unfolded target protein (Figure 33A) (Semisotnov et 
al., 1991; Pantoliano et al., 2001). It is based on the fact that binding partners/ligands increase 
the conformational stability of the protein, which is relevant to the change of Gibb’s free 
energy of unfolding (∆Gu). Melting temperature (Tm) of a protein can be defined as the 
temperature at which folded and unfolded protein are equal with the ∆Gu equal to zero. 
When any ligand from the library enhances the conformation of the target protein, the ∆Gu 
will increase, leading to an increase on the melting temperature (Tm) of the protein. 
 
Fluorescent dyes including Sypro Orange and Nile Red can be used to monitor the thermal 
unfolding process. Sypro Orange has excitation and emission maxima of 490 nm and 575 nm 
respectively. It is the most widely used dye for the differential scanning fluorimetry (DSF) or 
fluorescence-based thermal shift assay and has a high signal-to-noise ratio. The dye is 
characterised by a low quantum yield (QY)/ low fluorescence when in solvents with high 
dielectric constants (i.e. the buffer) but obtains high fluorescence/ high QY in solvents with 
low dielectric constants. Therefore, the low dielectric constant imparted by the melted or 
unfolded globule state of a protein, where the hydrophobic patches of the protein are 
exposed, will lead to an increase of the fluorescence signal (Ericsson et al., 2006). 
 
The preliminary differential scanning fluorimetry (DSF) screening of DNA ligase IV 230 
involved a library of 960 small molecule fragments. To distinguish the effect of fragments on 
DNA ligase IV 230, the unfolding curves from separate DSF measurements of the LigIV230 
control, without any added fragment, were measured. It indicated a Tm of 53.89±0.36°C of 
DNA ligase IV 230. Therefore, the analysis of the measured Tm indicates the fragments that 
induce a positive shift greater than one standard deviation (>0.36°C) or a negative shift lower 
than one standard deviation (<0.36°C). An example of the analysis of the melting curves with 
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positive shifts from a screened plate is shown and the full screen with positive hits is available 
in the supplementary material (Figure 33B, Figure S2). 
 
Multiple fragments had different effects on the melting curves of DNA ligase IV 230 and only 
the ones inducing a positive shift on the melting temperature were taken as positive hits. In 
total, there are 24 fragments from the library leading to positive shifts on the melting 
temperature. 
 
Subsequent steps in FBDD after initial fragment screening include fragment hit validation and 
characterisation. To understand the mode of action of the fragment, crystal structure with 
the fragment binding is important and it is crucial to obtain apo DNA ligase IV 230 crystal for 






Figure 33. Thermal Shift Assay/ DSF of fragment screening and an example of DNA ligase IV 
DBD. (A) Schematic diagram of the basic principle of fluorescence-based thermal shift assay. The 
native protein (orange) does not bind to the dye (green) because of the high dielectric constant 
of the solvent. As the temperature increases, the protein becomes more unfolded, exposing the 
hydrophobic regions to bind the dye and resulting in increasing fluorescence signal. Melting 
temperature (Tm) of a protein can be defined as the equilibrium temperature, under which the 
folded and unfolded protein are in equal amounts. (B) An example Thermal Shift Assay/ DSF 
profile of fragment screening on DNA ligase IV DBD. The example is the plate 7 of the NMR 
fragment library. Only the positive shifts in melting temperature on binding with fragments are 
shown in the example. 
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5.3 Temporal Organisation of NHEJ 
 
The spatial organisation of NHEJ can be studied via biochemical and structural studies of NHEJ 
complexes. However, in addition to the spatial organisation of NHEJ, the temporal 
organisation has also been of interest to the group and always been a key question in the 
field. Although the three main steps of DNA end recognition, end synapsis and processing and 
end ligation were known, it has been unclear at which points of the process different NHEJ 
components participate. The full timeline remains amorphous especially within the step of 
end synapsis and processing. Structural studies can help us understand the timeline but it is 
relatively challenging. In collaboration with the Strick group, we applied the technique of 
single-molecule study to the NHEJ system. Moreover, using a novel DNA molecular forceps, 
we were able to visualise and understand the temporal organisation of NHEJ for the first time. 
 
To study quantitatively the properties of complex molecular synapses and interactions, a 
DNA-scaffold-based single-molecule assay was developed to observe repeated cycles of 
synapsis and rupture. Microscopic properties including lifetime of synapsis and kinetics of 
formation can be derived from such assays (Figure 34A). The DNA molecular forceps is made 
up of two linear dsDNA segments around 1510 bp in length, connected to each other by a 
third double strand segment, termed “bridge,” of around 690 bp. The bridge is docked at the 
point that is 58 bp away from the ends of the DNA segments it tethers, allowing the ends to 
fluctuate freely and providing enough space of DNA for the loading of NHEJ components. One 
end of the DNA construct (around 3.6 kbp) is attached to a glass surface and the other end to 
a magnetic bead. This system enables real-time recording of DNA end synapsis/ligation by 
monitoring the molecule’s overall extension. If there is no synapsis/ligation between the ends, 
the extension of the 3.6 kbp construct will be around 1085 nm with the two linear dsDNA 
segments and bridge pulled to their full length. On the other hand, if there is any 
synapsis/ligation between the ends, the linking bridge will not be involved in the extension of 
the DNA forceps and the extension of the 3.6 kbp construct will be around 913 nm, which is 




Figure 34. Experimental design of studying NEHJ temporal organisation with the DNA forceps. (A) 
Schematic diagram of the single-molecule method using the DNA forceps with full NHEJ components 
leading to DNA ligation. Two 1.5 kbp dsDNA segments (blue, red) are joined by a 600 bp dsDNA 
“bridge” segment (magenta) to form the DNA construct used in this study. Stars at the DNA ends 
represent phosphate groups. One end of the construct is tethered to the bottom glass surface and 
the other end is tethered to a 1-micron magnetic bead. A pair of magnets located above the beads 
allows one to generate a controlled, vertical extending force on the DNA (green arrow). The resulting 
end-to-end extension of the DNA is determined by computer-based monitoring of the bead position 
above the surface. DNA ligation is observed following four steps: (1) at high force and in the absence 
of end-end interactions, a high-extension state is observed, (2) the force is lowered to allow the ends 
to encounter and the interaction of NHEJ to process, (3) the force is increase but if there has been 
end ligation, the construct cannot return to the full extension, (4) The full extension is recovered 
upon cleavage of SmaI. This system can be used repeatedly; (B) Real-time monitoring of the DNA 
extension upon the modulation of force (bottom red line) in the presence of full-length Ku70/80, 
DNA-PKcs, PAXX, XRCC4, XLF, and DNA ligase IV complex. At the beginning, DNA extension (blue 
points) is shown to switch between a low and a high value when force is modulated. Upon addition 
of NHEJ components (black up arrow), the extension under high-force situation is later reduced (∆l) 
due to the end ligation. After the addition of SmaI restriction enzyme (red up arrow), there is a 
sudden increase of the DNA extension (∆l) and the DNA extension is back to the initial full length; 
 147 
  
To test and validate the system, full-range NHEJ components were first applied including full-
length Ku, DNA-PKcs, PAXX, XRCC4, XLF, and DNA ligase IV complex. All the samples used for 
the single-molecule experiment are pure and the DNA ligase IV complex is physiologic (Figure 
34C D). The system was able to recapitulate the complete NHEJ as the ligation took place and 
a stable and lasting end ligation was monitored from the length of DNA extension under high 
magnetic force (Figure 34B)-- After adding NHEJ component and the incubation at low force, 
there was a decrease of the extension length (∆l), which was around 170 nm, suggesting that 
the ends should be ligated. Moreover, this could be inverted by adding the restriction enzyme 
of SmaI to cleave the ligated DNA.  
 
Stepwise assembly was then examined with the system to understand the temporal 
organisation of NHEJ especially during the step of DNA end synapsis. Ku and DNA-PKcs should 
always be there for DNA end recognition. It was found that the combination of the DNA-PK 
holoenzyme (Ku70/80 and DNA-PKcs) and PAXX is the minimal requirement to observe 
consistent and frequent yet short-lived interactions between the two DNA ends (Figure 35A). 
End synapsis was observed as a transient plateau in the DNA extension signal obtained after 
switching the force from Flow to Fhigh; The lifetime of the end synapsis, reflected by the 
duration of the plateau, was around 2.2 s and the change of the extension of the DNA upon 
rupture was around 166 nm (Figure 35A). However, this DNA synapsis interaction disappeared 
when the PAXX mutant (PAXX V199A F201A) was used instead of the wildtype (Figure 35B). 
The PAXX mutant is not able to interact with Ku, indicating that the interaction with Ku is vital 
for the synapsis. Nevertheless, adding XLF, which also interacts with Ku and belongs to the 
same XRCC4 superfamily with PAXX, did not form any end synapsis. Moreover, neither the 
combination of Ku and DNA-PKcs nor PAXX on its own could form the previous synapsis 
(C) Samples of the NHEJ components involved in the single-molecule study on a NuPAGE™ 4-12% 
Bis-Tris Protein Gels stained with Coomassie blue. The numbers shown next to gel are the molecular 
weights (kDa) of the markers. Among all the components, I purified and provided the samples of 
DNA-PKcs, PAXX constructs and DNA ligase IV constructs. (D) DNA ligation assays with DNA ligase IV 
complex and its catalytically dead mutant on a 1% agarose gel stained with SYBR gold. The DNA 
ligase IV complex is functional and the mutant complex is catalytically dead. The numbers shown 
next to gel is the ladder with DNAs of different lengths (kb). 
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(Figure 35C). This suggests that Ku, DNA-PKcs and PAXX should be the “upstream” 
components of NHEJ that enable the primary formation of DNA end synapsis. 
 
Figure 35. Ku, DNA-PKcs and PAXX are the minimal combination to form consistent and stable 
yet short-lived DNA end synapsis. (A) Schematic diagram of the experimental design for monitoring 
end synapsis with Ku, DNA-PKcs and PAXX and the real-time monitoring of the DNA extension. Stars 
at the DNA ends represent phosphate groups. There is a clear plateau representing the end synapsis 
when switching from low force to high force; (B) Real-time monitoring of the DNA extension of the 
reaction system of Ku, DNA-PKcs, and the PAXX mutant (left panel) and the system of Ku, DNA-
PKcs, and XLF (right panel); (C) Real-time monitoring of the DNA extension of the reaction system 
of Ku and DNA-PKcs (left panel) and the system of PAXX only (right panel). The DNA end synapsis is 
only happening in the system of Ku, DNA-PKcs, and PAXX, indicating the Ku, DNA-PKcs and PAXX 
are the upstream NHEJ components for end synapsis.  
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Other NHEJ components including XLF, XRCC4 and DNA ligase IV complex were then added to 
the “upstream” NHEJ system in different combinations. In general, the full NHEJ system with 
Ku, DNA-PKcs, PAXX, XLF, XRCC4 and DNA ligase IV complex has the longest DNA synapsis 
lifetime of around 66 s (Figure 36A). In this case, the DNA ends were dephosphorylated to 
prevent DNA end ligation. Getting rid of DNA ligase IV complex or XLF or XRCC4 reduced the 
lifetime of synapsis to around 2 s, which should be the primary synapsis formed by Ku, DNA-
PKcs and PAXX. This further confirmed the upstream effect of Ku, DNA-PKcs and PAXX and 
indicated that XLF, XRCC4 and DNA ligase IV complex are likely to be involved as one 
functional unit in the end-synapsis step.  Therefore, the unit of XLF, XRCC4 and DNA ligase IV 
complex was also added to the system of Ku and DNA-PKcs to test the function. Interestingly, 
end synapsis was observed with a lifetime of 9 s. It should be noted that Ku and DNA-PKcs 
must be included in the system or there will be no synapsis at all. Therefore, the functional 
unit of XLF, XRCC4 and DNA ligase IV complex must act on the base of DNA-PK.  
 
In general, based on all the combinations we had, a model of the NEHJ end synapsis was 
proposed (Figure 36B). Ku and DNA-PKcs first arrive at the DNA ends in the end-recognition 
step. The recruitment of PAXX and its interaction with Ku helps form short-lived but 
consistent DNA end synapsis, which is likely to be the upstream reaction in the end-synapsis 
step. Meanwhile, the functional unit of XLF, XRCC4 and DNA ligase IV complex can also help 
form DNA end synapsis together with DNA-PK with a longer lifetime. Together, in the full 






Figure 36. The effect of the full NHEJ complex in end synapsis and hypothesis of the NHEJ end 
synapsis process. (A) Schematic diagram of the experiment design of monitoring end synapsis with 
Ku, DNA-PKcs, PAXX, XLF, XRCC4 and DNA ligase IV complex and the real-time monitoring of the DNA 
extension. The DNA ends are dephosphorylated to prevent end ligation. There is a longer plateau 
representing the end synapsis compared to that in the system of Ku, DNA-PKcs and PAXX; (B) Model 
of the organisation of NHEJ end synapsis. The initial DNA-PK holoenzyme complex with a putative 
lifetime in the range of hundreds of milliseconds, which can be stabilized by the incorporation of 
PAXX (left) or XRCC4/XLF/DNA ligase IV complex (right). A complete complex stabilized by both PAXX 




The biochemical and biophysical characterisations facilitated findings that had not been 
previously observed. 
 
First, the assays of DNA-PKcs/ Artemis endonuclease complex, showing that the purified 
sample is functional, demonstrated that other NHEJ components Ku can inhibit the nuclease 
activity while XRCC4 and XLF/XRCC4 complex can reduce the level of inhibition in a 
concentration-dependent manner. Moreover, XLF strongly stimulates the endonuclease 
activity of DNA-PKcs/Artemis complex. 
 
Secondly, although the Artemis H115A is not active, it is structured and should be good for 
further structural studies. 
 
Moreover, the pulldown experiment identified the region of Artemis interacting with DNA-
PKcs for the first time. More importantly, it provides a stage for the subsequent cryo-EM 
structural study of DNA-PKcs/ Artemis complex. 
 
Besides, initial fragment screening showed that FBDD was practical targeting the interaction 
site of DNA ligase IV and Artemis with 24 fragments showing positive results in the initial DSF 
screening. 
 
Last but not least, the single-molecule methods revealed the temporal organisation of NHEJ 
especially in the step of end synapsis. PAXX was first shown to have a specific role in NHEJ to 
form very early end synapsis. In addition, XRCC4/XLF/DNA ligase IV was shown to be one 
function unit in end synapsis. Together, they could form strong and long-lasting end synapsis 





Chapter 6. Cryo-EM of DNA-PKcs/Artemis 
Related Complexes 
 
In Chapters 4 and 5 I have discussed the sequence of Artemis interacting with DNA-PKcs and 
the effects of other NHEJ components on the endonuclease activity of DNA-PKcs/ Artemis 
complex. However, to understand how DNA-PKcs and Artemis interact in detail, a structural 
study is necessary. Considering the flexibility and complexity of the complex and encouraged 
by the resolution revolution that has developed since 2013 in cryo-EM, I decided using cryo-
EM as the main structural method to study the DNA-PKcs/ Artemis complex.  
 
In fact, before the resolution revolution, there had already been many EM studies targeting 
the DNA-PKcs and its complexes. The initial studies can be traced back more than 20 years 
when EM and atomic force microscopy (AFM) were first used to study the structure of DNA-
PK (Cary et al., 1997; Yaneva et al., 1997). Later cryo-EM imaging of the catalytic subunit of 
the DNA-PKcs was successful in providing an image at resolution of 22 Å (Chiu et al., 1998), 
followed by another map at a similar resolution using electron crystallography (K. Leuther et 
al., 1999). Further EM studies on DNA-PKcs-related complexes were reported at the turn of 
the century, when it was shown that kinase activity of DNA-PKcs is related to DNA 
concentration and EM work revealed that two DNA-PKcs molecules can form complexes, 
which may play a role in DNA end synapsis (DeFazio et al., 2002). Later work from Spagnolo 
et al. (2006) further reinforced this point, presenting the structure of the DNA-PK assembled 
on DNA and discussed its implications for NHEJ. In addition, there were many EM studies at 
that time targeting DNA-PKcs and related complexes but the highest resolution was 7 Å 
(Boskovic et al., 2003; Rivera-Calzada et al., 2005, 2007; Williams et al., 2008). Since the 
resolution revolution, more cryo-EM studies have been conducted and the resolution of DNA-
PKcs was pushed to 4.4 Å, DNA-PK to 6.6 Å (Sharif et al., 2017; Yin et al., 2017). 
 
During the past four years, I have conducted cryo-EM studies of different constructs of DNA-
PKcs/ Artemis related complexes. Before starting the cryo-EM work, negative staining was 
conducted to check the sample quality of DNA-PKcs and full-length Artemis. Later, the first 
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cryo-EM experiments targeted DNA-PKcs in complex with wild-type Artemis, followed by the 
study of the protein/ DNA complex including DNA-PKcs, Artemis H115A and hpDNA. Last but 
not least, the structure of DNA-PKcs/ Artemis C-terminal peptide complex was studied and 
provided the highest resolution of 4.2 Å, clearly showing the extra density of Artemis peptide 
and revealing the interaction pattern between DNA-PKcs and Artemis. In parallel I have 
carried out a study of apo-DNA-PKcs, to provide the best structure of the molecule for further 
complex study and have achieved an improved map at 3.88 Å resolution, somewhat higher 
resolution than the earlier X-ray studies in the Blundell lab (Sibanda et al., 2017).  
 
6.1 Negative Staining of DNA-PKcs and Artemis  
 
Before initiating cryo-EM experiments, preliminary screening using negative staining was 
conducted to check the sample quality of DNA-PKcs and Artemis, in addition to the previous 
biophysical characterisation. Compared to cryo-EM, there are several advantages of negative 
staining. First, negative staining requires much less protein - ten-to-a-hundred-fold less - 
compared to cryo-EM, thanks to the supporting film on the grid. Second, negative staining 
Figure 37. Negative-staining screening of Artemis and DNA-PKcs. (A) Negative staining of wild-
type Artemis. The protein appeared to be homogeneous in size with various different shapes, 
indicating the different 2D projections and probably also flexibility of the sample; (B) Negative 
staining of DNA-PKcs. The protein particles are similar in size. Most of the particles were single 
while come of the molecules were adhering to others. 
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provides stronger contrast than cryo-EM. This is very helpful for visualising protein with low 
molecular weight, which is exactly the case of Artemis. Third, the sample preparation is much 
easier and faster, with no facility requirement, and the grids can be stored at room 
temperature for months. Fourth, the microscope requirement is lower and costs less. 
 
 
In the negative-staining micrograph of wild-type Artemis (Figure 37A), there are many single 
particles of Artemis, of the same size, evenly distributed. This suggests that the purified 
sample of Artemis should be homogeneous in the storage buffer. Moreover, it is noticed that, 
although the particles are similar in size, the shapes of the particles are relatively different. 
This may be due to the various views of the protein or the result of the flexibility of Artemis.  
 
In the negative-staining micrograph of DNA-PKcs (Figure 37B), the particles of DNA-PKcs are 
also evenly distributed, proving the homogeneity of the purified sample. Unlike Artemis, DNA-
PKcs appears to have a relatively fixed structure, as observed in previous studies. Moreover, 
although there are many nicely separated single particles, some of the particles also 
interacted with others, forming complexes with two or more molecules involved. 
 
In summary, the negative-staining results showed that the purified protein samples were 
nicely distributed without aggregation and should be good for subsequent cryo-EM 












6.2 Cryo-EM of DNA-PKcs/Artemis Complex 
 
A cryo-EM investigation was initiated targeting the structure of the DNA-PKcs/ Artemis 
complex, a protein-protein complex, to see how the full-length proteins interact with each 
other and whether there are any previously undiscovered interactions in addition to that of 
DNA-PKcs with Artemis C-terminal peptide (399-426).  
 
6.2.1 Sample preparation, grid screening and data collection 
The purified DNA-PKcs, at a final concentration of 0.3 mg/ml, was added to wild-type Artemis 
with a 1:2 ratio. The final buffer was the same as the nuclease assay buffer. Vitrobot was used 
for the grid preparation and aliquots of 2.5 µl sample were applied to glow-discharged grids 
(Quantifoil Cu 1.2/1.3, 300 mesh), which were then blotted for 2.5 s with filter paper and 
plunge-frozen in liquid ethane. 
 
The grids were first screened and an example of the micrographs is shown in Figure 38. 
According to the micrographs, there are a few interesting features regarding the behaviour 
of the sample. First, some particles remain single with no attachment to other molecules 
while others are inter-connected and form long curved filaments. Moreover, there are various 
visible strings linked with the particles of DNA-PKcs, which are very likely to be Artemis 
protein. Some of the strings behave like a tail of DNA-PKcs, floating in the buffer, while others 
connect different particles of DNA-PKcs. This indicates that Artemis may have the potential 
to link DNA-PKcs together, although it is unclear whether the linkages and filaments are due 
to interactions between DNA-PKcs and Artemis or DNA-PKcs and DNA-PKcs or Artemis and 
Artemis or all three.  
 
To obtain more information at higher resolution, the grid was viewed on a Thermo Fisher 
Titan Krios electron microscope (300kV) with a Gatan K2 detector and the movies were 
recorded under the counting mode with a magnification of 130,000 times. The pixel size used 
for the collection was 1.07 Å. Total dose for a movie stack was 49.4 electrons/Å2 with an 
exposure time of 14 s. A series of defocus value were used for collection including -1.3, -1.6, 
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-1.9, -2.2, -2.5, -2.8, and -3.1 µm. 3303 movies were collected at the end of the data collection 




























Figure 38. Cryo-EM screening and data collection of DNA-PKcs/Artemis complex. The left panel 
is an example of a micrograph of the grids of DNA-PKcs/Artemis complex. There are evenly 
distributed particles in the micrograph. The particles have the expected shape of DNA-PKcs, as it 
is the largest component in the complex, around six-time the molecular weight of Artemis. There 
are also many strings attached to some of the particles, which are very likely to be Artemis. Some 
of the particles are single with or without a tail-like string floating around, while others are inter-
connected. The right panel shows the parameters that were used for the final data collection. 
The dataset was collected at the cryo-EM facility of the Department of Biochemistry, University 
of Cambridge. 
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6.2.2 Data processing  
Cryo-EM data processing is a rapidly developing field. As mentioned in section 1.4.3, there 
are many software packages for single particle analysis and Relion has been the mostly used 
one during my PhD. 
 
The classical data processing procedure includes: motion correction, CTF estimation, particle 
picking, 2D classification, 3D classification, 3D refinement and post-processing (Scheres, 
2016). In general, the objective of the processing is to achieve three ultimate goals: picking 
clean and nice particles without contamination, accurate classification of particles of similar 
conformations and precise determination of projection angles for 3D reconstruction from 2D 
images. Therefore, the pathway for obtaining the EM map is not restricted to the classic one 
and can be altered to achieve a better map. 
 
Various pathways of data processing for DNA-PKcs/Artemis complex were attempted. The 
best map achieved was at the resolution of 6.2 Å following the pathway shown in Figure 39. 
The 3303 collected micrographs were first sent for motion correction and CTF estimation. 
3140 micrographs with good CTFs were picked and used for particles auto-picking. 110759 
particles were picked and extracted from the micrographs and sent for 3D classification 
directly into 8 classes. 3 classes accounted for most of the particles including classes 5, 6 and 
7.  When compared to the cryo-EM map of DNA-PKcs, only class 7 showed clear extra densities. 
Class 7 was then subjected to another 3D classification with class 1 having 96.2% of the 
particles, filtering out the contamination and bad particles in class 2 (3.8%). Particles of class 













Figure 39. Cryo-EM data processing pathway of the map of DNA-PKcs/ Artemis complex at the 
resolution of 6.2 Å. Unlike the classic data process, 2D classification was not involved for the 
reconstruction of the map. 3140 micrographs were picked from the original 3303 collected after 
motion correction and CTF estimation. 110759 particles were picked and extracted. 3D classification 
for 8 classes of those particles cleaned up most of the contamination from the nice particles and 
class 7 contained extra density compared to the apo DNA-PKcs map. Class 7 was then further 
classified in to two classes allowing filtering out 3.8% of the particles. The final class went through 
3D refinement and postprocessing to achieve a cryo-EM map of DNA-PKcs/ Artemis complex at the 
resolution of 6.2 Å. 
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6.2.3 Cryo-EM map analysis  
Generally, the cryo-EM map of DNA-PKcs/ Artemis complex has a similar overall shape to 
DNA-PKcs (Figure 40A). Of particular note, the N-terminal arm looks very different. It was 
known that the N-terminal arm is flexible and has continuous up-and-down movements. 
Therefore, the density of the N-terminal arm was relatively weak and hard to describe in both 
the cryo-EM and the crystal structure (Sharif et al., 2017; Sibanda et al., 2010; Sibanda et al., 
2017). In the map of the DNA-PKcs/ Artemis complex, the N-terminal arm region has more 
density than the apo-DNA-PKcs (Figure 40B site B). Moreover, the extra density builds up on 
the original N-terminal arm, as it approaches the FAT domain. Although the somewhat 
fragmented density is unlikely to allow association with the sequence, it is clear that the extra 
density in the N-terminal region results from DNA-PKcs/ Artemis interactions. Considering the 
flexibility of the density, it should come from the C-terminal tail of Artemis instead of the 
structured nuclease region.  
 
There are also two further differences between DNA-PKcs/ Artemis complex and DNA-PKcs 
(Figure 40B site A site C). Site A sits close to the polypeptide chain between the circular cradle 
and kinase head region. As mentioned in section 1.3.2.2, this is around residue 2576-2744 of 
DNA-PKcs, which covers the ABCDE cluster and has density missing. In the density map of X-
ray crystallisation, part of the region is observed and four-α-helices (probably representing 
2602-2665) are placed in the model hanging down into the central cavity of DNA-PKcs 
molecule. In all the available cryo-EM maps of DNA-PKcs (Sharif et al., 2017; Yin et al., 2017; 
Wu et al., 2019), there is no density observed in this region. However, in the map of DNA-
PKcs/ Artemis complex, there are extra densities in site A and they are very likely to be part 
of the missing 2576-2744 due to the continuity of the EM map. This suggests that the 
interaction between Artemis and DNA-PKcs may have an impact on the conformation of DNA-
PKcs and stabilise the flexible region covering ABCDE cluster. In addition, there is extra density 
in DNA-PKcs/ Artemis complex at site C compared to apo DNA-PKcs, which is at a similar 
position where Ku binds (Sharif et al., 2017; Yin et al., 2017). 
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Figure 40. Analysis of the cryo-EM map at the resolution of 6.2 Å of the DNA-PKcs/ Artemis complex. 
(A) Overall presentation of the map with the front view, side view and back view. The most obvious 
feature of the map is the fragmented density of the N-terminal arm; (B) Comparison of the DNA-PKcs/ 
Artemis complex map and the published apo DNA-PKcs map (emd_8751). The DNA-PKcs/ Artemis 
complex map is coloured green while the apo DNA-PKcs map (emd_8751) is coloured pink. There are 
three regions that as shown in the figure. At site A, there is extra density that comes down from the 
circular cradle and hangs on top of the central cavity of DNA-PKcs. This is similar to what was observed 
in the X-ray crystallisation density map (PDB: 5LUQ). Site B is the N-terminal bridge region of DNA-





Although it is difficult to fit the sequence to the map due to the low resolution, extra densities 
can be identified in the cryo-EM map of DNA-PKcs/ Artemis complex compared to that of apo 
DNA-PKcs. To have a clearer view of the DNA-PKcs/ Artemis interaction, further analyses were 
carried out and the sites A, B and C are highlighted to make clearer the changes related to the 























-nsity of the N-terminal arm is highly fragmented and is more extensive than in the map of the 
complex, indicating that the full-length Artemis interacts with the N-terminal arm and results in 
conformational changes. Site C sits on the circular cradle of DNA-PKcs and there is a tube of extra 
density on top of the apo DNA-PKcs HEAT repeats.  
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6.3 Cryo-EM of DNA-PKcs/ Artemis/ DNA Complex 
 
Cryo-EM was then used to study the structure of DNA-PKcs/ Artemis/ DNA complex to 
understand the interaction among all three components of the endonuclease complex. As the 
Artemis nuclease region was not detected in the previous DNA-PKcs/ Artemis complex, 
adding DNA may be able to stabilise and dock the nuclease region of Artemis to a certain 
conformation. To ensure that the Artemis will not cut the DNA and can be docked nicely on 
the DNA ends, Artemis H115A instead of wild-type Artemis was used. 
 
6.3.1 Sample preparation, grid screening and data collection 
The purified DNA-PKcs, at a final concentration of 0.5 mg/ml, was added to Artemis H115A 
and hpDNA in a 1:2:2 ratio. The final buffer was the same as the nuclease assay buffer and 
the hpDNA was the construct used for the nuclease assay without the fluorescence label. 
Vitrobot was used for the grid preparation and aliquots of 2.5 µl sample were applied to glow-
discharged grids (Quantifoil Au R1.2/1.3, 300 mesh), which were then blotted for 3 s with 
filter paper and plunge-frozen in liquid ethane.  
 
The grids were first screened and an example of the micrographs is shown in the figure (Figure 
41). The micrographs appeared to have a better signal-to-noise ratio with a cleaner 
background and better contrast than those of the DNA-PKcs/ Artemis complexes (Figure 38). 
This could be due to the change of the grid material from copper to gold. In the micrograph, 
particles of DNA-PKcs can be clearly seen evenly distributed. However, the density of the 
particles is lower than that of the DNA-PKcs/ Artemis complex (Figure 38). In addition, the 
association of DNA-PKcs particles as long filaments does not occur. It may be caused by 
changes of the surface property of the complex due to the addition of DNA or by changes of 
the grid type. The hpDNA added to the system can be clearly visualised as short strings, some 
of which float in the buffer on their own while others are linked with the particles of DNA-
PKcs. There are also many little black dots in the micrographs that are likely to be the 
structured nuclease region of Artemis. The black dots are distributed across the micrograph 
in different ways, either as individual single particles or close to the DNA-PKcs particles but 
not in contact.  
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The screened grid was used for data collection on the Thermo Fisher Titan Krios electron 
microscope (300kV) with a Gatan K2 detector and the movies were recorded under the 
counting mode using a magnification of 130,000 times. The pixel size used for the collection 
was 1.05 Å. Total dose for a movie stack was 60 electrons/Å2 with an exposure time of 12 s. 
The same defocus value series were used for collection including -1.3, -1.6, -1.9, -2.2, -2.5, -








Figure 41. Cryo-EM screening and data collection of DNA-PKcs/ Artemis/ DNA complex. Left 
panel is an example of the screened micrographs of the grids of DNA-PKcs/ Artemis/ DNA 
complex. There are evenly distributed DNA-PKcs particles in the micrographs. The hpDNAs added 
behave like strings. Some remain on their own while others appear connected to DNA-PKcs 
particles. The little black dots floating around the micrographs are likely the signals from the 
nuclease region of Artemis. Some of the dots are individual particles with no attachment to DNA-
PKcs or the hpDNA strings while some of them remain very close to the particles of DNA-PKcs; 
Right panel shows the parameters used for the final data collection. The dataset was collected at 
the Cryo-EM facilities at the UK national electron bio-imaging centre (eBIC). 
 164 
6.3.2 Data processing  
Different procedures for data processing for DNA-PKcs/ Artemis/ DNA complex were explored. 
The best map achieved was at the resolution of 6.6 Å following the approach shown in Figure 
42. 
 
First, the 2461 micrographs collected were sent for motion correction and CTF estimation. 
2158 micrographs were selected with good CTFs, used for the subsequent particle auto-
picking. As the backgrounds of the micrographs are clean with good signal-to-noise ratio, the 
auto-picking behaved relatively well. Considering the low density of the particles, manual 
cleaning was done on all 2158 micrographs to remove all contamination and add the unpicked 
particles. 67852 particles were finally picked and sent to 2D classification. After 2D 
classification, particles that could not be categorised by the software and particles of some 
contamination were discarded, leaving 60300 particles for the following 3D classification. 
Those particles were separated into four classes. However, the software did not manage to 
identify the differences, resulting in four similar classes with a similar number of particles. 
Therefore, all the particles were combined together for 3D refinement and postprocess. At 


















Figure 42. Cryo-EM data processing pathway of the map of DNA-PKcs/ Artemis/ DNA complex 
at the resolution of 6.6 Å. 2158 micrographs were picked from the original 2461 collected 
micrographs after motion correction and CTF estimation. 67852 particles were extracted from the 
micrographs after auto-picking and manual-cleaning. 2D classification was then applied to the 
extracted particles and 60300 were selected from them by removing particles that could not be 
categorised by the 2D classification and that have repeated views. 3D classification of the four 
classes of particles did not distinguish differences between the particles. Therefore, all four classes 
were combined together to proceed through 3D refinement and postprocessing to achieve a cryo-
EM map of DNA-PKcs/ Artemis/ DNA complex at the resolution of 6.6 Å. 
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6.3.3 Cryo-EM map analysis  
The map of the complex shows clearly the structure of DNA-PKcs with a protruding tail coming 
from the N-terminal arm (Figure 43A). There is extra density in the region of N-terminal arm 
that differs from the density of the complex of DNA-PKcs/ Artemis. Although the density at 
N-terminal arm is at low resolution, coming from weak signals that disappear first in the map 
when tuning down the contour level, the density is less fragmented. This indicates that, 
despite of a certain amount of flexibility, the N-terminal region here has a more fixed 
conformation compared to that of the DNA-PKcs/ Artemis complex (Figure 43B site B). Also, 
the helical protruding tail coming from DNA-PKcs is similar to the tail visualised in the map of 
DNA-PK when DNA is added to the system (Yin et al., 2017). The exact position of the DNA/ 
DNA-PKcs interaction site and the level of the uplift of the N-terminal arm are not identical 
but very close to those observed in DNA-PK. Therefore, without Ku, DNA can still gain access 
close to the N-terminal arm of DNA-PKcs. Due to the low resolution it remains unclear as to 
whether any part of the C-terminal tail of Artemis is contributing to the extra density at site 
B but it is clear that the Artemis nuclease region is not docked at the DNA end here as it is not 
possible to fit a structured region of 40kDa into the extra density at site B. This is consistent 
with the observation of the micrographs that the Artemis nuclease region (black dots in the 
micrographs) are not likely to dock on DNA-PKcs together with the DNA. The interaction mode 
of DNA-PKcs and Artemis is very different from that of DNA-PKcs and Ku, where the globular 
domain of Ku comes into contact with the N-terminal arm of DNA-PKcs with the help of DNA. 
 
In addition to the difference at the N-terminal region of DNA-PKcs (Figure 43B site B), 
comparison of this map with that of the DNA-PKcs/ Artemis complex also shows further 
differences at sites A and C (Figure 43B). In both sites the aforementioned extra densities in 
DNA-PKcs/ Artemis complex were all absent from the new map. It is obvious that DNA 







Figure 43. Analysis of DNA-PKcs/ Artemis/ DNA complex cryo-EM map at 6.6 Å resolution. (A) 
Overall presentation of the map with front, side and back views. The most obvious characterisation 
of the map is the protruding helical tail coming from the N-terminal arm of DNA-PKcs; (B) 
Comparison of the DNA-PKcs/ Artemis/ DNA complex map and the DNA-PKcs/ Artemis complex 
map. The map of DNA-PKcs/ Artemis complex is coloured grey, while that of DNA-PKcs/ Artemis 
complex is coloured green. Sites A, B and C, where differences between apo DNA-PKcs and DNA-
PKcs/ Artemis complex were evident, are examined in the new map. The extra densities at sites A 
and C are not present in the map when DNA is present. In site B, the density become continuous 
and less uplifted.  
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6.4 Cryo-EM of DNA-PKcs/Artemis 399-426 Complex 
 
Although the previous cryo-EM maps of DNA-PKcs/ Artemis and DNA-PKcs/ Artemis/ DNA 
showed the extra density for Artemis and DNA, it is difficult to define the interaction surface 
of DNA-PKcs and full-length Artemis due to the low resolution. This is likely to be due to the 
flexibility of both DNA-PKcs and the C-terminal tail of Artemis. Therefore, to reduce the level 
of flexibility and so improve the resolution, a cryo-EM study of the DNA-PKcs and Artemis 
399-426 complex was conducted, following the demonstration described in section 5.1.3 that 
Artemis 399-426 interacts with DNA-PKcs.  
 
6.4.1 Sample preparation, grid screening and data collection 
Purified DNA-PKcs, at a final concentration of 0.3 mg/ml, and the synthesised peptide of 
Artemis 399-426 were mixed at a 1:3 ratio. The final buffer was the same as that of the pull-
down experiment. Vitrobot was used for the grid preparation and aliquots of 2.5 µl sample 
were applied to glow-discharged grids (Quantifoil Cu R1.2/1.3, 300 mesh), which were then 
blotted for 3 s with filter paper and plunge-frozen in liquid ethane.  
 
The grids were first screened and an example of the micrographs is shown in the figure (Figure 
44). The particles of DNA-PKcs are evenly distributed across the micrograph. Unlike the cases 
of DNA-PKcs/ Artemis and DNA-PKcs/ Artemis/ DNA, the particles of DNA-PKcs appear to be 
of high density and homogeneous, staying as individual particles without forming any 
filaments or complexes with others. As the Artemis peptide has only 28 amino acid residues, 
it is impossible to visualise it in the micrograph directly and high-resolution information is 
needed to detect the presence of the peptide. However, it is clear that adding the Artemis 
399-426 peptide has a completely different effect on DNA-PKcs compared to full-length 
Artemis. It indicates that there may be further interactions between DNA-PKcs and full-length 
Artemis but higher-resolution details of the interactions are needed for further understanding.  
 
The screened grid was applied to data collection on the Thermo Fisher Titan Krios electron 
microscope (300kV) with a Gatan K2 detector and the movies were recorded under the 
counting mode with a magnification of 130,000 times. The pixel size used for the collection 
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was 1.07 Å. Total dose for a movie stack was 63.8 electrons/Å2 with an exposure time of 10 s. 
The defocus value series used for collection includes -1.0, -1.3, -1.6, -1.9, -2.2, -2.5, and -2.8 












Figure 44. Cryo-EM screening and data collection of DNA-PKcs/Artemis 399-426 complex. The 
left panel is an example of the screened micrographs of the grids of DNA-PKcs/Artemis 399-426 
complex. The particles of DNA-PKcs are nicely distributed across the micrograph as individual 
particles, although Artemis 399-426 peptide cannot be visualised in the micrograph directly. The 
right panel shows the parameters that were used for the final data collection. The dataset was 
collected at the cryo-EM facility of the Department of Biochemistry, University of Cambridge. 
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6.4.2 Data processing  
Various procedures for data processing for DNA-PKcs/ Artemis 399-426 were explored. As 
predicted, decreasing the flexibility of Artemis improved the resolution considerably and the 
best map achieved was at 4.2 Å resolution using the procedure shown in Figure 45. 
 
First, the 1747 micrographs finally collected were sent for motion correction and CTF 
estimation. 1670 micrographs with good CTFs were selected for subsequent particle auto-
picking. Thanks to the high density of the particles, 500180 particles were finally auto-picked 
and sent to 2D classification. After 2D classification, contamination and bad classes were 
discarded, leaving 374087 particles for later 3D classification. Those particles were separated 
into eight classes. All 3D maps were compared and the two classes with similar extra density 
compared to apo DNA-PKcs (class1 and class8). They were then combined for further 3D 
refinement and postprocessing and a cryo-EM map of DNA-PKcs/ Artemis 399-426 complex 
at a resolution of 4.9 Å was obtained, which was of better resolution compared to the 
previous cryo-EM maps. To further polish the map, Bayesian polishing, a new function of 
Relion 3.0, was used to reconstruct the map of 4.9 Å. After polishing, 3D refinement and 
postprocess were reapplied and the final map of DNA-PKcs/ Artemis 399-426 complex at a 
















Figure 45. Cryo-EM data processing procedure for the map of the DNA-PKcs/ Artemis 399-426 
complex at a resolution of 4.2 Å. 1670 micrographs were picked from the 1747 collected 
micrographs after motion correction and CTF estimation. 500180 particles were auto-picked and 
extracted from the micrographs. 2D classification was then applied to the extracted particles and 
374087 particles were selected after filtering. 3D classification for eight classes of those particles 
was able to distinguish differences. The two classes (class 1 and class 8) with similar extra 
densities were combined together to go through 3D refinement and postprocessing to achieve a 
cryo-EM map of DNA-PKcs/ Artemis 399-426 complex at the resolution of 4.9 Å. Later, Bayesian 
polishing was applied to the particles and a second round of 3D refinement and postprocessing 
on the polished particles produced a new map of DNA-PKcs/ Artemis 399-426 complex at the 
resolution of 4.2 Å. 
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6.4.3 Cryo-EM map analysis 
Generally, the map of DNA-PKcs/ Artemis 399-426 complex is more similar to that of apo 
DNA-PKcs than that of the DNA-PKcs/ Artemis complex (Figure 46A).  
 
Comparison between the maps of DNA-PKcs/ Artemis 399-426 complex and DNA-PKcs/ 
Artemis complex allowed further insights into the structure (Figure 46B). The extra density in 
the DNA-PKcs/ Artemis 399-426 map is mainly located on site C (Figure 46B site C). This extra 
density is also present in the map of DNA-PKcs/ Artemis complex, indicating that it belongs to 
the sequence of 399-426. However, the previously observed extra density in site A, which is 
likely to be part of DNA-PKcs, in the DNA-PKcs/ Artemis complex is now gone. In site B, which 
is also one of the full-length Artemis interaction sites, the extra fragmented density that is 
likely to come from Artemis C-terminal tail peptides is also absent. The similarities and 
differences of the maps indicate that the interaction modes of DNA-PKcs/ Artemis and DNA-
PKcs/ Artemis 399-426 are different. Artemis 399-426 is likely to be involved in the interaction 
of full-length Artemis and DNA-PKcs, but there should be other regions of the Artemis C-
















Figure 46. Analysis of DNA-PKcs/ Artemis 399-426 complex cryo-EM map at the resolution of 4.2 
Å. (A) Overall presentation of the map with the front view, side view and back view; (B) Comparison 
of the DNA-PKcs/ Artemis 399-426 complex map and the DNA-PKcs/ Artemis complex map. The DNA-
PKcs/ Artemis 399-426 complex map is coloured blue while the DNA-PKcs/ Artemis complex map is 
coloured green. Site A, B and C, where differences showed up between apo DNA-PKcs and DNA-
PKcs/ Artemis complex, are examined in the new map. The extra densities at site A is gone in the 
new map. As for site B, the volume of the density is smaller, more continuous and less uplifted. The 
extra density showed in site C still sits at the same place in the map of DNA-PKcs/ Artemis 399-426 
complex 
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Moreover, detailed comparison between the maps of DNA-PKcs/ Artemis 399-426 complex 
and apo DNA-PKcs reveals more about the interaction pattern and provides a better picture 
of the extra density of Artemis 399-426.  
 
Generally, the extra density of Artemis 399-426 is composed of two parts, the discontinuous 
linking region and the continuous binding region. As shown (Figure 47), there are many 
fragmented densities across the “hole” at the base of the circular cradle of DNA-PKcs. 
Although they are not continuous and it is difficult to define the sequence, there is a clear 
trend of the density linking regions of the circular cradle (residues 2080-2228) and the N-
terminal HEAT repeat (257-305). While the fragmented densities are difficult to trace, 
probably due to flexibility of some parts of the Artemis peptide, there is a continuous region 
of density sitting on the circular cradle of DNA-PKcs, interacting with two α helices (residues 
2176-2198 and 2230-2247) of the HEAT repeats. According to the cryo-EM structure of DNA-
PKcs, the exposed surface of those two helices is highly negatively charged. Furthermore, 
considering the conservation of the positively charged residues in the Artemis peptide (402-
404) and in the larger region of Artemis 399-426, and also previous studies on the importance 
of R402 to the Artemis/DNA-PKcs interaction, the N-terminal region of Artemis 399-426, 
including residue 402, is likely to be the continuous binding region. Unlike the Artemis/DNA 
Ligase IV interaction, in which the sequence of residues 485-495 within the generally 
intrinsically disordered region of Artemis undergoes concerted folding into a well-defined 
groove with regions to accommodate conserved aromatic sidechains of Artemis (Ochi et al., ), 
the interaction between Artemis and DNA-PKcs appears to be more of an unstructured 
peptide of Artemis sitting on the surface of DNA-PKcs. Based on the length of the density, 8 
residues of Artemis are likely involved. Also, E2188, E2243, E2236 of DNA-PKcs, which are 
conserved among different species down to zebrafish, are very likely to be the key acidic 

















Figure 47. Cryo-EM map of DNA-PKcs/Artemis 399-426 complex in comparison with cryo-EM 
apo-DNA-PKcs model (PDB: 5W1R). The map of DNA-PKcs/Artemis 399-426 complex is coloured 
blue and apo-DNA-PKcs model (PDB: 5W1R) is coloured grey. From the side view panel, it is 
visualised that the extra density of Artemis 399-426 is like a string going through the circular cradle 
and the empty space at the base of DNA-PKcs and get in contact with the N-terminal HEAT repeats. 
The extra densities can be separated into two parts—the binding peptide, shown in the front view 
panel, and the bridging peptide, shown in the base view panel. The region where the binding 
peptide sits is highly negative with the E2188, E2236 and E2243 of DNA-PKcs, indicating that the 
binding peptide is likely to be the positive N-terminal region of Artemis 399-426. The bridging 
peptide goes across the empty space at the base of DNA-PKcs. It is clearly shown in the base view 
panel that the bridging peptide links the N-terminal HEAT repeat helices and the circular cradle 
HEAT repeat helices and closes the empty space. 
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Interestingly, the Artemis continuous binding region (~399-407) sits on the site where the 
extra density of Ku80 interacts with DNA-PKcs, which was proposed in both crystal structure 
of DNA-PKcs in complex with Ku80 CTD and cryo-EM structure of DNA-PK. In the crystal 
structure, two helices of Ku80 CTD, proposed to be between the globular region of K80 CTD 
and the C-terminal helix (595-732), bind on the platform of four helices (2177-2198; 2230-
2247; 2267-2283; 2313-2334). In the cryo-EM structure, only one 4-turn helix can be 
accommodated in the density to interact with two helices of DNA-PKcs (2178-2197; 2231-
2248). This helix is predicted to be one of the Ku80 CTD helices of the crystal structure based 
on the length (Yin et al., 2017). Although the models proposed for Artemis and Ku80 C-
terminus differ and the sequences involved remain uncertain, Artemis C-terminal region is 
predicted in this model to compete for DNA-PKcs binding on the circular cradle. To test 
whether Artemis competes with Ku80 CTD, a serial pulldown of DNA-PKcs and Artemis 399-
426 was conducted under the low-to-high concentration gradient of Ku80ct140 (593-732), 
which contains the region proposed to have the extra density of Ku helixes on the circular 
cradle. There was no inhibition at any concentration of the Ku80CTD peptide, indicating that 
Ku80CTD on its own is not enough to stop the interaction between Artemis and DNA-PKcs 
(Figure S3). Moreover, there may be other unknown interactions within the Ku/ DNA-PKcs/ 
Artemis system and a complex that accommodates all three proteins. 
 
In general, the Artemis peptide 399-426 appears to be like a string, interacting with both the 
circular cradle and the N-terminal HEAT repeats (Figure 47). The interaction between Artemis 
and DNA-PKcs is not an interaction of an isolated single site but that of multiple sites in a 
connected way. The positive residues of Artemis around R402 interacting with the circular 
cradle HEAT repeats of DNA-PKcs are important and conserved. Moreover, the interaction 
between the C-terminal region of Artemis 399-426 (mainly Artemis 413-426) and DNA-PKcs 
N-terminal HEAT repeat further strengthens the binding. This indicates that Artemis is able to 
interact with DNA-PKcs in the presence of Ku and there may be a protein complex of higher 
magnitude. 
 
Comparison of the model/map of apo DNA-PKcs and that of DNA-PKcs in complex with 
Artemis peptide also indicates that DNA-PKcs undergoes a conformational change (Figure 47 
Base view). Although there was no evidence that Artemis has an allosteric effect on DNA-PKcs, 
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it shows that all the different domains of the DNA-PKcs molecule are connected and even 
slight changes of a small region could have allosteric effect on the whole molecule. One of 
the obvious conformational changes when Artemis C-terminal peptide interacts with DNA-
PKcs is the shrinking of the base window. As the string of Artemis holds it closer together, 
both the circular cradle and the N-terminal HEAT repeats tend to close the window—


























6.5 Cryo-EM of apo DNA-PKcs 
 
Although various groups have been working on cryo-EM of DNA-PKcs and related complexes, 
none of the published maps is at high-resolution (better than 3.5 Å) (Sharif et al., 2017; Yin et 
al., 2017; Wu et al., 2018). As a result, the modelling of the cryo-EM structures was based on 
the Blundell Group X-ray crystal structure at 4.3 Å, which used selenomethionine labelling for 
phase calculation and was a structure of DNA-PKcs bound to the C-terminus of Ku80. As there 
are various differences of the molecule between the crystal structure and cryo-EM structures, 
largely due to the nature of the complex, but also resulting from resolution and crystal packing, 
it is of great importance to define the apo-structure at higher resolution using cryo-EM. This 
may also allow ab-initio modelling to resolve some of the ambiguities in the sequence 
registration of the X-ray map, so providing firmer ground for the further study of DNA-PKcs 
related complexes.  
 
As the field of cryo-EM has been developing very fast and new methods of sample preparation, 
data collection and data processing are evolving rapidly, I have been trying various strategies 
to define the cryo-EM structure of apo-DNA-PKcs at higher resolution. During the last months 
of experiments and analysis of my PhD study, I managed to obtain a map of apo DNA-PKcs 
with the highest resolution (compared to the published ones so far) and I briefly present the 
results here, although further work is required to model the complete sequence.  
 
My apo-DNA-PKcs map has an overall resolution of 3.88 Å, with local resolution of the stable 
regions in the molecule of 3.3 Å (Figure 48). The kinase and nearby region sit in the heart of 
the “head” of the molecule and have high local resolution of around 3.3 Å. Unsurprisingly, the 
N-terminal arm has the highest flexibility and lowest local resolution. The other peripheral 
regions of the molecule also tend to be more flexible than the core region and exhibit lower 
resolution. This could be due to the biochemical properties of the hydrophilic residues on the 
interface as well as the data analysis algorithm. Therefore, sample optimisation and data 
processing optimisation may further improve the resolution. So far, the best map has been 
obtained from the recently introduced package-- cryoSPARC. Relion has also been used but, 
as yet, many other options of data processing including iterative particle polishing and multi-
body refinement have not been tested and may lead to better maps. In general, this is the 
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best map of apo DNA-PKcs so far, indicating a possibility of achieving high resolution in the 






Figure 48. Cryo-EM rediscovery of DNA-PKcs. (A) Overall presentation of the DNA-PKcs map 
with the front view, side view and back view with coloured overall resolution distribution; (B) 




Although the resolution is limited, cryo-EM studies of the DNA-PKcs/ Artemis complex, DNA-
PKcs/ Artemis/ DNA complex and DNA-PKcs/ Artemis 399-426 complex together provide 
insights for the first time of the complicated and flexible interactions between DNA-PKcs and 
Artemis: 
 
First of all, although it is difficult to register the sequence of Artemis to the map, the map of 
DNA-PKcs/ Artemis 399-426 complex at 4.2 Å reveals the interaction between DNA-PKcs and 
Artemis 399-426. Artemis 399-426 interacts mainly with the circular cradle HEAT repeats 
(DNA-PKcs 2176-2198 and 2230-2247) and HEAT repeat in the N terminal region (DNA-PKcs 
257-305). Moreover, the addition of Artemis 399-426 changes the conformation of DNA-PKcs 
molecule and partially closes the empty window at the base of the molecule as it pulls the N-
terminal HEAT repeat and the circular cradle HEAT repeat closer. 
 
Moreover, the map of DNA-PKcs/ Artemis complex demonstrates another mode of 
interaction. In addition to the density on the circular cradle HEAT repeats (DNA-PKcs 2176-
2198 and 2230-2247), there is extra fragmented density, very likely also from Artemis C-
terminal tail, at the site of the DNA-PKcs N-terminal arm. It indicates that there may be 
another previously unknown region of Artemis interacting with DNA-PKcs and moving the N-
terminal arm to a more flexible status. This interaction may also stabilise/change the 
conformation of DNA-PKcs as there is extra density around the region of 2576-2744 of DNA-
PKcs, which covers the ABCDE cluster.  
 
Furthermore, when DNA is added to the system of DNA-PKcs and Artemis, the interaction 
between DNA-PKcs and Artemis changes. The extra density on the circular cradle HEAT 
repeats and that at the N-terminal arm no longer exist. Instead, a helical protruding tail, which 
is very likely to be DNA, appears from near the N-terminal arm, revealing that DNA and the 
full-length Artemis share similar binding site on DNA-PKcs.  
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Last but not least, my very recent cryo-EM study of DNA-PKcs proves that achieving near 
atomic resolution for it and related complexes is practical and ab initio modelling of the apo 






























Chapter 7. Conclusion and Perspective 
 
NHEJ is the preferred DNA DSB-repair pathway in humans. It is a highly dynamic and open 
process in which various proteins and complexes may get involved, depending on the nature 
of the DNA damage, at different stages from DNA end recognition, DNA end synapsis and 
processing to the final DNA end ligation. Among the numerous components, DNA-PKcs and 
Artemis interactions are the central focus of my PhD project. DNA-PKcs/ Artemis is the main 
endonuclease involved in the DNA end-processing step. It is also the only endonuclease 
discovered in humans capable of cleaving DNA hairpins, which is indispensable in V(D)J 
recombination, which provides immunodiversity in antibodies and T-cell receptors. Despite 
its importance, little is known about the interaction pattern between DNA-PKcs and Artemis. 
Unlike most of the main NHEJ components with their full or major structures solved (Ku, DNA-
PKcs, XRCC4, XLF, PAXX, DNA ligase IV), no structural information of any Artemis or related 
complexes is available except for the Artemis 485-495 peptide in complex with DNA ligase IV 
catalytic domain (Ochi, Gu and Blundell, 2013). So far, published work regarding the DNA-
PKcs/ Artemis interaction mechanism has demonstrated that two residues of Artemis (L401 
R402) are important but the extent of the region of Artemis binding to DNA-PKcs remains 
unknown, not to mention the interaction region of DNA-PKcs (Soubeyrand et al., 2006). 
During my PhD, the mode of interaction between the two proteins was investigated and 
revealed for the first time. 
 
First, my research has shown that Artemis peptide (399-426), including residues of L401 and 
R402, was identified as sufficient for the interaction between DNA-PKcs and Artemis. This was 
achieved by designing different peptides covering L401 and R402 for a series of pulldown 
experiments on the basis of a bioinformatics analysis. Secondly cryo-EM of DNA-PKcs/ 
Artemis 399-426 complex further defined the interaction pattern. There are two main binding 
sites of the peptide with DNA-PKcs—one on the circular cradle HEAT repeat (2176-2198 and 
2230-2247) and the other at the HEAT repeat involving residues 257-305 in the N-terminal 
region. The peptide acts like a string, crossing the empty window at the base of DNA-PKcs to 
link the two interaction sites. The cryo-EM map also proves that the two regions around 401-
402 and 413-426 are both important for the interaction and explains why neither region is 
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able to pull down DNA-PKcs on its own. Moreover, the linkage by the peptide induces 
conformation change in DNA-PKcs, mainly contracting the size of the base window but also 
leading to other movements within the whole molecule that probably have mechanistic 
consequences. 
 
Cryo-EM work on the DNA-PKcs/ full length Artemis complex shows that further interactions 
between the two proteins may be important. In addition to the extra density shown in the 
DNA-PKcs/ Artemis 399-426 complex, there is other extra density at the N-terminal arm of 
DNA-PKcs. As the extra density, close to the FAT region, is fragmented, it may arise from the 
C-terminal tail of Artemis rather than the nuclease region. Moreover, as the density of the N-
terminal arm (especially the HEAT repeat region of 8-167) becomes less ordered, this specific 
interaction of Artemis may interfere with the docking of N-terminal arm with the circular 
cradle and may ‘open up’ the region. Besides, Ku and DNA bind to the same site based on the 
DNA-PK structure, indicating potential competition between them and Artemis. 
 
When DNA is added to DNA-PKcs/ Artemis complex, the protein-protein interaction mode 
changes. This could be caused by the competition between DNA and Artemis at the same 
binding site. Based on the map, DNA occupies the same N-terminal interaction site of DNA-
PKcs, forming a protruding “tail”. Moreover, unlike the case of DNA-PK, there was no extra 
density of Artemis nuclease region (globular region) docking around DNA-PKcs.  
 
The different interaction pattern may underlie the mechanism of the endonuclease activation. 
Indeed previous research indicated that the region around Artemis 456-458 is important for 
self-interaction and auto-inhibition of endonuclease activity (Niewolik et al., 2017). This is 
consistent with Artemis C-terminal tail interaction with DNA-PKcs inhibiting intramolecular 
interactions and reversing auto-inhibition. Considering the similar DNA-PKcs binding site 
between Artemis C-terminal tail and DNA, the endonuclease complex is likely to be activated 
in a trans fashion, meaning that the DNA molecule necessary for activation is not the one to 
be cleaved by the activated endonuclease.  
 
To know more about the endonuclease mechanism, it will be useful to solve the structure of 
the Artemis nuclease region. Previous attempts at crystallisation of the full-length molecule 
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were unsuccessful, probably due to high flexibility of low complexity regions of the tail and 
low stability of the protein. However, isolation of the nuclease region alone has not proved 
successful, indicating possible stabilising interactions between the nuclease region and the 
tail. Although Artemis is a relatively small protein, with only about half of it forming the 
nuclease region, cryo-EM may also be useful later. With the development of cryo-EM, it may 
be highly challenging but practical to study the structured region of Artemis. Recently, cryo-
EM structure of the 52 kDa streptavidin showed the potential of resolving small proteins 
under the help of Volta Phase Plate (VPP) (Fan et al., 2019). 
 
Not only the structure but also the function of DNA-PKcs/ Artemis endonuclease complex was 
investigated during my PhD, revealing the effect of other NHEJ components. Ku slowed down 
the endonuclease activity. This is consistent with the structural study as Ku interferes the 
interaction between DNA-PKcs and Artemis on both the N-terminal region and the circular 
cradle region. Surprisingly, XLF at high concentration strongly stimulates the endonuclease 
activity. XLF interacts with neither DNA-PKcs nor Artemis. Therefore, this stimulation should 
be caused by the interaction between XLF and DNA. Considering the trans activation of the 
endonuclease complex, it is likely that high-concentration XLF binds to DNA to enrich the local 
substrate concentration for the endonuclease interaction. Moreover, clinical data also show 
that there are mutations of four NHEJ component genes among patients with radiosensitivity 
and severe combined immunodeficiency (RS-SCID) including DNA-PKcs, Artemis, DNA Ligase 
IV and XLF (Woodbine, Gennery and Jeggo, 2014), suggesting that XLF likely plays a role in the 
endonuclease activity. However, when Ku is involved in the in vitro nuclease assay, the 
stimulation by XLF was inhibited. The reason could be that there was interference of the XLF-
DNA interaction due to the strong binding between Ku and DNA. Nevertheless, high-
concentration XLF/XRCC4 complex can reduce the interference of Ku and increase the 
endonuclease activity. Though the XLF/XRCC4 complex was well studied, this filament may 
have undiscovered functions in DNA-PKcs/Artemis endonuclease activity. 
 
In addition to the endonuclease complex, the interaction of Artemis with DNA ligase IV was 
studied as well during my PhD. Previous work from our group revealed the structure of DNA 
Ligase IV/ Artemis 485-495 complex (Ochi, Gu and Blundell, 2013), indicating a good site for 
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drug molecule development. Therefore, initial FBDD was carried out to assess whether good 
fragment hits could be obtained that would allow further elaboration to drug-like molecules.  
Furthermore, the temporal organisation of NHEJ was studied through collaboration with the 
Strick group in Paris during my PhD. Using novel DNA forceps in a single-molecule approach, 
we were able to track the temporal organisation of NHEJ for the first time. The full NHEJ 
process was successfully recapitulated. More importantly, we discovered the importance of 
PAXX and its role in early DNA end synapsis. Using this platform, we may be able to reveal the 
time points when other unknown NHEJ components participate in the process.  
 
With the development of cryo-EM, there are now things that can be done in addition to those 
previously envisaged. For instance, with the improvement on the methods for classification 
in data analysis, it is possible to conduct time-resolved structural studies. This can capture 
structures of transient states and enzymatic reactions, helpful in understanding many 
interaction processes within NHEJ. For example, the stepwise interactions between DNA-PKcs 
and Ku might be investigated to understand the transition from Ku80 CTD to the full Ku70/80 
complex with DNA-PKcs and DNA. Furthermore, the improvement of data analysis may 
provide us with powerful in silico purification, which may be able to distinguish previously 
unknown complexes involved in the dynamic and flexible NHEJ. Last but not least, the 
improvement of cryo-ET and site-specific cryo-Focused Ion-Beam (FIB) sample preparation 
makes in situ structural study possible, in which case we should be able to investigate how 
NHEJ develops on damaged DNA ends in cell. Altogether I am looking forward to the future 































Figure S1. Purification of catalytic domain of DNA ligase IV (DNA Ligase IV 609). (A) His-tag 
purification of DNA Ligase IV 609 using Ni-NTA; (B) HisTrap-column purification of DNA Ligase IV 
609 with gradient elution; (C) Heparin purification of DNA Ligase IV 609 using HiTrap Heparin 
column; (D) Pheyl purification of DNA Ligase IV 609 using HiTrap Phenyl column. (E) Gel-filtration 
purification of DNA Ligase IV 609 using Superdex 200 16/60 column. The numbers shown next to 
the gels are the molecular weights (kDa) of the markers. F stands for Fraction in the lane labels, 
followed by the fraction number. The red arrow indicates the final collected fraction. All SDS-PAGE 






















Figure S2. DSF profiles of fragment screening on DNA ligase IV DBD. Only the curves of positive 
















Figure S3. His-tag pulldown assay of DNA-PKcs with Artemis 399-426 and gradient Ku80 CTD 
(593-732). The triangle labelled with Ku80CTD concentration indicates the gradient of 
concentration from the low end to the high end. The gels was NuPAGE™ 4-12% Bis-Tris Protein 
Gels stained with silver staining. The numbers shown next to gel are the molecular weight (kDa) 
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